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Abstract 
 
Background  Hospital-acquired infections (HAIs) are a major cause of morbidity and mortality among hospitalised patients. The main economic burden arises from the longer hospital stays and additional treatments and healthcare services.  In addition, HAI also causes a health burden. Up to 25% of patients admitted to hospitals in some locations may acquire an HAI and the mortality rate attributable to some types of HAI could be as high as 50%. Hand hygiene amongst healthcare workers is believed to be one of the most effective measures to reduce the incidence of such infections, but compliance is often poor. A multimodal strategy has been developed by the World Health Organization consisting of five components (WHO-5): system change; training and education; observation and feedback; reminders in the hospital; and a hospital safety climate. However, evidence of effectiveness of this and other interventions intended to improve hand hygiene is still unclear. Previous systematic reviews have found too few high quality studies to draw firm conclusions about the effectiveness of such interventions in improving hand hygiene. In addition, little is known about the circumstances under which such interventions are cost-effective, particularly in resource-constrained hospital settings.  
Objectives The aim of this research is to develop and apply a framework for the economic evaluation of hand hygiene promotion interventions in resource-limited hospital settings. This study has three main objectives:  - To estimate the cost and effectiveness of documented hand hygiene promotion interventions in hospital settings in relation to levels of investment in these interventions. - To quantify life expectancy from the long-term survival of post intensive care unit (ICU) patients in a resource-limited hospital setting. 
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- To evaluate the cost-effectiveness of hand hygiene promotion as a hospital infection control strategy in resource-limited hospital settings as a function of baseline hand hygiene compliance. 
 
Methods  A systematic review with random effects network meta-analysis was performed to assess efficacy of the WHO-5 intervention and other combinations of the different intervention components. Studies implementing hand hygiene promotion amongst healthcare workers in hospital settings that met the Cochrane Effective Practice and Organisation of Care Group (EPOC) quality inclusion criteria were included. The effect size of different interventions were analysed separately for different study designs. Information on resources used for interventions was extracted in order to investigate the relationship between resource use and improvement in compliance.  In order to quantify the life years lost due to mortality attributable to HAI in ICU settings the average life expectancy was estimated from a large population of post-ICU hospitalised patients in Thailand using linked records from the local hospital database and the national death registry. Adults and paediatric patients who survived ICU stays were separately analysed.  These data were used to derive estimates of QALYs gained for each HAI-related death in the ICU prevented.  Transmission dynamic and decision analytic models were developed to simulate the dynamics of MRSA carriage in ICU patients, predict the impact of hand hygiene interventions on the number of MRSA bloodstream infection (MRSA-BSIs), and evaluate the cost-effectiveness of such interventions. Two ICU settings were considered: a 7-bed paediatric intensive care unit (PICU) and a 10-bed adult intensive care unit (adult ICU). Willingness to pay for health benefits was based on those recommended for Thailand. Epidemiological and economic parameters were derived from detailed local data from a typical tertiary hospital in North-east Thailand and literature. The maximum level of investment in the intervention at which it would still be cost-effective was 
  iii 
calculated. A series of hypothetical scenarios with different transmissibility and prevalence of MRSA colonization at admission was also considered. 
 
Results  Meta-analysis of two randomised controlled trials showed the addition of goal-setting to WHO-5 was associated with improved compliance (pooled odds ratio [OR]=1.39, (95% CI: 1.15, 1.67); I2 = 80.0%). Network meta-analysis from 13 interrupted time series studies indicated considerable uncertainty in the relative efficacy of interventions, but nonetheless provided evidence that WHO-5 is effective. In addition, there was evidence that further improvement in hand hygiene compliance could be achieved by adding interventions including goal-setting, reward incentives and accountability. It was not possible to reach firm conclusions about the relationship between resources used and compliance improvement due to lack of reporting of resource use data.  Of 7,070 adults and 1,935 paediatric patients discharged alive from ICUs in the hospital, the mean life expectancy was estimated as 18.3 years and 43.8 years (unpublished data) in post-ICU adult and paediatric populations respectively.   In the cost-effectiveness analysis, under base case assumptions (pre-intervention hand hygiene compliance 10%), a WHO-5 intervention was found to be cost-effective when compared with the standard practice in both PICU and adult ICU settings solely as a result of MRSA-BSI prevented. In the base case, when hand hygiene compliance increased to 40% as a result of the intervention, the total costs per year were $US 623.73 with 1.04 QALYs gained and $US 633.41 with 1.47 QALYs in the PICU and adult ICU, respectively. However, if baseline compliance was assumed to be 40% in both wards, to be cost-effective the intervention would need to have impacts on other infections in addition to MRSA-BSI.  In hypothetical scenarios analyses, for a typical situation in low-middle income-countries where the transmissibility is moderate, prevalence of MRSA colonization at admission is five percent, if baseline compliance is not greater 
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than 20% the intervention is always cost-effective even with only a 10% compliance improvement. When the baseline compliance is not greater than 20%, the intervention will always be cost-effective if the intervention cost per year is less than $US 1,557 in the PICU and $US 888 in the adult ICU providing the intervention increases compliance by 10% or more. 
 
Conclusions  The WHO-5 multimodal hand hygiene intervention is effective at increasing hand hygiene compliance in healthcare workers. There is evidence that adding goal-setting, reward incentives and accountability strategies can lead to greater improvements.  The WHO-5 intervention is also likely to be cost-effective in ICU settings in typical middle-income countries where baseline compliance is low solely as a result of reduced incidence of MRSA-BSI.  Where baseline compliance is already moderate or high, the cost-effectiveness of interventions to improve it further will depend on the impact on HAIs other than MRSA-BSI. Further work is required to estimate these. 
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Chapter 1: Introduction  
 
1.1 Background 
 1.1.1 Healthcare associated infections (HAIs)  More than 1.4 million patients around the world suffer from healthcare associated infections (HAIs) at any point in time.[1] HAI causes not only morbidity but is also associated with increased mortality.[2, 3] In general, the burden of HAI in low and middle-income countries is higher than developed countries.[4] Recently, a systematic review and meta-analysis estimated the pooled prevalence of HAI in developing countries to be 15.5 per 100 patients, which is much higher than those reported from Europe and USA, which were 4.5 and 7.1 per 100 patients, respectively.[5] The difference between these settings is much higher in intensive care units (ICU).[5, 6] In Thailand, the point prevalence of nation-wide nosocomial infection has been estimated to be about 6.5% and it has been estimated that 250,000 patients have an HAI each year.[7]   Several studies have shown such infections also represent a large economic burden to health care systems.[8, 9] Patients suffering from HAI are likely to have slower recoveries and to require longer hospital stays while additional antibiotics and supplemental material and services for additional stay at hospital are required.[2, 8, 10] HAIs not only cause additional costs due to the extra health care services but also impose a large health burden amongst the hospitalized patients particularly due to increased mortality. For quantifying appropriate levels of investment in interventions to reduce the burden of HAI it is important to have accurate measurement of both economic and health burdens. However, studies using appropriate methodology to estimate costs due to HAI and to quantify life years lost due to HAI mortality are lacking from resource-limited settings.[11]    
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1.1.2 Interventions  A report by the WHO in 2008 concluded that identifying effective interventions to prevent HAIs in developing countries was a major health priority.[4, 12] Several infection control interventions are routinely used in high income countries and there are varying degrees of evidence in support of these. Such interventions include use of topical antiseptics, patient isolation using barrier precautions (gloves and gowns), and targeted interventions (such as decolonisation or isolation) for those screening positive for target organisms.[13-16] Some of these may have very high resource implications especially those requiring screening, therefore, they might not be appropriate outside high income settings.    However, hand hygiene promotion is considered as an essential infection control intervention. The advantages of hand hygiene promotion are that it is a simple intervention, which is relatively easy to implement, and requires only limited investment. Therefore, this approach is especially appropriate where resources are very limited.   
Hand hygiene promotion  Direct patient contact with health-care workers (HCWs) who are transiently contaminated with nosocomial pathogens is believed to be the primary route of transmission for many nosocomial pathogens and can lead to patients becoming either colonized or infected. Improving health-care	   workers’	   hand	   hygiene	  compliance can minimize the impact of this transmission route and can potentially prevent hospitalised patients from acquiring nosocomial infection.[17-19] Although hand hygiene is widely thought to be the most important activity for the prevention of nosocomial infections, [20-23] a review of hand hygiene studies by the World Health Organization (WHO) found that baseline hand hygiene compliance among HCWs varied widely ranging from below 10% to almost 90%.[24]   In 2005, the WHO World Alliance for Patient Safety launched a campaign, the 
First	   Global	   Patient	   Safety	   Challenge,	   “Clean	   Care	   is	   Safer	   Care”	   aiming	   to	  improve hand hygiene in healthcare.[24] This campaign promotes a multimodal 
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strategy (WHO-5) consisting of five components: system change; training and education; observation and feedback; reminders in the hospital; and a hospital safety climate. Details of each component are shown in Table 1.1. However, previous evaluations of the evidence for the efficacy of different hand hygiene interventions have several important limitations. First of all, most evaluations of hand hygiene promotion interventions use non-randomized study designs, and in many cases the reported analysis is inappropriate or methodological quality is too low to allow meaningful conclusions to be drawn.[25-27] Next, there is wide variation between studies in the hand-hygiene promotion activities used in both implementation and comparison groups. Finally, direct head-to-head comparisons of most interventions are lacking.[28] In addition, previous systematic review studies were also unable to draw	   firm	   conclusions	   on	   the	  
effectiveness	   of	   such	   interventions.[25-28] However, recently, United Kingdom and Australia have introduced national hand hygiene campaigns. These two campaigns have been associated with substantial reduction in HAI rates, especially for drug resistant organisms.[20, 23] In addition, the national campaign in Germany reported the an improvement in hand hygiene compliance.[29] The promising conclusion from these observational studies may help convince other settings to consider implementing similar campaign especially in resource-limited settings. [30]  
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Table 1.1: Description of hand hygiene intervention components. 
   
Type of Hand hygiene 
intervention component Description 
    




Ensuring necessary infrastructure is available including a) access 
to water, soap and towels and b) alcohol-based handrub at the 
point of care.                                




Providing training or educational programme on the importance 
of hand hygiene and the correct procedures for hand hygiene, 





Monitoring hand hygiene practices among healthcare workers 
while providing the compliance feedback to staff. 
 





Prompting healthcare workers either through printed material, 
verbal reminders, electronic communications or other methods, 
to remind them about the importance of hand hygiene and the 
appropriate indications and procedures.  
 
5. Institutional safety climate 
 
 
Active participation at institutional level, creating an 
environment allowing prioritization of hand hygiene. 
     1.1.3 Policy decision-making for an infection control program in resource-limited settings  Healthcare decision-makers are often faced with the situation where they need to choose whether to adopt a new intervention or carry on with current practice. Because healthcare resources are limited, they need to assess not only the effectiveness of such an intervention but also the associated costs of the new program. Economic evaluation aims to promote efficiency in resource allocation by maximizing the benefits.[31] This framework has an increasing role in prioritising healthcare funding for new interventions.[32-35]  One outcome representing health benefits obtained from a particular intervention commonly used in economic analysis is the number of quality adjusted life years (QALYs) gained by the intervention. This is the number of life years gained where each life year gained is weighted by a health-related quality of life measure. The health-related quality of life weighting values range from zero (equivalent to death) to one (equivalent to full health). QALYs are 
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recommended for health technology assessment in several countries including Thailand.[32-35] QALYs gained by interventions that reduce hospital mortality can be quantified by estimating the number of life years lost (adjusted with quality of life weights) due to early death in the hospital setting. If patients discharged from hospital have full health the QALYs gained per hospital death averted is simply the life expectancy following hospital discharge.  More realistically, not all patients discharged from the hospital will have full health and the QALYs gained by preventing a hospital death must be adjusted downwards to account for quality of life weighting values below one.  Mathematical and decision analytic models are valuable tools for such economic evaluations: they aim to simplify complex clinical situations while describing the key features of a system. They allow us to combine evidence of effectiveness and associated costs in the same analysis and perform hypothetical scenario analyses, where we use the model to describe expected health and economic consequences of different decisions.[36, 37] For infectious disease studies, transmission dynamic models are particularly useful tools to help understand the likely impact of interventions. They are particularly useful when trials are difficult to conduct or when we wish to generalize the results of trials to different settings.[37] Moreover, their use in health-economic evaluations of interventions that reduce transmission is essential to fully capture the intervention benefits.[38] While several studies have used dynamic models to consider hospital infections,[39] economic studies of hand hygiene interventions have used only static models and neglected developing countries where the need for appropriate investment is most.[40-43]  Given limited information concerning the value for money of hand hygiene interventions in resource-limited hospital settings, health economic evidence about the intervention will not only aid local hospital decision-makers, but should also, at a national level, provide crucial guidance to ensure appropriate levels of investment in future national hand hygiene campaigns.  
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1.2 Research aims  This research aims to provide relevant information for policy makers regarding investments in hand hygiene improvement programmes to prevent HAIs in resource-limited hospital settings using a case study of such an intervention in a hospital in northeast Thailand and generalized to other similar settings.  A rational economic framework is used to determine under what circumstances investing in hand hygiene promotion as part of an infection control programme is likely to cost-effective in resource-limited hospital settings. This framework combines three main components (research objectives 1-3 below).   
 
Research objectives 
 1. To estimate the cost and effectiveness of documented hand hygiene promotion interventions in hospital settings in relation to levels of investment in these interventions.   2. To quantify life expectancy from the long-term survival of post-ICU patients in a resource-limited hospital setting. This information is needed to quantify the health benefits (in terms of life years gained and quality-adjusted life year gained) resulting from the hand hygiene intervention.  3. To evaluate the cost-effectiveness of hand hygiene promotion as a hospital infection control strategy in resource-limited hospital settings as a function of baseline hand hygiene compliance using a model-based approach. 
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1.3 Contribution of thesis   This thesis addresses an important knowledge gap regarding the value for money of hand hygiene interventions in developing countries.[40-43] It employs economic, mathematical, and statistical modelling approaches to evaluate an infection control strategy in a resource-limited hospital setting. It is anticipated that the findings from this research will help guide policy-makers tasked with making decision about appropriate levels of investment in hospital hand hygiene campaigns at the local and the national level, both in Thailand and other similar settings.   
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 Luangasanatip N, Hongsuwan M, Limmathurotsakul D, Lubell Y, Lee AS, Harbarth S, Day NP, Graves N, Cooper BS. Comparative efficacy of hospital hand hygiene promotion interventions: a systematic review and network meta-analysis. BMJ. 2015;351:h3728.  Luangasanatip N, Hongsuwan M, Lubell Y, Limmathurotsakul D, Teparrukkul P, Chaowarat S, Day NP, Graves N, Cooper BS. Long-term survival after intensive care unit discharge in Thailand: a retrospective study. Crit Care. 2013 Oct 3;17(5):R219.  Luangasanatip N, Hongsuwan M, Lubell Y, Limmathurotsakul D, Srisamang P, Day NP, Graves N, Cooper BS. Cost-effectiveness of hand hygiene promotion for MRSA bloodstream infection in ICU settings. Under review: Lancet Global Health 
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1.4 Outline of thesis  
 This thesis is in	  “thesis by publication” format, which consists of three papers: Systematic Review, Results Paper 1, and Results Paper 2.  Each paper was written for a particular journal. Therefore, repetitiveness in their introductions, methods, and discussions may be unavoidable. This introduction (Chapter 1) provides a brief overview of this thesis. The remaining chapters are arranged as follows:  Chapter 2 is a review of the current literature on healthcare associated infection, hand hygiene promotion policies and economic evaluation to explore and summarise existing knowledge.  Chapter 3 is a systematic review paper quantifying the efficacy of different hand 
hygiene	   strategies:	   “Comparative	   efficacy of hospital hand hygiene promotion interventions: a systematic review and network meta-analysis.” Information of the effectiveness of hand hygiene interventions in improving the hand hygiene compliance obtained from this review is a key input of the model-based economic analysis in Chapter 5.  Chapter 4 is results paper 1: “Long	   term	   survival after intensive care unit 
discharge	  in	  Thailand:	  a	  retrospective	  study.” This estimates the life expectancy amongst patients discharged alive from hospital. This information is needed to quantify the health benefits of infection control interventions that prevent unnecessary deaths during hospital stays. The life expectancy adjusted with quality of life is used in the economic analysis in Chapter 5.  Chapter 5 is results paper 2: “Cost-effectiveness of hand hygiene promotion for MRSA bloodstream infection	  in	  ICU	  settings.” Model-based economic analysis is performed incorporating the information from Chapter 4 and 5 as well as other local data.   
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Chapter 6 provides general discussion and summarises findings from these various publications. Generalisability, strengths and limitations of this research, and recommendations for future research directions are considered.  
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Chapter 2: Literature Review  In section 2.1, the literature related to healthcare associated infections is reviewed and appropriate definitions provided for different types of HAI.   In section 2.2 and 2.3, literature concerning the epidemiology and economic burden due to HAIs in high income and low-middle income countries including Thailand is summarised. Infection control programmes to prevent HAIs including hand hygiene promotion and the evidence of their effectiveness are reviewed in section 2.4.  In section 2.5, methods for conducting economic evaluation are discussed. Finally, in section 2.6, a review of existing economic analyses of hand hygiene promotion is performed. 
 
2.1 Healthcare-Associated Infection  Healthcare associated infection (HAI) is a major healthcare problem worldwide in both developed and developing countries and represents one of the leading causes of death and increased morbidity among hospitalised patients.[44] By convention, infections with nosocomial pathogens at least 48 hours after hospital admission are classified as HAI or nosocomial infection[45] The risk of such nosocomial infection depends on factors including age, degree of cross contamination, immunocompromised condition, and antibiotic pressure. HAIs can be caused by pathogens including bacteria, viruses, fungi, and macroparasites. However, the most common HAIs are bacterial infections. Patients may have HAI caused by organisms carried asymptomatically on their body sites (endogenous flora). Such colonising organisms may become invasive only under appropriate conditions, which allow them to penetrate to normally sterile sites. Patient contact with healthcare workers, other patients or exposure 
to	   contaminated	   instruments,	   devices	   or	   patients’	   surroundings,	   are	   possible	  routes of transmission of HAI due to exogenous flora.   
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HAIs produce unfavourable impacts at both the individual level and to healthcare systems. Patients suffering from HAI are likely to have slower recoveries and to require longer hospital stays. Moreover, additional treatments with antibiotic drugs and special care services are needed to support these patients. In severe infections, especially with bacteraemia, the mortality rate attributable to HAI could be as high as 50%.[3, 46] From	  the	  healthcare	  provider’s	  perspective, the cost of antibiotic drug treatments, supplemental materials and services for additional stay at hospitals[2, 8, 10] affect the overall healthcare budget. This expense can be dramatically increased if the incidence of antimicrobial resistant HAI is high due to the need for new expensive antibiotic treatment.[47] Moreover, the impact of HAI also affects bed occupancy. The longer hospitalization of patients with HAI causes longer waits for other patients accessing medical services.   The identification and classification of HAI cases requires criteria combining clinical outcomes and laboratory confirmation. Some of the most widely used guidelines come from Centers for Disease Control and Prevention (CDC).[6] HAIs can be classified depending on the different sites of infection and also according to the types of medical	   device	   they	   are	   associated	  with.	   The	   CDC’s	   guidelines classify HAIs as bloodstream infections (BSI), urinary tract infections (UTI), respiratory tract infections (RTI), surgical site infections (SSI), skin and soft tissue infections, central nervous system infections, infections of eye and conjunctiva and others. HAIs are also classified as device-associated and non device-associated infections. The device-associated HAIs include central line-associated bloodstream infection (CLABSI), catheter-related urinary tract infection (CAUTI) and ventilator-associated pneumonia (VAP). 
 
2.2 Incidence and Prevalence of HAI  
High-income countries  Prevalence and incidence of HAI vary worldwide depending on the healthcare system and facility. The burden of HAIs in resource-rich settings or developed countries is relatively low compared to developing countries.[48] Evidence from 
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USA and Europe is representative for the situation in industrialized countries. The incidence rate of HAI in the US was estimated as 4.5 per 100 admissions in 2002, or about 9.3 infections per 1000 patient-days.[6] An annual report from the European Centre of Disease Prevention and Control (ECDC)[49] reported  that the overall prevalence of HAI varied between 3.5% (525 of 14,996 patients) and 10.5% (604 of 5,750 patients) across industrialised countries, and was about 7.1% on average. In addition, the prevalence of HAI is higher in intensive care units (ICUs). One multi-center point prevalence study in Europe reported that on the date of study, the proportion of patients in ICU with an HAI could be in excess of 50% (7,087 of 13,796 patients).[50] Moreover, large-scale studies in the US show that the incidence density of HAI in ICU ranged from 13.0 to 19.8 events per 1,000 patient-days.[6, 51, 52] Of note, most of these are associated with the use of invasive devices including catheters and ventilators. In general, the most common type of HAI in both US and Europe is UTI, which accounts for about 36% and 27% of all HAIs, respectively.[6, 49] In the US, the second most frequent type of HAI is SSI (20%) followed by BSI and Pneumonia (overall 11%)[6] while in the EU RTI (24%) is the second most frequent and then SSI (17%) and BSI (10%).[49]  
Low and middle-income countries  In developing countries, where resources are more limited, the risk of infection has been reported to be 2 to 20 times higher than in developed countries, and the proportion of infected patients can exceed 25 percent of patients admitted to acute care hospitals.[24, 53] A recent systematic review by Allegranzi et al.[48] showed that hospital-wide prevalence of HAI combined from 22 studies in developing countries was 15.5 per 100 patients, varying from 5.7 to 19.1%. The pooled HAI density in ICUs was 47.9 per 1000 patient-days, approximately three fold higher than the number reported from the US. Moreover, a six-year study by Rosenthal et al.[3] reported that the mean prevalence and incidence of device-associated HAI in 173 ICUs in 25 countries, mostly from low and middle income countries, were 15.5 per 100 patients and 34.2 per 1000 patient-days. Overall, SSI was the most frequent type of HAI in developing countries 
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(accounting for 29.1% of all HAI) followed by UTI, BSI, and hospital acquired pneumonia (HAP) (23.9%, 19.1 and 14.8% respectively).[48] 
 
Thailand  In Thailand, national surveillance of nosocomial infection studies has been studied since 1988.[7, 54, 55] The trend of the prevalence is apparently decreasing. The latest surveillance study in 2006 collected data from 20 hospitals representing all sizes of hospital in Thailand, and used a 2-week period prevalence study. It showed that the overall prevalence of nation-wide nosocomial infection was about 6.5%,[7] with a tendency to be higher in university hospitals (7.6%), and slightly lower in provincial and regional hospitals, 6.5% and 4.9% respectively. This study found that the most common HAI was lower RTI followed by UTI and SSI, 36.1%, 25.5%, and 11% respectively. The highest prevalence rate was in ICUs, where about 23% of patients develop an HAI while the prevalence at other wards ranged from 1.1 to 6.8%. More than half of HAI cases were potentially related to device-associate infections. The commonest organisms causing HAIs were Gram-negative bacteria, accounting for about 75.7% of infections, including Pseudomonas 
aeruginosa, Klebsiella spp., Acinetobacter baumanni, and Escherichea coli. HAI caused by Gram-positive bacteria accounted for 18.4% of infections. Most of these were S. aureus, of which two thirds were methicillin-resistant S. aureus (MRSA).[7] However, it is possible that these figures represent a substantial underestimate due to underdiagnosis of hospital infections. The total annual number of HAI cases was estimated to be about 390,000 assuming that 6 million people are admitted to hospital each year in Thailand.[56] The total number of deaths due to HAI was estimated to be 26,000 per year, assuming a mortality rate attributable to HAI of 6.7%.[55]  
 
2.3 Economic burden of HAI  HAIs impose significant economic consequences on the healthcare system worldwide. The major costs derive from the longer stay in the hospital and also more care and treatments.[2, 8, 57] Moreover, patients with HAI are more difficult 
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to treat when they have multiply drug resistant infections.[47] This has the potential to result in higher costs of treatment (due to more expensive antibiotics) and therefore this will affect the national healthcare expenditure.  The economic burden of HAI is believed to be high even in developed countries. Based on prevalence data from six European countries and the number of hospital admissions among 27 European countries, and taking estimates of attributable mortality due to HAI from the US CDC, HAIs have been estimated to cause 16 million extra days of hospitalisation and 37,000 attributable deaths yearly in 2008, in Europe.[49] In addition, accounting for only direct costs, HAI cost about 7 billion Euros per year.[49] However, in the US, there were 99,000 deaths attributable to HAI in 2002 and more than half of these cases were due to pneumonia and BSI.[6] The economic burden of HAI was estimated to be as high as $US 6.5 billion in 2004.[6] The cost per case of HAI has also been estimated. In the US, Stone et al.[58] estimated the cost per infection of HAI ranged from $US 1,006 for CAUTI to $US 36,441 for CLABSI. Another cost estimation study conducted in the UK by Plowman et al.[59] used a linear regression model to estimate that on average (considering all types of HAI) patients with HAI incurred hospital costs 2.9 times higher than uninfected patients, an additional £3,154 in 1995 (range from £1618 to £9,152 per case). However, the costs of HAI also varied depending on the types and number of sites of infection.  The estimated economic impacts in developing countries have a wide range and different methods have been used for the estimates. For example, the cost due to hospital acquired BSIs in India was estimated in 2009 to be $US 14,818 per case[60] from a 200-bedded private tertiary care cardiac hospital in New Delhi  while in another study in the same country estimating the cost of antibiotics alone for MRSA-HAI case from a medical ICU in a 2,600-bed tertiary care hospital in Vellore, the median cost was $US 124 per case (while comparatively low, this is still enough to render effective antibiotic treatment unaffordable by a significant proportion of the Indian population, very few of whom have medical insurance).[61] The average additional cost of central-line related bloodstream infection (CRBSI) and hospital acquired pneumonia (HAP) in ICUs 
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were estimated as $US 4,888 per event in Argentina, in 2005 prices.[57] In Malaysia, the cost of antibiotics for treating HAI was estimated to be $US 521,000 per year in an 800-bed tertiary hospital.[62] In Thailand, the cost of antibiotics for treating a single HAI was estimated using a matched case-control in the year 2001 to range from 6,000 to 16,000 baht ($US 200-500), depending on the number of infected sites.[55]  A systematic review by Stone et al.[63, 64] revealed that there is a wide range in estimated costs of HAI. Several statistical methods have been used to estimate these costs including regression models, multiple matched comparisons, and case review.[65-67] Costs of HAI have two components:  the excess length of stay (LOS) i.e. the additional time spent at hospital that would not have been spent had the patient avoided the infection, and the cost per infected bed day, i.e. the costs of the extra resources used for treating the resulting HAI (such as antibiotics).  
 In most cases, in high income countries, most of the excess costs result from the excess length of stay (LOS), as antibiotic and other pharmaceutical costs are usually a small proportion of these.[68] Estimating the excess LOS with commonly used statistical approaches is subject to time dependent bias. This bias can arise from the fact that the analysis erroneously treats the infection as present at baseline. While an HAI probably usually does increase the length of stay (though in some cases increased associated mortality can actually decrease length of stay), a longer stay will certainly increase the risk of HAI and failure to account for this will lead to over-estimation of the increase in length of stay due to infection.[69, 70] As a result of this bias, two group comparisons, matched cohort studies, and matched cohort with matching on time of infection all tend to overestimate this additional LOS due to HAI.[71] More appropriate statistical approaches accounting for the time-varying exposure that HAI represents should be used instead. 
 In addition, the value of bed-days used in most of the previous studies was estimated based on the accounting approach using the hospital budget divided by the total patient bed-days over the same period.[63-67] As this accounting cost 
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is fixed and dependent on budget decisions that have already been made, this would not reflect the opportunity cost of the occupied bed to be used.[11] A health economist would focus on the extra beds and other resources released and variable costs saved when implementing an infection control program. This would support the decision-making process when considering investment in a new infection control program to free up beds. Willingness to pay for accessing this bed-day released would reflect the value of opportunity cost. However, for a centralized healthcare system, this cost of a blocked bed should be valued by hospital management.[11] The value of a bed day based on a willingness to pay approach is generally much lower and could be only one third of the value derived using the accounting approach.[72] Using this willingness to pay approach therefore tends to reduce the estimated economic burden of extra stay due to HAI.  Both shortcomings in the literature tend to exaggerate the burden of HAIs[11] and could cause healthcare decision makers to make inappropriate budget allocations. More accurate estimation is required to support decision makers to evaluate the potential benefits of infection control interventions as a building block of cost-effectiveness analysis of infection control programmes. A few studies overcoming the problems associated with previous methods have recently been published.[10, 73, 74]  
 
2.4 Infection control programmes 
 
2.4.1 Hand hygiene promotion interventions  Direct patient contact with healthcare staff who are transiently contaminated with nosocomial pathogens is believed to be the primary route of transmission for several nosocomial pathogens and can lead to patients becoming either 
colonised	   or	   infected.	   Improving	   the	   healthcare	   team’s	   hand	   hygiene	  compliance can reduce the impact of this transmission route.[75-77]   The first obvious evidence of effectiveness of hand hygiene intervention was in 1847. Ignaz Philip Semmelweis, a Hungarian physician, noticed a high maternal 
  18 
mortality rate from one of the two obstetric clinics in a general hospital in Vienna. He investigated the different factors between those settings and found that in the first clinic (with the high mortality rate), medical students attended straight from autopsy class to the delivery suite while at the other clinic midwifery students were the main staff and had no involvement with the necropsy. As he believed that the infecting particles were from the corpse and transmitted by hands, chlorinated lime as disinfection agent was introduced for those leaving the necropsy room. After this intervention the mortality declined to be comparable with the other clinic over four years (11% to 1%).[78] This is one of the earliest pieces of evidence that reveal clear benefits of hand disinfection.  Later, in 1994, a landmark study was conducted in Geneva. Pittet et al. rigorously promoted a hospital-wide campaign in the University of Geneva Hospitals, Switzerland.[79] They integrated multi-component interventions including improving hand hygiene facilities, providing individual containers of alchohol hand rub solution at all beds, using visual reminders through the display of 70 different colour posters, giving performance feedback, initiating regular meetings amongst multidisciplinary groups of healthcare workers (HCWs), and obtaining strong institutional endorsement as a package of interventions. They found an improvement in compliance from 48% to 66%, reduction in prevalence of nosocomial infection from 16.9% to 9.9%, and reduction in MRSA transmission rate from 2.16 to 0.93 episodes per 10,000 patient-days over the three years study period. These findings highlighted the importance of a multi-component hand hygiene intervention that could 
successfully	   improve	   HCWs’	   hand	   hygiene	   compliance	   and,	   therefore,	   reduce	  nosocomial infections.  Although hand hygiene is widely thought to be the most important activity for the prevention of nosocomial infections, many observational studies demonstrate poor adherence by HCWs. A review of hand hygiene studies by the WHO including both developed and developing countries [80] found that the baseline hand hygiene compliance among HCWs varied between 5% and 89%, and was on average about 38.7%. There was evidence that recorded compliance 
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varied with workload, the ward type and observation methods. Factors commonly associated with poor hand hygiene adherence include being physicians and nurse assistants, staff workload, and use of gloves.[81-83] For physicians, adherence has been reported to be associated with awareness of being observed, the belief of being a role model for other colleagues, a positive attitude toward hand hygiene after patient contact, and easy access to a hand-rub solution. 
 
2.4.1.1 WHO hand hygiene campaign  The	  WHO	  World	  Alliance	   for	  Patient	  Safety	  has	  been	  trying	  to	   improve	  HCWs’	  hand hygiene by launching a campaign, the First Global Patient Safety Challenge, 
“Clean	   Care	   is	   Safer	   Care”,	   aimed	   to	   reduce	   HAI	   worldwide	   by	   increasing	  awareness of HAI globally, encouraging	  countries’	  commitment	  to	  keep	  working	  on this field, and trying to implement basic infection control programmes at local hospitals worldwide. Hand hygiene improvement plays a major role in this campaign. A multimodal approach with five moments for hand hygiene has been recommended in the WHO guidelines on hand hygiene in healthcare. These guidelines aim to encourage good hand hygiene practice in the real world in both developed and developing countries and are designed to be readily adapted to local settings depending on the available resources at each setting. The multimodal implementation strategy consists of five components (WHO-5), which are system change, training and education, observation and feedback among healthcare workers, reminders in the hospital, and a hospital safety climate. The guidelines also emphasise the importance of increasing the use of alcohol hand rub, which is considered as the preferred practice in most circumstances and a crucial factor for improving hand hygiene.[79, 84] The alcohol hand rub is preferred because, in most cases, it is more effective at decontaminating hands than soap.[80] Several studies have reported that introduction of alcohol hand rub as part of a multimodal strategy can decrease the HAI rate.[85]   
2.4.1.2 National hand hygiene campaigns 
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Several countries (mostly high-income countries) have implemented similar multimodal interventions as a national hand hygiene campaign.[20, 21, 23, 29, 86, 87] A few of these have reported their findings.  In 2004, a nationwide hand hygiene promotion intervention consisting of providing alcohol hand rub at the bed-side, displaying hand hygiene promotion materials and regular audits in order to enhance hand hygiene compliance and reduce HAI across England and Wales hospital was implemented.[20] This was evaluated in a four-year interrupted time series study which showed that the MRSA bacteraemia rate fell from 1.88 to 0.91 cases per 10,000 bed days while 
Clostridium difficile infections fell from 16.75 to 9.49 cases per 10,000 bed days The procurement of soap and alcohol hand rub per patient bed day, an indirect measurement of hand hygiene compliance, increased almost 300%. Results from regression analysis also showed that an additional use of 1 mL of soap per bed day was associated with a 0.7% reduction in Clostridium difficile infection and a 1% reduction in MRSA bacteraemia.   
In	  2009,	  a	  national	  hand	  hygiene	  programme	  based	  on	   the	  WHO’s	  5	  moments	  campaign was introduced in Australia[21] and produced similar results. The overall hand hygiene compliance increased from 43.6% to 67.8% among 521 hospitals and the mean annual rate of MRSA bacteraemia declined significantly (P=0.008) from 0.50 per 10,000 patient-days in 2008 to 0.39 and 0.35 per in 2009 and 2010, respectively. Later, more sophisticated analysis after four years of the program found similar results.[23] With segmented regression analysis, they found four of the six states showed a reduction in the infection rate; two states had an immediate reduction of 17 and 28% and another two showed a linear decreasing trend of 8% and 11% per year. However, the other two states found no change in infection rates.  In Germany, the nationwide WHO-5 intervention was implemented in 2010. The overall baseline compliance was reported as 61% from 163 hospitals. They found average compliance from 62 observed hospitals increased by 11% after the intervention. However, there was no reporting of HAIs outcomes.[29]  
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2.4.1.3 Hand hygiene interventions in resource-limited settings  There are no reports from studies evaluating national hand hygiene campaigns in low- or middle-income countries. However, some hospital-based studies promoting both WHO-5 and other hand hygiene strategies have been conducted in developing country settings. Key studies are considered below.  Allergranzi et al. described the implementation of a hospital-wide WHO-5 campaign in a 456-bed university hospital in Mali.[88] They found the overall compliance in HCWs from 13 hospital wards increased from 8.0% (95% CI: 6.8-9.3%) to 21.8% (95% CI: 19.9-24.0%) (P<0.001) and the overall HAI reduced from 18.7% (95% CI: 12.5-26.3%) to 15.3% (95% CI: 9.8-22.3%) (P=0.453).  Rosenthal et al.[57] conducted an intervention study at two ICUs in a hospital in Argentina. This study found that hand hygiene promotion was followed by an improvement in hand hygiene compliance from 23.1% to 64.5% and there was also an associated decrease in overall nosocomial infections (including pneumonia, bacteraemia, and urinary tract infection, both device and non device associated) in both ICUs from a combined total of 47.55 per 1000 patient-days to 27.93 per 1000 patient-days (P<0.0001).   Another study conducted at two neonatal intensive care units (NICUs) in Manila, Philippines[89] evaluated an intervention including hand hygiene promotion and reported a reduction in the overall mortality rate. Hand hygiene compliance was significantly improved and the overall mortality rate decreased by 12% from one ward and 15% from another ward. However, activities including the use of checklists, staff education, and alcohol-based hand rub introduction were also implemented during the intervention period.   In summary, a number of studies have reported findings from both national hand hygiene campaigns and campaigns in local hospital settings. These studies showed evidence that interventions improved the compliance, potentially reducing HAIs, especially for multiple drug resistant organisms including MRSA.[20, 23] However, the results from these studies should be interpreted with caution as almost all of the intervention studies in the literature are performed 
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with quasi-experimental study designs and are vulnerable to a number of biases.  
2.4.1.4 Effectiveness of hand hygiene intervention  Previous systematic reviews of hand hygiene interventions in healthcare settings have important limitations.[25-28] One of these, a Cochrane Collaboration review, found very few studies of sufficient methodological quality to reliably evaluate hand hygiene promotion interventions and was unable to reach firm conclusions.[25] The other three reviews, which included studies of much lower methodological quality, pointed out the potential effect of a multimodal approach,[27] reported associations between two specific bundles of interventions and improved hand hygiene[28] and addressed the correlation between the increase in the compliance and the number of determinants of behavior change in hand hygiene strategies.[26] However, because of methodological shortcomings of the included studies, most of which do not meet minimal inclusion criteria of Cochrane Effective Practice and Organisation of Care Group (EPOC), a causal association cannot be reliably inferred. [90, 91] Further limitations include the fact that most interventions were compared 
with	   an	   unspecified	   “standard	   care”	   baseline,	   and	   direct	   head-to-head comparisons of interventions were lacking. Moreover, the authors highlighted the lack of information on relative effectiveness of different components of hand hygiene promotion interventions.[25-28]  
 
2.4.2 Other infection control strategies   Apart from hand hygiene promotion, several other infection control strategies such as quality care bundles including checklists, ward cleaning, screening and decolonization and others have been reported to be effective in preventing hospital-acquired infections. Some of these infection control interventions are briefly reviewed below.  
  23 
Care bundles practice 
 
A	  “care	  bundle”	   refers	   to	   the	   combination	  of	   several	   interventions	  which	  may	  include hand hygiene promotion, use of checklists, staff education, performance monitoring and feedback, standard and enhanced precautions.[13] Such bundles have been implemented worldwide.[76, 89, 92] One study of such a care bundle with a quasi-experimental design was conducted in Thailand[93] and aimed to evaluate the effectiveness of catheter-associated bloodstream infection (CA-BSI) prevention bundle. This bundle consisted of hospital-wide education in hand hygiene practice, education on the use of maximum sterile barrier precautions during catheter insertion, use of a chlorhexidine-based skin preparation, optimisation of central venous catheter (CVC) insertion practices, and daily review of the need for CVC in each patient. The results showed a substantial reduction of CA-BSI rate from 14 cases to 6.4 cases per 1,000 catheter day and improvement in hand hygiene compliance, from 8% to 24% and 54% during the intensive hand hygiene promotion. Another healthcare bundle was reported by Gill et al.[89] It was associated with a decline of overall mortality rate of about 50%. However, the individual effects of component interventions were impossible to estimate since the interventions were combined. Moreover, the limitations of the study design, as discussed by Apisarnthanarak,[94] included the fact that effects regarding the intervention might be interfered with by a secular or seasonal trends. This study would have provided a much higher grade of evidence if it had been analysed as an interrupted time series design (with multiple measurement for each outcome before and after the intervention) instead of as a before-after study (just a single measurement for each outcome before and after the intervention).  
Ward cleaning 
 Ward cleaning is one of the potential interventions that could prevent HAI. Dancer et al.[95] reported that some nosocomial pathogens such as MRSA, 
Clostridium difficile, vancomycin-resistant enterococci and Acinetobacter spp. are able to survive on the surfaces of hospital surroundings for extended periods of time. This can be a source for transmission to patients. Cleaning the 
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hospital environment, especially surfaces frequently touched by HCWs and patients, such as the bed rail, the bed surface and the supply cart[96] would possibly help preventing HAI. A number of studies [97, 98] have suggested the efficacy on environmental cleaning to reduce HAI. However, large prospective controlled trials are required to clarify the effect of this intervention.[99] 
 
Screening and decolonisation  Search and destroy policies making use of routine or responsive screening of patients for asymptomatic carriage of nosocomial pathogens, especially for MRSA, coupled with decolonisation of these patients, represents another class of potential intervention to reduce infections which has been implemented in many parts of the world (though usually limited to developed countries).[100-103] A systematic review by McGinigle et al.[104] provided some evidence for the effectiveness of active surveillance, which was estimated to account for about 40 to 60% reduction of hospital-acquired MRSA incidence in ICU settings. However, these studies have limitations in several ways such as study design with no control group, possible confounders, and no intervention compliance record. For decolonisation, mupirocin nasal ointment[105] and washing with chlorhexidine are two possible treatments for reducing MRSA carriage in settings where resistance to these agents is lacking.[106] According to economic evaluation studies, it seems that this infection control approach can be cost-effective in ICUs in high-income countries.[68, 107] However, both screening and decolonisation involve extensive staff time and require more resources compared to other infection control interventions. Little is known about implementing these measures in low-middle income countries where resources are more limited and where they have traditionally not been used.   
2.5 Economic Evaluation Framework 
 
2.5.1 Forms of Economic Evaluation 
 Resources available for healthcare are limited, and spending should seek to maximize population health benefits. Economic evaluation is an essential economic tool to compare two or more healthcare interventions in terms of 
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costs and outcomes. Information resulting from these analyses is helpful for policy makers who have to allocate budgets within the health sector. Economic evaluation has been described as 
‘‘The	  comparative	  analysis	  of	  alternative	  courses of action in terms of both 
their	  costs	  and	  consequences	  in	  order	  to	  assist	  policy	  decisions.’’         Drummond et al. [31] Economic evaluation consists of two parts: costs and consequences. Costs are always measured in monetary terms while consequences can be measured in terms of clinical outcomes, monetary (economic) terms, or utility. Economic analyses examining both costs and effects would be defined as full economic evaluation while analyses considering only costs or outcomes of the alternatives alone or without any estimations of cost per unit of health benefit are classified as partial economic evaluation (called cost analyses, efficacy or effectiveness evaluation and cost-consequences analysis). Types of full economic evaluation in healthcare are described below.[108, 109]  Cost-Minimisation Analysis (CMA)  This form of economic evaluation is used for comparing two or more equivalent interventions assuming that the consequences of alternatives are identical. This type of analysis focuses on costs incurred from different interventions assuming the lowest cost will be preferred. However, in practice, it is unlikely that interventions will produce identical outcomes rendering this approach inappropriate in most circumstances.  Cost-Effectiveness Analysis (CEA)  The consequences of this form of analysis are measured in terms of natural effects or physical units such as number of pain free days, reduction of mmHg in blood pressure, number of infection cases averted and number of life years gained. This approach has a potential benefit in the aspect of having more flexibility in measuring outcome. However, a crucial limitation of this approach is that it usually uses disease-specific measures. Consequently, there might be difficulties in comparing results across other programmes due to the differences in outcome measurement. 
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Cost-Utility Analysis (CUA)  In this form of analysis, consequences or outcomes are assessed in a generic measure known as quality adjusted life years (QALYs), which captures the health change in both morbidity and mortality. Utility values or quality of life weights are attached to different health states in the analysis from 0 (death) to 1 
(full	  health)	  based	  on	  individuals’	  preferences.	  Results	  are	  commonly	  presented	  as costs per QALY gained. This approach has wider applicability than CEA because the outcomes are measured in terms of long-term health combining multiple dimensions of health status and the results are comparable across different areas of illness.  Cost-Benefit Analysis (CBA)  CBA values the consequences resulting from interventions in monetary terms. The benefit of this is that the result can be used to compare health expenditure with investment in other sectors. The results of this analysis can be shown as net present value (NPV) or benefit-cost ratio.[110]  Different forms of economic evaluation have different potential uses based on the situation and purpose of analysis. The terminology of CEA and CUA are often used interchangeably. However, the most frequently used approach in the healthcare sector is CUA since this approach measures the same outcomes, and allows decision-makers to compare different interventions from several areas of disease and to maximise health benefits obtained using a fixed budget. 
 
2.5.2 Methods in Economic Evaluation  Economic evaluation can be carried out in two main ways. One approach is to conduct the evaluation alongside or as a part of a prospective study such as a randomized controlled trial (RCT); another approach is to perform the evaluation using a decision analytic model.[36]  Economic evaluations are sometimes conducted alongside RCTs or other prospective studies. The main advantages of this approach is that patient-
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specific data can be obtained from real world situations with low marginal costs of collection because the economic evaluation is an add-on to the data being collected for the trial. However, there are some limitations to trial-based economic evaluations. To begin with, the time frame used in trials is usually short and measured outcomes may sometimes represent transient behaviour, not the final outcomes. Consequently, the impact of interventions on long-term outcomes such as death can sometimes not be adequately captured. Also, the population in a single trial is usually relatively small in size compared to the targeted population. This can cause difficulties in generalisation of the findings. Moreover, it is only possible to evaluate a restricted number of strategies (rarely more than three) within a single trial due to study design limitations. Therefore, while important, conducting economic evaluation alongside RCTs does not generally provide enough information to inform policy decision makers.[111]  Decision analytic modeling can overcome these limitations, though at the expense of requiring a number of assumptions. This type of analysis requires the use of a mathematical model to synthesise data on alternative clinical strategies. Multiple inputs are used to construct the model, often including epidemiological and clinical data, estimates of intervention effectiveness over an extended time-horizon, unit costs and resources used, and health state valuations. One of the main benefits of this approach is the capability of extrapolating from observed RCT data. The models can enable estimates of the benefit of the intervention in the longer term (after the trials have finished) and link intermediate clinical outcomes to final outcomes. In addition, modelling can compare several strategies or interventions at the same time or allow head to head comparisons of interventions not directly compared in trials. Models can also be used to generalize results from trials to other settings by altering the parameter inputs to fit with the population of interest. In this way modelling approaches can be used to aid decision-making processes. For these reasons, decision analytic modeling is increasingly undertaken as a valuable approach for economic evaluation of various healthcare interventions.  
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Choices of modeling in economic evaluations  The aim of decision analysis is to make explicit the best decision under specified criteria, and to quantify and account for the uncertainty associated with these decisions. Multiple sources of information including systematic reviews with meta-analyses, RCTs, hospital datasets, observational studies, and expert opinions can be used to develop a model. Several types of modelling techniques are available for conducting economic evaluation.[37, 38, 112] The selection of model type should depend on the clinical research questions and natural history of the disease of interest. One distinction for choosing the appropriate type is whether or not individuals in the model have independent risks of becoming diseased.[112] In case of interaction between individuals (dependence) as is expected for infectious disease (where the number of infected patients influences the infection risk of the others), discrete event simulation and compartmental dynamic models may be more appropriate.[113-115] However, in other cases (when there are no important interactions between individuals), decision trees and Markov models are frequently used[38, 116] and micro-simulation is sometimes used.[117] 
 
Modelling in healthcare associated infections  Mathematical modelling is a useful tool to describe the essential features of a complex system. Transmission dynamic models are widely used to understand the epidemiology of infectious diseases and effects of different interventions including vaccines.[118] Different epidemiological model have been developed to simulate the spread of pathogens causing HAI. Several models have been constructed to investigate the spread of bacterial and viral infections in hospital settings, especially for antibiotic resistant bacteria including MRSA infection,[119, 120] vancomycin-resistant enterococci,[121] and Clostidium difficile.[122, 123] In addition, infection control measures including hand hygiene promotion, decolonization, patient isolation, and antibiotic stewardship, have been incorporated into the model to predict the consequences of implementation.[39] A number of these models have incorporated a community reservoir in the model structure as the density of colonized at admission patients will affect the 
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hospital dynamics.[124-127] The modelling techniques used and model structure are varied based on particular research questions and data availability.   Modelling of the effects of hand hygiene interventions in hospital settings have been constructed with two populations, patients and HCWs. [128-132] These are host-vector models where HCWs act as vectors having direct contact with patients and can cause cross transmission from one colonised patient to another by carrying pathogens on their hands. These models have a useful application in describing the expected relationship between hand hygiene compliance and HAI infection rates. This relationship is difficult or impossible to derive from intervention trials. Most of the hand hygiene models have considered only a single ward, mostly in ICU settings where the incidence is higher. In addition, hospital-wide models and models incorporating community reservoirs have also been developed.[39, 133] However, the more complex the model, the more epidemiological data are required to parameterize the model.  Transmission dynamic models combined with decision analytic models to perform economic analyses have increasingly been used because dynamic models can often more fully capture health benefits than conventional static models.[115] Although, a number of studies have combined dynamic modeling and economic evaluation to assess infection control interventions,[68, 134] none of these have considered interventions intended to improve hand hygiene. 
 
2.6 Economics of hand hygiene promotion in hospital settings 
 The potential benefit of hand hygiene promotion is to reduce transmission of nosocomial pathogens to patients leading to a reduction in HAI and reduced patient morbidity and mortality. Hand hygiene promotion could potentially be a highly effective intervention representing good value for money meriting increased investment. Economic analysis is a useful tool to evaluate the circumstances under which further investment would be warranted. For example, it might be that only when hand hygiene levels fall below a certain threshold, or resistant organisms above a certain threshold that further investments in hand hygiene promotion are likely to be cost-effective. Such 
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analyses can potentially help healthcare decisions makers gain the maximum health benefits out of a limited budget.  Most of the economic analyses of hand hygiene promotion in peer-reviewed journals were conducted as business case analyses, comparing the cost of hand hygiene interventions to the potential cost savings from the HAI cases avoided.[135-138] This approach is used to illustrate the effect of intervention implementation on budgets, and does not take into consideration the health benefits to the patients from the intervention (except insofar as they affect costs). An example of a business case analysis was conducted by Cummings et al.[137] This study performed a model-based analysis predicting the relationship between the increase of hand hygiene compliance and cost saving. It combined data about hand hygiene compliance and MRSA colonization and infection with MRSA rates. The authors estimated that a one percent increase in hand hygiene will save about $US 39,650 annually, mainly due to preventing MRSA cases, in a 200-bed hospital. This study demonstrated the economic value of improving hand hygiene compliance for the healthcare provider based on a 750-bed hospital in Durham, North Carolina, USA. However, costs of hand hygiene promotion required to achieve the higher rates of compliance and the consequences in terms of patient outcomes were not measured in this analysis.   However, this kind of analysis gives no information to inform budget allocation decisions. It only informs the healthcare policy decision makers about allocation efficiency. There are two broad types of economic evaluation, partial and full economic evaluations, as mentioned in section 3.4.1. Economic evaluation studies of hand hygiene interventions using both partial and full economic evaluation are reviewed below. 
 
Partial economic evaluation  Pittet et al.[43] reported the cost of the intervention from a hospital-wide programme at the University of Geneva Hospital, Switzerland (2,600 bed hospital). Components of the intervention in this study were provision of individual bottles of hand rub solution, visual display of the importance of hand 
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cleaning, posters promoting hand hygiene, performance feedback, and strong support from the medical and nurse directors. Costs of the hand hygiene intervention were composed of direct costs including cost of hand rub and other materials, and indirect costs including salary and expenses for office supplies. The costs were calculated on a yearly basis (1994 to 2001) and presented as incremental costs of each year compared to the baseline year (1994). The estimated average costs ranged between $US 62,743 to $US 108,348 per year (103,526 to 178,774 Swiss Francs). 
 
 Full economic evaluation  Chen et al.[41] conducted a hospital-wide hand hygiene intervention programme focusing on promoting the use of alcohol hand rub at 2,200-bed hospital in Taiwan. This cost-benefit analysis study collected the cost of hand hygiene promotion including alcohol hand rub expense and material costs and time used according to the campaign alongside the intervention study. The additional cost of the hand hygiene programme for 4 years was estimated to be US$ 233,044 and more than 90% of the cost was from alcohol hand rub (AHR) expense as a major focus was on promoting the use of AHR. The financial benefits from the programme were estimated to be $US 5,522,408 from preventing 1,424 HAI cases. Consequently, the net benefit of the programme was calculated as $US 5,289,364 and the benefit-cost ratio was 23.7 (with 3 % discounting rate).  The National Patient Safety Agency (NPSA) in the UK conducted an economic evaluation in England considering hypothesized impacts of a national hand hygiene intervention programme.[40] In this analysis, they evaluated a planned multi-faceted	   campaign	   “CleanYourHands”,	   aimed	   at	   improving hand hygiene compliance among NHS clinical staff. The campaign included the provision of alcohol hand rub at each bedside and personal alcohol handrub dispensers, posters and promotional messages to staff and empowerment of patients in the hand hygiene process. Costs of the intervention were mainly from the alcohol hand rub and promotional material while the consequences were measured as financial benefits and QALYs gained from reduction in fatal and non-fatal HAIs. Costs and health benefits were discounted at an annual rate of 3.5 and 1.5%, 
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respectively. Compliance with hand hygiene recommendations was assumed to improve from 28% to 76% in the first year and to be sustained at this level over a 5-year time horizon. The intervention was assumed (conservatively, according to the authors) to lead to a 9% reduction of the overall HAI rate, based on a survey and an expert opinion. At one 500-bed hospital, the intervention would produce a cost saving of about £ 460,000 pounds with 12 QALYs gained, annually. At the national level (England), the cost saving was estimated to be £ 137 million pounds with 3,246 QALYs gained per year. Recently, Huis et al.[42] conducted an economic evaluation alongside a cluster-randomised trial in 67 wards from three hospitals in the Netherlands to assess the cost-effectiveness of a multimodal hand hygiene intervention equivalent to WHO-5 plus goal-setting compared with WHO-5 alone. They found the effect of goal-setting improved the compliance by 9% with an average extra cost of 
€5,497 per ward. However, HAI rates could not be collected from the trial but there was assumed to be a 0.15% reduction in the HAI rate from 1% improvement in compliance. As a result, the incremental cost was reported to be €4,125 per additional percentage of HAI rate reduction.  Economic analyses of hand hygiene promotion have been conducted in different countries both at hospital and national level. The results have suggested that the investment in hand hygiene promotion is cost-saving with additional health benefits in settings where the hand hygiene compliance is low. However, all but one of these studies did not evaluate interventions using the strongest study designs, randomised trials, and the costs of HAI due to additional length of stay are likely to be overestimated due to the time-dependent bias.[11, 71] The value of a bed-day is based on the accounting approach in most studies performed. This is typically much higher than the opportunity cost for the occupied bed-day.[72] Moreover, there are no studies in the literature conducted in low-middle income countries where the higher HAI incidence and the tighter constraints on healthcare expenditure represent additional challenges. 
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3.1 Abstract 
Objective:  Many interventions have been proposed to improve hand hygiene compliance amongst healthcare workers, and in 2005 the World Health Organization launched a campaign promoting a 5-component strategy (WHO-5).  We aimed to evaluate the relative efficacy of WHO-5 and other hand hygiene promotion interventions and to summarize associated resource-use information.  
Design: A search strategy was developed and electronic databases searched for studies published between 1980 and February 2014. Random effects and network meta-analyses were performed on studies considered sufficiently homogeneous with regard to interventions, participants and outcome measures. Information on resources required for interventions was extracted, and graded into three levels.  
Inclusion criteria:  Studies implementing an intervention to improve hand-hygiene compliance amongst healthcare workers in hospital settings and measuring hand-hygiene compliance or appropriate proxies that met the Cochrane Effective Practice and Organisation of Care Group (EPOC) quality inclusion criteria were included. Where studies had not used appropriate analytical methods, we re-analysed primary data.  
Results: Of 3,633 studies retrieved, 36 met the inclusion criteria (6 randomized controlled trials (RCTs), 26 interrupted time-series (ITSs), 2 controlled trials, and 2 controlled before-and-after studies). Meta-analysis of two RCTs showed the addition of goal-setting to WHO-5 was associated with improved compliance (pooled odds ratio [OR] = 1.39, 95% confidence interval 1.15 to 1.67; I2= 80.0%). Of the 13 ITS pairwise comparisons, 12 showed stepwise increases in hand-hygiene compliance and all but three showed a post-intervention trend for increasing hand-hygiene compliance. Network meta-analysis indicated considerable uncertainty in the relative efficacy of interventions, but nonetheless provided evidence that WHO-5 is effective, and that compliance can be further improved by adding interventions including goal-setting, reward 
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incentives and accountability. The reported cost of interventions ranged from $US 225 to 4,669 per 1,000 bed-days. 
 
3.2 Introduction  More than 1.4 million patients around the world suffer from healthcare associated infections (HAIs) at any point in time.[1] HAI causes excess morbidity and is associated with increased mortality.[2 3] Direct patient contact with healthcare workers (HCWs) who are transiently contaminated with nosocomial pathogens is believed to be the primary route of transmission for several organisms and can lead to patients becoming colonised or infected. Although hand hygiene is widely thought to be the most important activity for the prevention of nosocomial infections, a review of hand hygiene studies by the World Health Organization (WHO) found that baseline hand hygiene compliance among HCWs was on average only 38.7% (range: 5% to 89%).[4]  In 2005, the WHO World Alliance for Patient Safety launched a campaign, the 
First	   Global	   Patient	   Safety	   Challenge,	   “Clean	   Care	   is	   Safer	   Care”	   aiming	   to	  improve hand hygiene in healthcare.[4] This campaign promotes a multimodal strategy (WHO-5) consisting of five components: system change; training and education; observation and feedback; reminders in the hospital; and a hospital safety climate. More recently, additional strategies for improving hand hygiene have been evaluated, including those based on behavioural theory.   Evaluating the evidence for the efficacy of different interventions is complicated by three factors: first, most evaluations of hand hygiene promotion interventions use non-randomized study designs, and in many cases the reported analysis is inappropriate or methodological quality is too low to allow meaningful conclusions to be drawn;[5-7] second, there is wide variation between studies in the hand-hygiene promotion activities used in the comparison group; third, direct head-to-head comparisons of most interventions are lacking.[8]  
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In this review and meta-analysis we aimed to overcome these problems by: i) restricting attention to randomized trials and high quality non-randomized studies, re-analysing data where necessary; ii) explicitly accounting for hand hygiene promotion activities in the comparison group in each study; iii) using a network meta-analysis to allow indirect comparison between interventions.    Information on resources used in different interventions is essential for those wishing to implement such interventions or evaluate their cost-effectiveness.[9 10] A secondary aim was therefore to document information on resources used in hand-hygiene promotion interventions.   
3.3 Methods 
 A protocol was developed and systematic methods were used to identify relevant studies, screen study eligibility, and assess study quality. This review is reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.[11] 
 
Search strategy A two-stage search strategy was used. First, all studies included in two previous reviews (covering the period up to November 2009) were obtained.[5 6] Second, we extended the search from these studies from December 2009 to February 2014. The following electronic databases was searched: MEDLINE, EMBASE, Cumulative Index to Nursing and Allied Health (CINAHL), Database of Abstracts of Reviews of Effects (DARE), National Health Service Economic Evaluation Database (NHS-EED), National Health Service Centre for Reviews and Dissemination (NHS-CRD) and British Nursing Index (BNI), Cochrane Library (Cochrane database of systematic reviews, Cochrane central register of controlled trials, Cochrane methodology register, Database of abstracts of reviews of effects, Health Technology assessment database), Clinical Trial.gov, Current Clinical Control trial, EPOC register, ACP journal, and Evidence-based medicine reviews. Results were limited to peer-reviewed publications. The complete search strategy is provided in Appendix A1. 
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Inclusion and Exclusion  A study was considered to meet initial inclusion criteria if i) it evaluated one or more interventions intended to improve hand hygiene compliance among HCWs in a hospital setting  AND ii) it measured hand hygiene compliance either using opportunities with pre-specified indications or using proxies linked to compliance (eg soap and alcohol hand rub consumption). AND iii) it was either a  randomized controlled trial (RCT), controlled clinical trial (CCT), controlled before and after study (CBA), or used an interrupted time series (ITS) design.   No restrictions were placed on hand hygiene promotion in the comparison group. Studies were excluded if they were retrospective, not reported in peer-reviewed publications or not written in English.   We then applied a methodological filter by excluding studies that failed meet minimal quality criteria specified by the Cochrane Effectiveness Practice and Organisation of Care Group (EPOC).[12] 
 
Data extraction and Quality assessment Two reviewers (NL and BSC) independently screened the titles and abstracts of the citations obtained from the search to assess the eligibility. Consensus was reached by discussion if initial assessments differed. Evaluation of the full-text and data abstraction was conducted by NL and checked by BSC.   The reviewers abstracted data on study design, population, interventions, comparisons, outcomes, and settings. Interventions implemented in each study were extracted and classified according to WHO guidelines on hand hygiene in healthcare.[4] Results and raw compliance data from each study were extracted for further re-analyses. In addition, cost of hand hygiene interventions or resource use data (materials and time spent on interventions) were extracted 
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where appropriate. Additional information was obtained from the authors if it was not clear from the manuscript. For all included studies we recorded the level of information (high, moderate, or low) about resources used for hand hygiene promotion using pre-specified definitions (Appendix A2). 
 
Assessment of risk of bias in included studies 
Risk	   of	   bias	   was	   assessed	   using	   the	   Cochrane	   Collaboration’s	   tool,[13] Nine standard criteria for RCTs, CCTs, and CBAs, and seven standard criteria for ITS 
studies	  were	  applied	  and	  	  used	  to	  classify	  each	  study’s	  risk	  of	  bias	  as	  low,	  high	  or not clear.  
Data synthesis and Statistical analysis 
Measurement of intervention effect Data synthesis was performed separately for different study designs. The primary evidence synthesis was based on studies measuring hand hygiene compliance (HHC%) by direct observation. We restricted our analysis to this outcome because it reflects the opportunities for hand hygiene.  For RCTs, the natural logarithm of the odds ratio and associated variance were calculated and used to estimate the pooled odds ratio with a random effects model,[14] using Cochrane Review Manager (RevMan) version 5.1. The same method was applied to CCTs and CBAs if applicable.  For ITS studies, a two-step approach was used.[15] First, we used a generalized linear segmented regression analysis to estimate the stepwise change in level and change in trend associated with the intervention. This approach is similar to that proposed by Ramsey et al. and Vidanapathirana et al. except that it accounts for the binomial nature of the data, appropriately weighting each data point by the number of observations.[16 17] If there was evidence of autocorrelation, we accounted for this by using Newey-West standard errors.[18] Analysis was performed with STATA 13 (Statacorp LP, College Station, TX, USA). In addition, we estimated two summary measures that combined both effects. First, we calculated the mean natural logarithm of the odds ratio for hand hygiene associated with the intervention, a measure of relative improvement. 
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Second, we calculated the mean percentage change in hand hygiene compliance in the post-intervention period (compared to that expected if there had been no intervention), an absolute measure of improvement in hand hygiene compliance. Standard errors were derived using the delta method using the 
emdbook package in R (Bolker, 2008).[19 20] See Appendix A3 for details. 
 
Network meta-analysis Network meta-analysis aims to combine all of the evidence, both direct and indirect, in order to estimate the comparative efficacy of all the interventions.[21] Each intervention strategy is represented by a node in the network. If a study directly compares two interventions they are directly connected by a link on the network and a direct comparison is possible. If two interventions are connected indirectly (for example, if there are studies comparing each with a third intervention), then indirect comparison is possible. Studies permitting a segmented regression analysis and with a clearly-defined baseline intervention and directly observed hand hygiene compliance were included in the network meta-analysis.[22 23] Intervention activities were grouped into eight components: 1) system change, 2) education, 3) feedback, 4) reminders, 5) safety climate, 6) incentives, 7) goal-setting, and 8) accountability (Table 3.1). This gave 12 hand hygiene strategies (T1-T12) (Table 3.2).  The mean of the natural logarithm of the odds ratio for the hand hygiene intervention was estimated using the segmented regression model. The weighted and pooled effect sizes obtained from each direct comparison were estimated and combined to perform a network meta-analysis using a random effects model.[15] The mean difference of pooled effect sizes estimated from direct evidence was used to estimate indirect effect sizes when head to head comparison was lacking. Intervention rankings and associated credible intervals were obtained. Model-fitting was carried out within a Bayesian framework using WinBUGS.[24] Inconsistency checks were performed for closed loops in the network.[25] Full model details are provided in Appendix A4.   
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We performed a sensitivity analysis by excluding studies that implemented multicomponent strategies in a stepwise manner without sufficient data to evaluate individual components. This led to the exclusion of four studies.[26-29] 
 
3.4 Results 
 Overall description  A summary of the review process is shown in Figure 3.1. Of 3,633 studies screened, 136 studies met initial inclusion criteria and 36 of these met EPOC criteria. Amongst these 36 studies, six were RCTs (including four cluster RCTs), [30-35] 26 were ITSs,[26-29 36-57] two were CCTs[58 59] and two were CBAs.[60 61] Reasons for exclusions are provided in Appendix A5.  15 studies applied interventions to the whole hospital while 17 studies enrolled hospital wards. Four studies recruited the HCWs as the participant units.[30 32 35 61] 25 studies were conducted in either a hospital-wide setting or combined ICU and general wards, while 11 were conducted in ICU or general wards alone. Of eight studies conducted in more than one hospital, three studies included two or more countries.[40 46 48] Only six of the 36 studies were conducted in low or middle income countries.[32 35 44 47 49 62]  Study periods ranged between 4 months and 6 years. In nine studies the period was d1 year; in 16 studies it was >1 year and d3 years; and in 11 it was >3 years. Amongst the 26 ITS studies, only eight were longer than 12 months.  In 30 studies hand hygiene was observed in all HCW types with patient contact while four studies considered only hand hygiene in nurses and/or nursing assistants.[33 35 58 61] One study recruited only nursing students as participants.[52] Patients’	  relatives	  were	  also	  included	  in	  one	  study.[38]  In six studies a single-faceted intervention was employed: four implemented education alone[32 44 52 61] and two applied system change or reminders.[38 42] 14 studies employed interventions equivalent to WHO-5 and six of these added supplemental interventions including goal-setting, incentives, and 
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accountability.[26 33 39 43 54 59] 16 studies implemented two to four-modal interventions; four of these applied components not in WHO-5 including goal-setting and incentives.[27 31 35 58]  25 studies (4 RCTs, 19 ITS, and 2 CCTs) measured hand hygiene compliance with direct observation. Two of these used a combination of video recorders and external observers.[36 37] Proxy measures were assessed in 16 studies including the rate of hand hygiene events, consumption of hand hygiene products (alcohol hand rub or soap), and a hand hygiene score checklist (2 RCTs, 12 ITSs, and 2 CBAs). Finally, HAI or device-associated HAI rate were measured as one of the outcomes in 10 studies.[26 28 34 45 47 49 53-55 57] Study characteristics including study design, setting, intervention and comparison groups are reported in Table 3.3. 
 
Quality assessment 10 studies were considered to have a high risk of bias. 26 studies had either low or unclear risk. High risk of bias was present in all of four CCTs or CBAs, but only in six out of 26 ITS designs. No RCTs or CRCTs were thought to have a high risk of bias (Figure 3.2).  The two CBAs[60 61] had high risks for inadequate allocation sequence and concealment, while both CCTs[58 59] had high risks of dissimilarity in baseline outcome between experimental and control groups.   14 studies (39%) had a low risk of bias due to the knowledge of allocated intervention, as these studies either measured objective outcomes (eg. alcohol consumption or output from electronic counting devices) or stated that the observers were blinded to the intervention. The rest of the studies had unclear risk as they did not report whether the observers were blinded.  Risk of selective outcome reporting was unclear in 33 studies as pre-specified protocols were reported only in three RCTs.[31 33 34] Two of the ITS studies had a high risk of selective outcome reporting as they reported on a non-periodical basis.[26 57] Amongst the ITS studies, five had a high risk that outcomes were 
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affected by other interventions such as a universal chlorhexidine body-washing program,[40] reinforcement of standard precautions,[40] screening and decolonization for multidrug-resistant micro-organisms,[46] quality improvement program,[44 57] and antibiotic use and HAI control policy implemented at the same time.[55] 
 
Level of information on resource use Reporting of cost and resource use information was limited with 3, 25 and 8 studies classified as having high, moderate and low information respectively (Appendix A6 in supplement). Three studies reported costs associated with both materials and person time;[33 50 59] in two cases these reports were in separate papers.[63 64] The estimated cost of interventions ranged from $US 225 to 4,669 per 1,000 bed-day (Table 3.4).  
 
Meta analysis/Data synthesis 
 
RCTs Four of six RCTs measured hand hygiene compliance by direct observation with indications similar to WHO-5.[31-34] In two of these studies, WHO-5 was compared with WHO-5 with goal-setting.[31 33] Meta-analysis showed this additional intervention to be associated with improved hand hygiene compliance. The pooled odds ratio (OR) was 1.35 (95% confidence interval 1.04 to 1.75; I2= 81%) (Figure 3.3). The other two studies also showed significant improvement in hand hygiene compliance after implementing a bundle of education, performance feedback, and visual reminders,[34] and an education program.[32] 
 Fisher et al. randomized individuals to either a control group where hand hygiene was not actively promoted, or an intervention arm which used audio reminders and individual feedback. Compliance was assessed using an 
automated	  system	  at	  entry	   to	  and	  exit	   from	  patients’	   rooms.	  The	   intervention	  was associated with a 6.8% (95% confidence interval 2.5 to 11.1) improvement in compliance.[30] Salmanti et al. randomized nursing personnel to either a 
Motivational Interviewing intervention (a behaviour-modification approach 
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initially developed to treat patients with alcoholism) or a control group. Both arms also received an educational intervention. The outcome measure was a composite hand hygiene score, which was found to increase significantly in the intervention arm. The scoring details, however, are unclear.[35]  
 
Interrupted Time Series Studies (ITSs)  Of 26 ITS studies, 19 measured hand hygiene compliance. However, only 15 studies with direct observation reported the number of observations at each time point making them eligible for re-analysis.[26-29 36 37 39-41 43 44 46 48 52 54] As some of these studies were conducted at multiple sites[46] or had multiple intervention phases,[54] 19 pair-wise comparisons from these 15 studies were available for re-analysis (Figure 3.4). In four studies there was evidence of positive first order autocorrelation.[36 37 39 54]  The baseline compliance ranged between 7.6% and 91.3%. 11 of 19 comparisons showed a declining trend in compliance during the pre-intervention period while 13 pair-wise contrasts showed a positive post-intervention change in trend for hand-hygiene compliance (Table 3.5). All but three contrasts showed both stepwise increases in hand hygiene compliance associated with the intervention and in increase in mean hand hygiene compliance in the post-intervention period compared to that expected in the absence of the intervention. However, the range was wide: the mean hand hygiene change attributed to the intervention varied between a decrease of 14.8% and an increase of 83.3% (Table 3.5). Two studies had an intervention period lasting at least two years; neither showed evidence for any decline in compliance over this period.[27 39] In only one study was there a net trend for decreasing hand hygiene compliance over the post-intervention period (Figure 3.4).[43]  
CCTs and CBAs Both CCT studies reported positive effects of hand hygiene interventions. Mayer et al.,[59] using an appropriate analysis, found that a bundle of interventions, WHO-5 and reward incentive compared with a combination of system change, education and feedback and a standard practice as control group were 
  45 
associated with improved compliance (odds ratio 1.78, 95% confidence interval 1.34 to 2.37).   Harne-Britner et al. reported that a combination of education, group incentives and goal-setting were associated with an increase in mean compliance of 21.7% while education and poster reminders were not associated with any improvement (change in mean: -1.8%).[58] Confidence intervals were not reported.  Benning et al., using a CBA design, reported an increased hospital-wide trend of soap and alcohol consumption in both intervention (package of system change, reminders, and safety climate) and control (no intervention) groups but found no evidence of an increased effect in the intervention group.[60] Gould et al. found no evidence of improvement in hand decontamination frequency in surgical ICU wards resulting from a series of educational lectures compared to no intervention (control).[61] 
 
Network meta-analysis Amongst 15 ITS studies, 11 had clear details about interventions and similar indications for hand hygiene compliance amongst qualified HCWs. These were eligible for network meta-analysis (see Appendix A7 for exclusion reasons). 15 direct pairwise comparisons between interventions were possible from 12 different hand hygiene intervention strategies (Figure 3.5). 10 strategies are connected in the network (Figure 3.6), making indirect comparisons possible. The comparative efficacy amongst nine of these strategies in a connected network was assessed compared with T1 (no intervention or standard practice).  The network meta-analysis showed that although there was large uncertainty in effect size amongst the pairwise comparisons, all intervention strategies were associated with an improvement in hand hygiene compliance compared with T1 (Figure 3.7). For four strategies, T7 (WHO-5), T8 (system change+education +feedback+reminders+incentive+goal-setting), T11 (WHO-5+incentive+goal-
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setting), and T12 (WHO-5+incentive+goal-setting+accountability), 95% credible intervals for odds ratios did not include one (Table 3.2).  Strategies T8, T9, T10, T11, and T12, which combined WHO-5 with (respectively) incentives, goal-setting, and accountability, showed additional improvement compared with T7 (WHO-5) alone. T8 (system change+education+feedback+reminders+incentive+goal-setting) had the highest probability (90%) and highest median rank of being the best strategy in improving hand hygiene compliance (Figure 3.7).   When excluding studies with multiple stepwise interventions in the sensitivity analysis there was a decrease in the effect size of T2 (system change), T6 (system change+education+feedback+reminders) and T7 (WHO-5). Other interventions were not affected. As T8 (system change+education+feedback+reminders +incentive+goal-setting) and T10 (WHO-5+goal-setting) strategies were unavailable in the network structure, T12 (WHO-5+incentive+goal-setting+accountability) became dominant with the highest probability (57%) of being the best intervention, and the highest median rank of being the most effective strategy (see Appendix A4).  
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Figure 3.1:  Systematic review flow chart.   
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Figure 3.2: Assessment of risk of bias in included studies.   
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Figure 3.3: Forest plot of the associations between WHO-5 and goal setting compared with WHO-5 alone and hand hygiene compliance from RCTs using intention to treat results. Fuller 2012a refers to results from acute care of the elderly wards and Fuller 2012b to results from intensive care units.  
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Figure 3.4: Re-analysis of studies involving interrupted time series where the outcome was hand hygiene compliance. Points represent observations, solid lines show expected values from fitted segmented regression models, and broken lines represent extrapolated pre-intervention trends.  *The last four studies (Jaggi et al., Armellino et al. (2012), Armellino et al. (2013), and Salmon et al.) were not eligible for the network meta-analysis.  
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Figure 3.5: Forest plot showing the effect size as mean log odds ratios for hand hygiene compliance for all direct pair-wise comparisons from interrupted time series studies. (Note that Lee H4, Lee H7, Lee H8, and Lee H9 all come from a multi-centre study. In two of the hosptials (H7 and H9) the baseline strategy was already equivalent to WHO-5.) 
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Figure 3.6: Network structure of indirect treatment comparison of 12 different hand hygiene intervention strategies from interrupted time series studies. 
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Figure 3.8: Rankograms showing the probabilities of possible rankings for each intervention strategy (rank 1=best, rank 10=worst).  
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Table 3.1: Description of hand hygiene intervention components. 
   
Type of Hand hygiene intervention 
component Description 
    
1. System change a 
 
 
Ensuring necessary infrastructure is available including a) access to water, soap 
and towels and b) alcohol-based handrub at the point of care.                                
2. Education and Training 
 
 
Providing training or educational programme on the importance of hand hygiene 





Monitoring hand hygiene practices among healthcare workers while providing 
the compliance feedback to staff. 
 




Prompting healthcare workers either through printed material, verbal reminders, 
electronic communications or other methods, to remind them about the 
importance of hand hygiene and the appropriate indications and procedures.  
 
5. Institutional safety climate 
 
 
Active participation at institutional level, creating an environment allowing 





Setting of specific goals aimed at improving hand hygiene compliance, which may 
both apply at the individual and group level and may include healthcare 
associated infection rates. 
 




Interventions involved with providing any reward incentive for the participants 
once they achieve a particular task or reach a certain level of hand hygiene 




Interventions  involved  with  improving  healthcare  workers’  accountability  both  at  
an individual and unit level. 
   
a
 if the intervention period included changing the place or formulation or installing more dispensers of alcohol based handrub, the baseline intervention was counted as no intervention 
or standard practice (no system change component) although the alcohol-based handrub had been used during the baseline. 
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Table 3.2: Mean odds ratios with 95% credible intervals for hand hygiene intervention strategies. Results are from random effects network meta-analysis model. 
 
Code Hand hygiene strategies System change Education Feedback Reminders Safety climate Incentives Goal-setting Accountability Mean OR 95% Credible Interval 
T1 None/Current practice ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✕ Reference   
T2 System change ✓ ✕ ✕ ✕ ✕ ✕ ✕ ✕ 3.50 0.12 100.38 
T3 Education ✕ ✓ ✕ ✕ ✕ ✕ ✕ ✕ 7.72 0.14 435.28 
T4 Reminders ✕ ✕ ✕ ✓ ✕ ✕ ✕ ✕ Not in the network   
T5 Education+Feedback+Reminders ✕ ✓ ✓ ✓ ✕ ✕ ✕ ✕ Not in the network   
T6 System change+Education+Feedback+Reminders ✓ ✓ ✓ ✓ ✕ ✕ ✕ ✕ 4.52 0.18 112.51 
T7 WHO-5 a ✓ ✓ ✓ ✓ ✓ ✕ ✕ ✕ 6.65 1.33 33.41 
T8 System change+Education+Feedback+Reminders +Incentives+Goal-setting ✓ ✓ ✓ ✓ ✕ ✓ ✓ ✕ 2,646.52 18.39 396,329.02 
T9 WHO-5+Incentives ✓ ✓ ✓ ✓ ✓ ✓ ✕ ✕ 9.64 0.56 164.84 
T10 WHO-5+Goal-setting ✓ ✓ ✓ ✓ ✓ ✕ ✓ ✕ 11.54 0.68 189.81 
T11 WHO-5+Incentives+Goal-setting ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✕ 17.27 1.07 288.30 
T12 WHO-5+ Incentives+ Goal-setting+Accountability ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 50.10 1.01 2578.60 
Model fit statistic: posterior mean residual deviance= 13.82 and deviance information criterion (DIC)= 26.41 
T1-T12: 12 hand hygiene intervention strategies. Refer to Table3.1 for details of components. 
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Settings and Details of the 
design 
Unit of 
Participant Population Interventions Comparison group 
Methods of 





Total: 39 months 
Baseline: approx. 20 months  
Intervention: approx. 20 months 
 
October 2006 to December 2009 
60 wards from 16 hospital trusts 
 
Experimental: 33 mixed wards from 13 
trusts 
Control: 27 mixed wards from 11 trusts 
Ward HCWs WHO-5+GOAL+FED WHO-5 (UK national 
campaign) 
Direct observation  
by ward 
coordinators 
Before and after patient 
contact 
Hand hygiene compliance 
Soap and AHR 
consumption 
England and Wales 
Huis 
(2013) 
CRCT Total: 13 months 
Baseline: 1 month  
Intervention: 6 months 
Follow up (no intervention): 6 months 
 
September 2008 to November 2009 
67 wards from 3 hospitals 
 
Experimental: 30 mixed wards  
Control: 37 mixed wards  
Ward Nurses WHO-5+GOAL WHO-5 (except SAF) Direct observation  
by nursing student 
Before and after patient 
contact, patient 
surroundings and use of 
gloves 





CRCT Total: 15 months  
Baseline: 3 months  
Intervention: 12 months 
 
October 2006 to December 2006 
(Baseline) and June 2007 to May 2008 
(Intervention) 
30 wards from 3 acute care sites 
 
Experimental: 15 mixed wards  
Control: 15 mixed wards 
 
Randomized stratified by hospital site 
and type of hospital unit. 
(number of bed not reported) 
Ward HCWs SYS+EDU+FED+REM SYS (with AHR at point of 
care) 
Direct observation  
by researchers 
Before and after patient 
contact, skin wounds or 
mucous, insertion of an 
intravenous line and use 
of gloves 







RCT Intervention: 4 months period  
(Pre and Post-test) 
 
September 2000 to January 2001 
100 randomly selected nurses from a 
1,300 bed hospital 
 
Experimental: 50 nurses  
Control: 50 nurses 
Individual Nurses EDU None (unclear AHR) Direct observation  
by researchers 







RCT Total: 24 weeks 
Baseline: 14 weeks 
Intervention I: 6 week  
Intervention II: 4 weeks 
 
Start from January 2012 
233 participants from 3 wards from 2 
hospitals 
 
Experimental: 119 participants 
Control: 114 participants  
Individual HCWs SYS+REM+FED SYS (with AHR at point of 
care) 
Direct observation  
by trained nurses 





RCT No data provided 
 
Year 2010 
128 participants from a 109-bed 
hospital  
 
Experimental: 64 participants 





SYS+EDU+FED SYS+EDU Direct observation  
by infection control 
supervisor 
Unclear Hand hygiene score with 
unclear details 
Iran 
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Derde 
(2014) 
ITS Total: 36 months (3 years) 
Baseline: 6 months 
Intervention I: 18 months 
Intervention II: 12 months 
 
May 2008 to April 2011 
13 European ICUs  
(all with least 8 beds) 
Ward HCWs EDU+FED+REM REM (unclear AHR use) Direct observation  
by researchers 
Before and after patient 
contact, before an aseptic 
task, and after contact 
with patients' body fluids 
and surroundings 




ITS Total: 24 months (2 years) 
Baseline: 6 months 
Intervention: 12 months 
Post-Intervention (Wash out): 6 
months 
 
March 2008 to July 2010 
33 Surgical wards of 10 hospitals in 9 
countries 
Ward HCWs WHO-5 None (with AHR) in 1 
hospital, 
SYS in 1 hospital and 
WHO-5 in 2 hospitals 
Direct observation  
by researchers 
Before and after patient 
contact, before an aseptic 
task, and after contact 
patients' body fluids and 
surroundings 
Hand hygiene compliance Multi-center  








ITS Total: 12 months 
Baseline: 3 months  
Intervention: 9 months 
 
August 2011 to July 2012 
9 wards (8 ICUs and 1 general ward) 
from 7 tertiary hospitals in 2 countries 
 
 
Ward HCWs WHO-5 None (with AHR) Direct observation  
by trained nurses 
WHO "Five Moments of 
Hand Hygiene" 
Hand hygiene compliance Brazil and Thailand 
Al-Tawfiq 
(2013) 
ITS Total: 54 months (4 years 6 months)  
Baseline: 9 months 
Intervention: 42 months 
(implemented at multiple time points) 
Post-Intervention: 3 months 
 
October 2006 to December 2011 
A 350-bed hospital Hospital HCWs WHO-5+GOAL None (with AHR) Direct observation  
by infection control 
team 
Before wearing gloves, 
after removing gloves, 
before and after patient 
contact, after leaving 
patient’s  room,  before  
and after performing 
invasive procedures, and 
after contact with 
patient’s  body  fluids. 







ITS Total: 17 months 
Baseline: 1 month 
Intervention: 16 months 
 
March 2010 to July 2011 
An 18-bed surgical intensive care unit 
(SICU) from a 804-bed hospital 
Ward HCWs FED + GOAL None (unclear AHR use) Electronic motion 
sensor and video 
recorders and sinks 
and dispensers. 
Review and audit by 
researchers 
Room entry and exit Hand hygiene compliance USA 
Armellino 
(2012) 
ITS Total: 25 months 
Baseline: 4 months 
Intervention: 4 months 
Maintenance: 17 months 
 
June 2008 to June 2010 
A 17-bed medical intensive care unit 
from a 804-bed hospital 
Ward HCWs FED + GOAL None (unclear AHR use) Electronic motion 
sensor and video 
recorders and sinks 
and dispensers. 
Review and audit by 
researchers 
Room entry and exit Hand hygiene compliance USA 
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Chan 
(2013) 
ITS Total: 7 months  
Baseline: 1 month  
Intervention: 6 months 
 
April 2009 to October 2009 
A general medical unit with 10 single 
rooms 









ITS Total: 63 months (5 years 3 months) 
Baseline: 9 months 
Intervention: 15 months 
(implemented at multiple time points) 
Post-Intervention: 39 months 
 
October 2006 to December 2011 
 
A 46-bed children hospital Hospital HCWs SYS+EDU+FED+REM+ 
INC+GOAL 





Before and after contact 
patient or environment 
Hand hygiene compliance USA 
Salmon 
(2013) 
ITS Total: 45 months (3 years 9 months) 
Baseline: 18 months 
Intervention: 3 month 
Post-Intervention: 24 months 
 
January 2009 to September 2012 
A 1,032-bed hospital Hospital Nursing students EDU None (unclear AHR use) Direct observation 
by infection control 
nurses 
WHO "Five Moments of 
Hand Hygiene" 
Hand hygiene compliance Singapore 
Talbot 
(2013) 
ITS Total: 68 months (5 years 8 months)  
Baseline: 29 months  
Intervention phase I: 18 months 
Intervention phase II: 21 months 
 
January 2007 to August 2012 
A university medical center  








Phase I: WHO-5 
+INC+GOAL 
Phase II: WHO-5 
+INC+GOAL+ACC 
Phase I: EDU (unclear AHR 
use) 




WHO "Five Moments of 
Hand Hygiene" 






ITS Total: 30 months (2 years 6 months) 
Baseline: 15 months 
Intervention: 15 months  
 
November 2009 to April 2012 
A tertiary referral private hospital 
(acute healthcare setting) 
 
(number of bed not reported) 
Hospital HCWs WHO-5+INC None (with AHR) Direct observation  
by trained infection 
prevention control 
nurses 
WHO "Five Moments of 
Hand Hygiene" 
Hand hygiene compliance Ireland 
Helder 
(2012) 




BA (for HHC% 
observation) 







Total: 4 months 
Baseline: 2 months  
Intervention: 2 months 
 
January 2008 to May 2008 
A 27-bed Neonatal Intensive Care Unit 
(NICU) 
Ward HCWs (SYS+) REM SYS (with AHR at POC) Electronic 
dispensers counting 
Direct observation  
by medical students 
Before and after touching 
a patient, before sterile 
procedures, before and 
after the use of gloves 
and after contact with 
body fluids 
Hand hygiene compliance 
(pre-post test) 
Hand hygiene event per 
patient-day 
Netherlands 
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Kirkland 
(2012) 
ITS Total: 48 months (4 years) 
Baseline: 6 months 
Intervention: 42 months 
 
January 2006 to November 2009 
A 383-bed teaching hospital Hospital HCWs WHO-5 None (with AHR) Direct observation  
by trained infection 
control staff 
Before and after contact 
with patients or their 
immediate environment 
Hand hygiene compliance USA 
Morgan 
(2012) 
ITS Total: 30 weeks 
Baseline: 15 weeks 
Intervention: 15 weeks 
 
March 2010 to October 2010 
2 ITS wards; Neurological ICU and 
Cardiac ICU, 15 beds each 
Ward HCWs SYS+EDU+FED+REM None (with AHR) Direct observation  
by trained 
researcher 
Room entry and exit Hand hygiene compliance USA 
Stone 
(2012) 
ITS Total: 48 months (4 years)  
Baseline: 5 months  
Intervention: 43 months 
 
July 2004 to June 2008 
187 acute hospital trusts Trust (Hospital) HCWs WHO-5 None (unclear AHR use) n/a Procurement AHR consumption 
Antimicrobial 
consumption 
Incidence of hospital 






ITS Total: 12 months 
Baseline: 6 months  
Intervention: 6 months  
 
January 2009 to December 2009 
A 215-bed tertiary-care hospital 
 
 
Hospital HCWs Unclear Unclear Direct observation  
by staff 
Unclear Hand hygiene compliance India 
Lee 
(2012) 
ITS Total: 6 years 
Baseline: 3 years  
Intervention: 3 years 
 
January 2004 to December 2010 
A 1162-bed tertiary-care university 
hospital  
Hospital HCWs WHO-5 None (with AHR) n/a Procurement AHR consumption 
Antimicrobial 
consumption 
Incidence of healthcare 





ITS Total: 51 months (4 years 3 months) 
Baseline: 27 months 
Intervention phase I: 12 months 
(2010) 
Intervention phase II: 12 months 
(2011) 
 
March 2007 to December 2011 
A private 200-bed hospital Hospital HCWs Phase I: WHO-5 
Phase II: WHO-5 
(intense) + 
Reinforcement 
Phase I: None (with AHR) 
Phase II: WHO5 
Direct observation  
by infection control 
and nursing 
supervisors 
WHO "Five Moments of 
Hand Hygiene" 





ITS Total: 36 months 
Baseline: 12 month 
Intervention: 12 months  
Post-Intervention: 12 months 
 
December 2006 to November 2009 
A medical-surgical ICU 
 
(number of beds not reported) 





EDU+FED None (with AHR) Direct observation  
by infection control  
Upon entering the patient 
care environment and 
after leaving 
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Doron 
(2011) 
ITS Total: 18 months 
Baseline: 6 months 
Intervention: 12 months 
 
September 2007 to February 2009 
A 425-bed hospital, an academic 
medical center 
Hospital HCWs WHO-5 SYS+EDU+FED+REM (with 
AHR) 
Direct observation  
by trained staff 
Before touching the 
patient or an object in the 
patient’s  room  and  
before or after the 
encounter with the 
patient 







ITS Total: 21 months, 
East Step-down Unit (SDU) 
Baseline: 3 months 
Intervention: 19 months 
 
West Step-down Unit (SDU) 
Baseline: 6 months 
Intervention: 15 months 
 
April 2008 to November 2009 
Two 20-bed SDUs from a private 
tertiary care hospital (all had single bed 
rooms) 
Ward HCWs WHO-5 None (with AHR) n/a Dispenser count Hand hygiene event 
Alcohol gel consumption 





ITS Total: 10 months  
Baseline: 3 months 
Intervention: 6 months 
 
September 2004 to June 2005 
A 110-bed multidisciplinary district 
hospital 
Hospital HCWs SYS+EDU+FED+GOAL None (with AHR) Direct observation  
by trained nurse at 
each ward  
Use of short-sleeved 
uniforms, protective 
clothing, aprons and 
gloves, hand disinfection 
with AHR, and wearing 
rings and wristwatches 
 
Basic hygiene compliance  
Incidence of healthcare 
associated infection in 
ventilated patients 
(healthcare-associated 
infections with regard to 
ventilator associated 
pneumonia, intubation-
related infections in 






ITS Total: 12 months 
Baseline: 3 months  
Intervention: 9 months 
 
August 2007 to July 2008 
A 116-bed hospital Hospital HCWs WHO-5 None (with AHR) Direct observation  
by selected staff 
members and 
volunteers 




Hand hygiene compliance 
Incidence of HAIs; urinary 
tract infection, ventilator 
associated pneumonia 




ITS Total: 57 months (4 years 9 months)  
Baseline: 21 months 
Intervention: 36 months 
 
April 2005 to December 2009 
A hospital, part of a 9-hospital 
healthcare system 
Hospital HCWs WHO-5+INC+GOAL None (with AHR) Direct observation  
by a staff liaison 
from each 
department 
Based on opportunities Hand hygiene compliance 
 
USA 
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Vernaz 
(2008) 
ITS Total: 72 months (6 years) 
Baseline: 22 months  
(1 year and 10 months) 
Intervention: 50 months  
(4 years and 2 months) 
 
February 2000 to September 2006 
A 2,200 bed tertiary university hospital Hospital HCWs WHO-5 (Swiss 
national campaign) 
SYS (with AHR at point of 
care) 
n/a Procurement AHR consumption 
Antibiotics use 
Incidence of MRSA and 
C.difficile (number of 





ITS Total: 2 years 
Baseline: 4 to 5 months  
Intervention: 18 months 
 
2004 to 2006 
5 wards from a 800-bed hospital 
with 3 intervention groups 
1) Washington campaign (1 ward)  
2) Geneva campaign (2 wards) 
3) AHR substitution (2 wards) 
Ward HCWs Group I: WHO-5 
Group II: 
SYS+EDU+REM+SAF 
Group III: SYS 
None (with AHR) n/a Dispenser (liquid soap) 
count 





CCT/ITS Total: 16 months  
CCT step-down  
Baseline: 2 months  
Intervention phase I: varied between 
2 to 7 months 
 
August 2000 to November 2001 
 
ITS (less than 3 time points baseline); 
2 years 9 months 
 
April 2003 to December 2006 
3 units (6 wards) from a 450-bed 
hospital 
 
Intervention 2 units (4 wards) 
Control 1 unit (2 wards) 
Step-down phase 1 and 2 
 
Ward HCWs Phase I: 
SYS+EDU+FED 
Phase II: WHO-5+INC 
None (unclear AHR use) Direct observation  
by trained part-time 
staff 
Before, after, or before 
and after contact patient 
or patient's environment. 






CCT Total: 7 months 
Baseline: 1 month 
Intervention: 6 months 
 
April to October 2005 
3 medical-surgical units from an urban 
healthcare system 
 
Intervention: 2 wards with different 
interventions 
Control: 1 ward 
Ward Nurses and 
patient care 
assistants 
Phase I: EDU+REM 
Phase II: 
EDU+INC+GOAL 
EDU (with AHR use) Direct observation  
by trained staff 
Before or after, or before 
and after patient contact. 





CBA Total: 20 months (as a second phase 




March 2007 to September 2008 
Total 18 hospitals 
 
Intervention: 9 hospitals 
Control: 9 matched hospitals  
by size and geographic area 
Hospital HCWs SYS+REM+SAF None (with AHR) n/a Procurement Soap and AHR 
consumption 
England and Wales 
Gould 
(1997) 
CBA Total: 3 months intervention period 
 
Data on date is not available 
Total 4 surgical wards from a teaching 
hospital 
 
Intervention: 2 surgical wards  
Control: 2 surgical wards  




duration of hand 
decontamination 





*SYS: system change, EDU: education, FED: feedback, REM: reminders, SAF: institutional safety climate, INC: incentives, GOAL: goal-setting, ACC: accountability, WHO-5: a combined intervention strategies including SYS, EDU,FED, REM, and SAF, 
AHR: alcohol based hand rub, HHC: hand hygiene compliance, HCW: healthcare worker, n/a: information is not available. 
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Table 3.4: Resource use extracted data 
 
No Author (year), Study design Intervention Comparison Settings Resource use (Material) Resource use (Time) Sources 
Total cost 
($US) No of bed 
Intervention 
period (day) 












Netherlands State of art strategies  
 Alcohol hand rub 
 Material including 
website, leaflets, posters, 
newsletters, article in 
hospital magazines 
State of art strategies  
 Hand hygiene direct 
observation 




 320,278 Υ 
 
(€ 246,368)  
993 365 883.7 2009 
          Team and leader directed 
strategies 
 Same as above 
Team and leader directed 
strategies 
 Same as SAS above 
 Coach salary 
 Staffing costs for 
managers, role models and 






1225 365 1,060.5 
 






Ireland A mobile interactive stand-
alone computer using 
gaming technology  and 
annual license 
Swab and ATP machine 
Research Assistant for 
audit and training 1.79 full-
time equivalent (287 
hours) assuming salary as 





(£ 26,474)  



















USA 60 alcohol dispensers 
system in two wards 
12 posters in total 
1.46 FTE (234 hours) of 
research assistant (10-20 
hours a week for trouble 
shooting, refilling, and 
collecting data from the 
devices, and 2 hours a 




 6,960  27 105 2,455.0 2010 
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5 Mestre (2012), 
ITS 




WHO-5 (intense) + 
Reinforcement 
Phase I:  
None (with AHR) 
 
Phase II:  
WHO-5 
Spain Alcohol handrub solution 
Material for campaign 
including posters, pens, 
and candy 
Hand hygiene direct 
observation 




 19,259  n/a 365 385.2 2011 
6  Doron (2011), 
ITS 
WHO-5 System change 










425 365 225.6-322.3 2008-9 
7 Mayer (2011), 
CCT 











USA Prizes as candy, chocolate 
bars, pizza and others 
2.25 FTE (yearly) of 
Infection preventionists 
0.6 FTE of Manager 
0.35 FTE of Clark 
Paper  165,600  450 365 1,008.2 2003-6 











(with AHR use) 
USA Printing, supply for 
education program 
Staff time for preparation 
of education program 
Attendance at education 
programs including data 
collection training, in 
services, review material. 
Investigator monitoring for 
study. 
Validation of data 
collection tool and analysis 
Author 
contact 
4,835 n/a 180 n/a 2005 
Υ  Assumed exchange rates: € 1 Euro = $US 1.3 and £1 British pound = $US 1.6  
* HHC: hand hygiene compliance, HCW: healthcare worker, POS: point of care service, AHR: alcohol based hand rub, CRCT: cluster randomized controlled trial, RCT: randomized controlled trial, ITS: Interrupted time series study, CCT: controlled 
clinical trial, CBA: controlled before and after study, WHO-5: a combined intervention including system change, education, feedback, reminders, and institution safety climate, n/a: information is not available.
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Table 3.5: Results of the re-analysis of studies using interrupted time series. 
 
Study Comparison 
Baseline Level (intercept) Baseline trend Change in trend Change in level  d Hand Hygiene change (%HHC) 
%HHC Coefficient (SE) Coefficient (SE) Coefficient (SE) Coefficient (SE) Mean  95% Confidence interval 
Lee, Hosp 4 T1 vs T7 44.6 -0.215 (0.30) -0.081 (0.10) 0.130 (0.10) 0.606 (0.26) 29.9 3.5 56.4 
Lee, Hosp 7 T7 vs T7 53.8 0.154 (0.29) 0.281 (0.07) -0.151 (0.08) -1.042 (0.25) -11.5 -13.5 -9.5 
Lee, Hosp 8 T2 vs T7 44.6 -0.215 (0.26) 0.059 (0.06) 0.014 (0.06) 0.563 (0.19) 13.3 -9.2 35.8 
Lee, Hosp 9 T7 vs T7 62.3 0.503 (0.33) 0.088 (0.13) -0.094 (0.13) -0.007 (0.51) -9.7 -63.6 44.3 
Derde T4 vs T5 52.8 0.112 (0.04) -0.015 (0.01) 0.133 (0.02) 0.346 (0.05) 16.3 13.6 19.1 
Higgins T1 vs T9 37.2 -0.428 (0.17) -0.009 (0.25) -0.030 (0.03) 2.448 (0.25) 48.8 45.4 52.3 
Doron T6 vs T7 70.7 0.204 (0.12) 0.187 (0.10) -0.040 (0.03) 0.586 (0.01) 4.7 2.3 7.1 
a Chou T1 vs T11 54.9 0.198 (0.03) -0.039 (0.00) 0.151 (0.01) 0.453 (0.17) 56.4 53.1 59.8 
Marra T1 vs T7 45.7 -0.173 (0.07) 0.020 (0.06) 0.063 (0.03) 0.218 (0.06) 11.5 3.4 19.6 
Helms T1 vs T7 91.3 2.350 (0.42) -0.297 (0.18) 0.354  (0.19) 0.706 (0.33) 35.9 -5.8 77.7 
Kirkland T1 vs T7 51.3 0.052 (0.14) -0.097 (0.04) 0.111  (0.04) 4.443 (1.03) 83.3 77.0 89.6 
Al-Tawfiq T1 vs T10 41.3 -0.350 (0.09) -0.014 (0.02) 0.081 (0.07) 2.328 (0.21) 49.9 42.8 57.0 
Crews T3 vs T8 50.7 0.028 (0.12) -0.070 (0.02) 0.103 (0.02) 3.679 (0.22) 38.2 35.5 40.9 
a Talbot (Phase I) T3 vs T11 56.7 0.271 (0.20) -0.006 (0.02) 0.109 (0.02) 0.363 (0.41) 18.5 -1.4 38.4 
Talbot (Phase II) T11 vs T12 81.1 1.455 (0.45) -0.020 (0.01) 0.060 (0.01) 0.464 (0.05) 15.0 10.6 19.5 
b Jaggi cUnclear intervention details 19.5 -1.420 (0.26) 0.080 (0.02) -0.006 (0.03) -0.586 (0.34) -14.8 -33.1 3.6 
a, b Armellino (2012)    T1 vs Feedback+Goal-setting 7.6 -2.493 (0.15) -0.088 (0.133) 0.849 (0.235) 3.046 (0.68) 45.4 38.5 52.3 
a, b Armellino (2013) T1 vs Feedback+Goal-setting 29.0 -0.895 (0.04) 0.122 (0.10) -0.109 (0.08) 2.267 (0.14) 74.9 65.5 84.4 
b Salmon T1 vs T3 42.7 -0.295 (0.17) 0.003 (0.02) 0.021 (0.02) 0.485 (0.22) 17.9 -0.3 36.2 
a Evidence of auto correlation; Newey-West standard errors are reported.  
b Studies excluded in the network meta-analysis (see Appendix A6 for exclusion criteria). 
c Details of intervention were not clear. 
d The mean change in hand hygiene compliance during the post-intervention period attributed to the intervention accounting for baseline trends (see Appendix A3 for details) 
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3.5 Discussion  We found that a multi-faceted hand hygiene intervention, WHO-5, and single interventions including system change, training and education, or reminders alone are associated with improved hand hygiene compliance compared with standard practice. Results from both RCT and ITS designs provided consistent evidence that adding supplemental interventions including goal-setting, reward incentives, and accountability to the WHO-5 strategy led to additional improvements in compliance. Information about resources used in the interventions was not well-reported.  We are aware of four previous systematic reviews of hand-hygiene interventions in healthcare settings.[5-8] One of these found only four studies of sufficient methodological quality to reliably evaluate hand hygiene promotion interventions and was unable to reach firm conclusions.[5] Overlap between included studies in the other three and ours is small: respectively 1 (4.8%),[7] 2 (4.9%),[6] and 5 (11.1%)[8] of studies included in our review were included in previous reviews, while 20 (95.2%), 39 (95.1%), and 40 (88.9%) of the studies in these reviews failed to meet the minimum quality threshold in ours.[12] While high quality non-randomized studies can potentially play an important role in the evaluation of interventions if analysed using appropriate methods, there are many reasons for thinking that simple before-after studies (a design used by the majority of the studies included in previous reviews) do not provide a reliable basis for evaluating interventions.[65-67] In contrast to ITS studies, a strong quasi-experimental design where multiple outcome measures are taken before and after the intervention, a before-after study compares a single outcome measure pre- and post-intervention and is vulnerable to distorting effects of pre-intervention trends.  
We	   found	   an	   increasing	   number	   of	   “high	   quality”	   hand	   hygiene	   intervention	  studies after 2009. A systematic review conducted by Gould et al.[5] examining the literature from 1980 to November 2009, found only four studies meeting the EPOC criteria (1 RCT, 2 ITSs and 1 CBA). With the same criteria, our review found 31 studies (5 RCTs, 13 ITSs, 2 CCTs and 1 CBA) published between 
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December 2009 and May 2014. Most of them used an ITS design, possibly reflecting logistical difficulties in conducting RCTs.   A particular strength of our study is that the network meta-analysis allows us to quantify the relative efficacy amongst a series of different intervention strategies with different baseline interventions, even where the direct head-to-head comparisons were absent.  Reporting on resource implications for interventions was generally very limited with some notable exceptions. Most included studies reported only part of the resources used and methodologies for collecting cost data were unclear. Such resource-use information is important both for those wishing to implement similar strategies and for economic evaluation of different interventions.[10 68] A good framework to collect such data has also been proposed.[69] Cost-effectiveness analysis of hand hygiene promotion is required to assess under what circumstances these initiatives represent good value for money and when resources might be better directed at supplemental interventions including care bundles,[70] ward cleaning,[71] and screening and decolonization,[72] to complement well-maintained hand hygiene compliance.   This study has several limitations. First, implementation details of intervention components may vary substantially. For example, personal feedback and group feedback were classified together but, in practice, the impacts of these strategies may vary. Moreover, different studies may implement the same program with different quality of delivery and level of adherence, so-called intervention fidelity or Type III error.[73] Both issues are common to many interventions to improve the quality of care in hospital settings and are likely to be responsible for much of the unexplained heterogeneity between studies.[74 75] Second, most direct pairwise comparisons between strategies in the network meta-analysis were based on a single study. Third, publication bias may be substantial, particularly for non-randomized studies, although a funnel plot of ITS study results did not display obvious asymmetry (Appendix A7). There might also be a low level of language bias because studies in languages other than English were excluded. However, the magnitude of such bias is likely to be small.[76 77] Finally, 
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linking improved compliance to clinical outcomes such as number of infections prevented would provide more direct evidence about the effectiveness of interventions.[10] Such direct evidence is still limited in hospital settings, although the association is supported by a large body of indirect evidence as well as biological plausibility.[78 79]  
3.6 Conclusion  While there is some evidence that uni-modal interventions led to improvements in hand hygiene, there is strong evidence that the WHO-5 intervention can lead to substantial, rapid and sustained improvements in hand hygiene compliance in HCWs. There is also evidence that goal-setting, reward incentives and accountability provided additional improvements beyond those achieved by WHO-5. Important directions for future work are to improve reporting on resource implications for interventions, increasingly focus on strong study-designs, and evaluate the long-term sustainability and cost-effectiveness of improvements in hand hygiene. 
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What is already known on this topic - Hand hygiene amongst healthcare workers is widely believed to be one of the most effective measures to reduce healthcare-associated infections, but compliance remains poor in many hospital settings. - In 2005 the World Health Organization (WHO) launched a campaign to improve hand hygiene in healthcare settings by promoting a multimodal strategy consisting of five components: system change; training and education; observation and feedback; reminders in the hospital; and a hospital safety climate. - More recently, additional strategies for improving hand hygiene have been evaluated. 
 
What this paper add - These meta-analyses provide evidence that the WHO campaign is effective at increasing hand hygiene compliance in healthcare workers. - We also found evidence that additional hand hygiene interventions (used in conjunction with the WHO campaign elements) including goal-setting, reward incentives and accountability can lead to further improvements. - Reporting on resource implications of such interventions is limited. 
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4.1 Abstract 
 
Introduction: Economic evaluations of interventions in the hospital setting often rely on the estimated long-term impact on patient survival. Estimates of mortality rates and long-term outcomes among patients discharged alive from the intensive care unit (ICU) are lacking from lower- and middle-income countries. This study aimed to assess the long-term survival and life expectancy (LE) amongst post-ICU patients in Thailand, a middle-income country. 
Methods: In this retrospective cohort study, data from a regional tertiary hospital in northeast Thailand and the regional death registry were linked and used to assess patient survival time after ICU discharge. Adult ICU patients aged at least 15 years who had been discharged alive from an ICU between 1st January 2004 and 31st December 2005 were included in the study, and the death registry was used to determine deaths occurring in this cohort up to 31st December 2010. These data were used in conjunction with standard mortality life tables to estimate annual mortality and life expectancy. 
Results: This analysis included 10,321 ICU patients. During ICU admission, 3,251 patients (31.5%) died. Of 7,070 patients discharged alive, 2,527 (35.7%) were known to have died within the five year follow-up period, a mortality rate 2.5 times higher than that in the Thai general population (age and sex matched). The mean LE was estimated as 18.3 years compared with 25.2 years in the general population. 
Conclusions: Post-ICU patients experienced much higher rates of mortality than members of the general population over the five-year follow-up period, particularly in the first year after discharge. Further work assessing Health Related Quality of Life (HRQOL) in both post-ICU patients and in the general population in developing countries is needed. 
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4.2 Introduction 
Hospital mortality amongst intensive care unit (ICU) patients is high throughout the world, typically ranging from 14 to 44% [1-6]; in Thailand the reported range is between 24 and 40% [5-7]. Interventions to improve the quality of ICU care have the potential to reduce this mortality. Examples of such interventions include development of clinical guidelines [8,9], improvements to infection control practices [10], and appropriate use of medical devices [11].  There is growing interest not just in the effectiveness of such interventions at reducing mortality, but in their cost-effectiveness, and formal economic evaluation is increasingly used to aid decisions about allocation of scarce health care resources in these settings [12]. Such analyses consider both costs of the interventions and the associated health benefits. Outcomes such as the number of life years (LYs) or quality adjusted life years (QALYs) gained or disability adjusted life years (DALYs) averted are commonly used to represent the benefit of particular interventions. However, to estimate the change in LYs caused by preventing a single ICU death, estimates of post-ICU survival are needed. A number of studies have assessed long-term survival (defined as survival for at least one year post-ICU discharge) [2,13-29]. All but one of these studies were conducted in high-income countries and high quality data are lacking from lower and middle income countries [26]. The aim of this study was to quantify the long-term survival of post-ICU patients in Thailand and to estimate life expectancy (LE) in this population. 
4.3 Materials and methods 
Setting and facilities 
Sappasithiprasong hospital is a 1,100-bed tertiary referral hospital located in rural northeast Thailand. In 2004 and 2005, it had a catchment of 1.8 million people, predominantly rice farmers and their families. Universal health coverage has been operating in Thailand since 2002, ensuring access to this hospital for the entire population in the catchment area [30]. In 2004 Sappasithiprasong hospital had 36 general wards and 16 ICUs (4 pediatric and 
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12 adult), representing 6 ICU beds per 100,000 people. These wards provided care for critically ill patients and patients recovering from major surgery. Adult ICUs comprised of four medical ICUs (including one respiratory ICU), two surgical ICUs, two neurosurgical ICUs, one trauma ICU, two coronary care units, and one cardiovascular and thoracic ICU. ICUs contained a median of 8 beds (range 8 to 16) and the mean nurse-to-patient ratio was 1:1.5 (including both registered nurses and practical nurses). All of these ICUs could be defined as Level II open ICUs according to the guidelines from the American College of Critical Care Medicine [31] since there were no intensivists accredited by the Royal College of Physicians of Thailand working at Sappasithiprasong hospital in 2004. Further details about the ICUs in this hospital have been described elsewhere [32]. 
Data 
Retrospective patient-level data from January 2004 to December 2005 were obtained from Sappasithiprasong hospital. Adult patients, aged at least 15 years who had been admitted to an adult ICU and discharged alive from the ICU between January 1st, 2004 and December 31st, 2005, were included in this retrospective cohort analysis. For patients who were subsequently readmitted to an ICU during this period, only the time since the end of the first ICU episode was considered. The regional death registry for northeast Thailand from 2004 to 2010 was obtained from the Thai Ministry of Public Health and linked to the patient data using the national identification number (ID). We verified the 
validity	  of	  each	  patient’s	  ID	  number	  using	  the	  checksum	  digit	  and	  cross-checked the name and date of birth between hospital data and the regional death registry to validate the data.  Use of these data was approved by ethical committees from 1) The Faculty of Tropical Medicine, Mahidol University, 2) Sappasithiprasong hospital, Ubon Ratchatani, and 3) The Ministry of Public Health, Thailand [33]. No patient consent was required as this study was retrospective and did not use patient identifiable data.  
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Patients with a recorded date of death during the ICU admission period were classified as ICU deaths. It is not uncommon practice in Thailand and other Southeast Asian countries to discharge moribund patients to die at home [33]. We therefore also classified deaths occurring within two days of ICU discharge as ICU deaths. Survival time for discharged patients was assessed for five years after hospital discharge. Patients were assumed to be alive if no death was recorded within five years of ICU discharge in the death registry. 
Analysis 
The primary outcome was survival time after ICU discharge. A Kaplan-Meier survival curve showing the estimated proportion of post-ICU patients alive at each time point was plotted over the five year follow-up period. To quantify the potential impact of differential mortality following year five, we fitted an exponential curve to the annual risk of death from years two to five. From year eight onwards, the extrapolated post-ICU mortality differed by less than 1% from that in the general population matched for age and sex. Therefore, mortality from year eight was assumed to be equal to that in the general Thai population which we took from standard mortality life tables [34]. In the base case analysis we assumed that in years six and seven post-discharge the relative risk of death for former ICU patients compared to the general population was the same as that observed in year five (relative risk of 1.35). Since this assumption may underestimate post-ICU survival, we performed a sensitivity analysis in which we assumed that mortality rates in years six and seven post-discharge were the same as those in the general population matched for age and sex (i.e. a relative risk of one). The life expectancy (LE) amongst patients discharged from the ICU was taken as the area under the lifetime survival curve. The LE was calculated for the overall ICU population and for each age group.  Survival analysis stratified according to major diagnostic categories for ICU admission from the International Statistical Classification of Diseases, tenth revision (ICD10) [35] was also performed. The diagnostic groups were: a.) Cerebrovascular diseases (ICD10 codes: I60-I69); b.) Cardiovascular diseases except Cerebrovascular diseases (ICD10 codes: I00-I99 except I60-I69); c.) 
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Digestive system (ICD10 codes: K00-K93); d.) Neoplasms (ICD10 codes: C00-D48); e.) Respiratory system (ICD10 codes: J00-J99); and f.) Injury, poisoning and other external causes (ICD10 codes: S00-T98). The analysis was performed using STATA 11 (Stata Corp., College Station, Texas) and Microsoft Excel 2010, (Redmond, WA, USA).  We also performed a systematic search in order to review the related literature investigating long-term survival amongst post-ICU patients in low and middle income countries. The search strategy and inclusion criteria are provided in Appendix B. 
4.4 Results 
There were 11,985 adult patients admitted to an ICU in Sappasithiprasong hospital between 2004 and 2005 and discharged before 1st January 2006. After verifying the hospital dataset, 1,664 patients (13.9%) were not eligible for this analysis due to missing data, incomplete or invalid ID numbers, or coming from other countries (and therefore not recorded in the regional mortality records). As a result, 10,321 patients were included in this analysis. There were 7,223 patients who were discharged alive from the ICU; 153 of these died within two days and were counted as ICU deaths. Of these 61 (39.9%) died at the hospital and 92 (60.1%) died at home. We studied five-year survival in the remaining 7,070 patients who were discharged from the ICU alive (31.5% ICU fatality rate). Patient-flow is shown in Figure 4.1. Demographics and ICD10 codes in the group of patients who were discharged alive differed slightly from those in patients who died within the ICU (Table 4.1). In contrast, the group of post-ICU patients who died within five years of discharge tended to be older and much less likely to have ICD10 codes relating to injury, poison and other external causes than those who were alive after five years (Table 4.2). Of the 7,070 patients who were discharged alive, 79.3% survived the first year, then 74.0%, 70.3%, 66.9%, and 64.2% survived each subsequent year (Figure 4.2). Overall, within five years, 2,527 of the original 7,070 (35.7%) had died. The Kaplan-Meier survival curve indicated a greatly elevated risk of death in the first year post-ICU discharge, with 9.5% (241 of 2,527) of all deaths occurring within 
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seven days. Of these, 67 (27.8%) died at the hospital and 174 (72.2%) died at home. Of the total 2,527 deaths over five years 21.4% (540) occurred within the first month, 35.5% (896) within 3 months, 46.0% (1,162) within 6 months, and 57.9% (1,464) within the first year. Mortality rates became close to those in the general population between years two to five after ICU discharge. The annual risks of death for each year during these periods were 0.21, 0.07, 0.05, 0.05, and 0.04, respectively. In the general population, the annual risk of death (matched for age and sex with those discharged alive from the ICU) was 0.03. Overall, half of the post-ICU patients would have been expected to die within 12.1 years of ICU discharge under base case assumptions. In a sample of the general population matched for age and sex, half would be expected to die within 21.2 years (Figure 4.3). The LE under base case assumptions and the sensitivity analysis are presented in Table 3. The overall LE amongst post-ICU patients was estimated to be 18.3 years while the LE in the general population (matched for age and sex) was estimated to be 25.2 years. The sensitivity analysis yielded estimates of LE 1.6% higher than under the base case assumption.  Survival categorised by specific diagnostic categories is presented in Figure 4.4 and Table 4.4. The lowest survival within six months of discharge was seen in patients admitted with cerebrovascular disease, though at five years post-discharge the lowest survival (33.6%) was seen in patients with neoplasms. The highest survival rates were consistently seen in those admitted due to injury, poisoning or other external causes; 86.5% of patients in this group survived at least five years.  In the systematic search for studies of long-term survival amongst post-ICU patients studies in low and middle income countries, we found only one study evaluating post-ICU survival across all diagnostic categories [26]. This study followed up 187 post-ICU patients in Malaysia for two years. It was reported that 97 of 105 post-ICU patients (92.4%) who responded to a questionnaire survived for two years. However, the high loss to follow up in this study (43.8%, 82 from 187) makes interpretation of these findings difficult.  
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Figure 4.1: Patient flow from intensive care unit (ICU) admission to discharge and until 5-year follow-up.
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Table 4.1: Demographic data for ICU patient 
 Patients dying in the 
ICU1 
Patients discharged alive 
from the ICU 
N=3,251 N=7,070 
Age (Med [IQR]) 57.6 [42.6, 71.1] 54.5 [38.2, 67.8] 
Age group (number of patients)   
 15-29 408 (12.6%) 1,132 (16.1%) 
 30-44 492 (15.1%) 1,298 (18.4%) 
 45-59 879 (27.0%) 1,821 (25.8%) 
 60-74 901 (27.7%) 1,914 (27.1%) 
 >75 571 (17.6%) 905 (12.8%) 
Length of hospital stay 3.0 [1,7] 7.0 [3,12] 
(Med [IQR])   
Sex (% female) 1,241 (38.2%) 2,700 (38.2%) 
ICD10 (Top five, by %)   
Circulatory system (I00-I99) 1,040 (32.0%) 2,627 (37.2%) 
 - Cerebrovascular diseases (I60–I69) 535 404 
 - Other forms of heart disease (I30–I52) 179 615 
 - Ischemic heart diseases (I20–I25) 152 886 
 - Chronic rheumatic heart diseases (I05–I09) 86 441 
Injury, poison and other external causes (S00-T98) 751 (23.1%) 1,598 (22.6%) 
 - Injury (S00–T14) 715 1,490 
 - Poisoning and certain other consequences 36 108 
of external causes (T15–T98)   
Digestive system (K00-K93) 328 (10.1%) 789 (11.2%) 
 - Other diseases of the digestive system (K90–K93) 106 125 
 - Diseases of oesophagus, stomach and 
duodenum (K20–K31) 
48 225 
 - Disorders of gallbladder, biliary tract and 
pancreas (K80–K87) 
43 166 
Respiratory system (J00-J99) 248 (7.6%) 376 (5.3%) 
 - Influenza and Pneumonia (J09–J18) 145 129 
 - Chronic lower respiratory diseases (J40–J47) 35 82 
 - Suppurative and necrotic conditions 10 61 
of lower respiratory tract (J85–J86)   
Neoplasms (C00-D48) 186 (5.7%) 488 (6.9%) 
 - Malignant neoplasms (C00-C99) 160 331 
 - Neoplasms of uncertain or unknown behaviour 
(D37–D48) 
22 128 
 - Benign neoplasms (D10–D36) 4 27 
Hospital mortality (%) N/A 139 (2.0%) 
Five years mortality (%) N/A 2,527 (35.7%) 
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Table 4.2: Demographic data for post-ICU patients 
 
 
Post-ICU patients dying within 5 
years of ICU discharge 
Post-ICU patients alive 5 years 
after ICU discharge 
N=2,527 N=4,543 
Age (Med [IQR]) 64.6 [52.6, 74.0] 47.46 [32.6, 62.2] 
Age group (number of patients)   
 15-29 127 (5.0%) 1,005 (22.1%) 
 30-44 256 (10.1%) 1,042 (22.9%) 
 45-59 618 (24.5%) 1,203 (26.5%) 
 60-74 949 (37.6%) 965 (21.2%) 
 >75 577 (22.8%) 328 (7.2%) 
Length of hospital stay 8.0 [4,15] 7.0 [3,11] 
(Med [IQR])   
Sex (% female) 1,041 (41.2%) 1,659 (36.5%) 
ICD10 (Top five, by %)   
Circulatory system (I00-I99) 1,023 (40.5%) 1,604 (35.3%) 
 - Cerebrovascular diseases (I60–I69) 337 549 
 - Other forms of heart disease (I30–
I52) 
225 390 
 - Ischemic heart diseases (I20–I25) 216 188 
 - Chronic rheumatic heart diseases 
(I05–I09) 
114 327 
Neoplasms (C00-D48) 324 (12.8%) 164 (3.6%) 
 - Malignant neoplasms (C00-C99) 249 82 
 - Neoplasms of uncertain or unknown 
behaviour (D37–D48) 
70 58 
 - Benign neoplasms (D10–D36) 5 22 
Digestive system (K00-K93) 321 (12.7%) 468 (10.3%) 
 - Other diseases of the digestive 
system (K90–K93) 
86 139 
 - Diseases of oesophagus, stomach and 
duodenum (K20–K31) 
67 99 
 - Disorders of gallbladder, biliary tract 
and pancreas (K80–K87) 
60 65 
Injury, poison and other external causes 
(S00-T98) 
215 (8.5%) 1,383 (30.4%) 
 - Injury (S00–T14) 182 1,308 
 - Poisoning and certain other 
consequences 
33 75 
of external causes (T15–T98)   
Respiratory system (J00-J99) 190 (7.5%) 186 (4.1%) 
 - Influenza and Pneumonia (J09–J18) 75 54 
 - Chronic lower respiratory diseases 
(J40–J47) 
58 46 
 - Suppurative and necrotic conditions 15 24 
 of lower respiratory tract (J85–J86)   
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Figure 4.2: Kaplan-Meier survival estimates for post-ICU patients (solid line) and age- and sex- matched survival for the general population in Thailand (broken line)  
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Figure 4.3: The extrapolated lifetime survival curve under base case assumptions of post-ICU patients and age- and sex- matched survival in the general population in Thailand. 
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Life Expectancy (LE) 
†Base  case *Sensitivity Analysis ◊General  population 
15-29 43.16 43.80 48.97 
30-44 28.87 29.56 36.01 
45-59 16.41 16.98 24.03 
60-74 8.72 8.96 13.66 
≥  75 4.75 4.61 6.36 
Overall 18.26 18.56 25.15 
†   Base   case   analysis:   we   assumed   that   from   year   five   to   seven   post-discharge the relative risk of mortality 
amongst post-ICU patients was the same as that in year five. From year eight onwards, the relative risk was 
assumed to be 1. 
* Sensitivity Analysis: we assumed the mortality rates among the post-ICU patients after five years post-
discharge to be the same as those in the general population matched for age and sex. 
◊  General population: we applied the mortality rate of the Thai general population age- and sex-matched to all 
post-ICU patients since ICU discharge.  
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Figure 4.4: Kaplan-Meier survival estimates for post-ICU patients stratified by diagnostic group. 
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Table 4.4: Comparison of survival (%) at ICU discharge and 1, 2, 3, 4, and 5 years after ICU discharged by age and diagnostic group. 
 
 
Time of follow up At ICU 
discharge 
1 year 2 year 3 year 4 year 5 year 
Number of patients at 
each follow up time 
7070 5606 5236 4972 4730 4543 












Length of hospital stay 7.0 [3,12] 7.0 [3,11] 7.0 [3,11] 7.0 [3,11] 7.0 [3,11] 7.0 [3,11] 
Sex (% female) 38.2% 37.6% 37.3% 37.2% 36.7% 36.5% 
Age group       
 15-29 100.0% 93.0% 91.8% 90.7% 89.8% 88.8% 
 30-44 100.0% 88.4% 85.1% 83.1% 81.8% 80.3% 
 45-59 100.0% 80.2% 75.0% 71.4% 68.4% 66.1% 
 60-74 100.0% 70.7% 64.5% 58.9% 53.7% 50.4% 
 ≥  75 100.0% 65.4% 54.6% 48.5% 41.9% 36.2% 
Diagnostic group       
Heart diseases, other 
forms (I00-I99 except I60-
I69) 
100.0% 83.0% 76.9% 72.0% 67.9% 63.7% 
Cerebrovascular diseases 
(I60–I69) 
100.0% 62.1% 55.9% 52.5% 49.3% 46.5% 
Injury, poison and other 
external causes (S00-T98) 
100.0% 92.6% 90.9% 89.3% 87.4% 86.5% 
Digestive system (K00-K93) 100.0% 78.2% 71.9% 67.7% 62.9% 59.3% 
Respiratory system (J00-
J99) 
100.0% 69.1% 62.0% 57.2% 52.9% 43.6% 
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4.5 Discussion  This study found that post-ICU patients had a substantially higher mortality rate (and substantially reduced LE) compared to the general population, with most of the difference seen in the first year post-discharge. Overall, the LE among the post-ICU patients was estimated to be seven years lower than in the general population and the number of life years gained from preventing one ICU death was found to be about two thirds that from preventing one death in the general population (matched for age and sex).  Results from this study are broadly consistent with those from previous studies conducted elsewhere in high-income countries [2,13,14,16-18,36-38]. Our estimate that cumulative mortality over the five years was 35.7% (or 2.5 times higher than in an age and sex-matched general population) is slightly higher but comparable with estimates from previous studies which found that the five years cumulative mortality rate ranged from 17.9 to 33.5% [2,13,14,16-18,36-38]. Our estimate of the risk of death in year five, 0.04, is at the upper end of the range estimated in studies conducted in high-incomes countries (0.01 to 0.04) [14,36,37]. The mortality rates among post-ICU patients in our study were high in the first 12 months, then decreased rapidly, and were projected to closely approximate those of the general population by year eight post-ICU discharge. Studies conducted in Finland, Norway, and Scotland [13,36,37] also demonstrated substantially greater risk of death during the first year, but these became similar to the general population within one to four years. On the other hand, studies conducted in the United Kingdom [16] and Australia [38] found that the mortality rate amongst former ICU patients was higher than the general population over a 5-year and 15-year follow-up period, respectively.  There are several possible reasons for differences in the time for post-ICU mortality rates to approach those in the general population. Firstly, there was considerable variation between the studies in the frequency of different diagnostic categories. Our study had a relatively high proportion of patients with ICD10 codes relating to injury, poisoning and other external causes (23% compared to a range of 7 to 15% in other studies) [18,36-38]. Conversely, there 
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was a low proportion of patients with ICD10 codes relating to the respiratory system (5% compared with a range of 8 to 36%) [13,36,37]. Figure 4.4 suggests that these differences are likely to be associated with both a shorter period for post-ICU mortality to approach that in the general population and a relatively high five-year post-ICU survival rate.  Quality of care in different settings [39,40] is another possible factor that could impact on long-term survival rates. Higher quality of care should reduce ICU mortality, but could potentially either increase or decrease the long-term survival in patients discharged alive from ICU. The latter could occur if higher quality of care prevents ICU deaths in patients with poor long-term prognosis (where some of these patients would have died in the ICU if in lower quality of care settings). Quantifying such competing effects is challenging, but important for evaluating the cost-effectiveness of interventions to improve quality of ICU care in low and middle income countries. Currently, however, there are few studies of long-term survival following ICU stays in lower and middle income countries. While the systematic search identified a small number of studies evaluating long-term survival following ICU discharge in specific diagnostic categories (liver transplants, myocardial infarction, metastatic solid cancer, chronic obstructive pulmonary disease) [41-45], long-term follow-up of representative ICU cohorts was lacking.  Our analysis accounted for the common practice in Southeast Asia of discharging moribund patients to die at home by classifying deaths occurring within two days of discharge as ICU deaths. The two-day cut off was chosen because post-ICU mortality showed a clear spike on day two post-discharge (with 116 deaths, or 1.12% of total ICU patients) but showed a gradual decline from day three (48 (0.47%), 46 (0.45%), 36 (0.35%), 28 (0.27%), and 29 (0.28%) for day three to seven, respectively). This resulted in only slightly higher ICU mortality than would have been obtained had we only considered deaths occurring during the admission (31.5% versus 30.0% mortality, or 153 more deaths), and consequently slightly lower cumulative five year mortality amongst the non-ICU deaths (37.1% versus 35.7%).  
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The mortality rates during years six and seven post-ICU discharge are likely to be somewhat lower than assumed in the base case (which assumed the same relative risk for death as in year five), but somewhat higher than assumed in the sensitivity analysis (which assumed a relative risk of one). However, these two assumptions yielded estimates of LE that differed by less than 2% (Table 4.3) indicating that improved estimates of mortality in years six and seven would have negligible impact on the results.  Interestingly, among individuals over 75 years of age, the mortality rate was higher in the post-ICU group than in the general population in the first two years, but lower in the following years, resulting in a slightly longer LE than the general population. This might be explained by the possibility that these patients are on average healthier than the general population, having survived their ICU admission. 
Limitations 
This study has several limitations. Data from a single regional hospital may not be representative of the national population due to differences in patient characteristics and quality of hospital care. However, similar regional hospitals provide care to most of the population in Thailand and the large population (n>7,000) and long-term follow-up strengthen our findings. Nonetheless, had resources permitted, this study could have been improved (and its external validity strengthened) by collecting data from multiple sites across Thailand. A second limitation is that this study was based on retrospective data which were inevitably incomplete. Moreover, as the regional death registry was used (not national data), it is possible that we have missed some deaths in patients who moved and died outside of the northeast region. Our analysis might therefore underestimate mortality. However, any such bias is likely to be small as the five year migration rate amongst the northeast Thai population was estimated to be 3.1% in 2000 [46]. This rate is likely to be even lower in older age groups where most of the mortality occurs. Another limitation is the lack of a standardised measure of severity of illness. A standard severity score (such as APACHE II) would have helped to inform comparisons of our findings with those from other 
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studies, but such data is not routinely collected in ICUs in Thailand. Finally, this study would have been improved by the addition of Health Related Quality of Life (HRQOL) data to estimate the quality adjusted life expectancy (QALE) amongst the post-ICU patients. Ideally, such HRQOL information would be obtained from a long-term cohort study in the local population; resources for this were not available to us. Given the range of the HRQOL between 0.56 and 0.88 as shown in the literature [13,14,16,19] (all from high-income countries) the expected QALE of post-ICU patients would range from 10.2 to 16.1 QALYs. Prospective collection of such quality of life data is an important area for future health economic research in developing countries. 
4.6 Conclusions 
This study represents one of the first attempts to estimate long-term post-ICU survival in a developing country context. Post-ICU patients had higher mortality than members of the general population (matched for age and sex) over the five year follow-up period. The estimated LE is useful for economic evaluations and should support decision-makers considering potential investments in interventions that could prevent unnecessary deaths during ICU or hospital admissions. 
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Key messages 
• Five year mortality amongst post-ICU patients in Thailand was estimated to be 35.7%. This is about 2.5 times higher than that in the general population (age and sex matched). 
• The risk of death was greatly elevated in the first year after ICU discharge and approached that in the general population in subsequent years. 
• The extrapolated lifetime survival indicated that post-ICU patients had 27.4% lower life expectancy than the general population (age and sex matched). 
• Patients admitted to the ICU as a result of injury, poisoning or other external causes had the lowest mortality rate over the five year follow-up; patients with neoplasms had the highest. 
• Estimates of the number of life years gained from interventions preventing ICU deaths will aid policy-makers considering potential investments in this area. 
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5.1 Abstract 
 
Background: Multimodal interventions are effective in increasing hand hygiene (HH) compliance amongst healthcare workers, but it is not known whether such interventions are cost-effective outside high-income countries. We developed a model-based framework to address this question and to determine whether reductions in Methicillin-resistant Staphylococcus aureus bloodstream infections (MRSA-BSI) alone would make HH interventions cost-effective in intensive care units (ICUs) in a middle-income country. 
 
Method: Transmission dynamic and decision analytic models were combined to determine the expected impact of HH interventions on MRSA-BSI incidence and evaluate their cost-effectiveness. Epidemiological and economic parameters were derived using data from a tertiary hospital in North-east Thailand.  
 
Findings: Interventions increasing HH compliance from a 10% baseline to 
≥20%	   are	   likely	   to	   be	   cost-effective solely through reduced MRSA-BSI. Increasing compliance from 10% to 40% was estimated to cost $US 89·10 per bed-year with 4·07 QALYs gained per 10,000 bed-days in the paediatric ICU (PICU) and $US 63·34 per bed-year with 4·03 QALYs gained per 10,000 bed-days in the adult ICU. If baseline compliance is not greater than 20%, the intervention is always cost-effective even with only a 10% compliance improvement.  
 
Interpretation: Effective multimodal HH interventions are likely to be cost-effective in ICU settings in typical middle-income countries where baseline compliance is low due to preventing MRSA-BSI alone. Where compliance is higher, the cost-effectiveness of interventions to improve it further will depend on the impact on HAIs other than MRSA-BSI. 
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5.2 Introduction Hospital-acquired infections (HAIs) are a major cause of morbidity and mortality amongst hospitalised patients.1 HAIs are also associated with a substantial economic burden due to longer hospital stays and additional antibiotic costs.2-4 The risk of infection in developing countries is two to 20 times higher than in developed countries.5 In Thailand, amongst hospitalized patients, the point prevalence of nosocomial infection has been estimated to be 6·5% and ~250,000 patients are believed to have an HAI each year.6 The economic burden was estimated in 1995 to be 1·5 – 2·5 billion baht ($US 500-800 million) annually.7 Direct patient contact with healthcare workers (HCWs) transiently contaminated with nosocomial pathogens is believed to be the primary route of transmission for many nosocomial pathogens. Improving HCW hand hygiene compliance can minimize the impact of this transmission route and reduce the incidence of nosocomial infection.8-10 A multimodal intervention including system change, training and education, observation and feedback, reminders, and a hospital safety climate has been developed and promoted by the World Health Organization (WHO) and this campaign (which we refer to as WHO-5) has been shown to be effective in increasing hand hygiene compliance.11 Hand hygiene promotion is also relatively easy to implement and requires a relatively low level of investment. Nevertheless, in many healthcare settings, particularly in low and middle-income countries, compliance remains poor and reports of compliance rates of below 10% may well be typical.12-15 Transmission dynamic models are useful tools to help understand the likely impact of hypothetical interventions to control communicable diseases.16 Moreover, their use in health-economic evaluations of interventions that reduce transmission is essential to fully capture the intervention benefits.17 However, while several studies have used dynamic models to consider hospital infections,18 economic evaluations of hand hygiene interventions have used only static models and neglected developing countries where the need for appropriate investment is greatest.19-22 
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The aims of this study are to develop a dynamic model-based framework for evaluating the cost-effectiveness of hand hygiene promotion interventions and use it to evaluate the cost-effectiveness of such interventions for reducing Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection (MRSA-BSI) in typical ICU settings in a middle-income country. Our model is informed by data from a typical regional hospital in Thailand, a middle-income country with a gross domestic product (GDP) per capita approximately equal to 
the	  world’s	  median.	  We	  focus	  on	  MRSA-BSI as this is one of the most serious and best-studied types of infection in ICU patients. Moreover, there is clear evidence of frequent patient-to-patient transmission of MRSA in ICUs in Thailand,23 and evidence that such transmission can be interrupted by improved hand hygiene.24-26 Hand hygiene interventions should also reduce other types of MRSA infections and infections with other organisms. However, since these are harder to quantify, we take a highly conservative approach by focusing on MRSA-BSI alone and almost certainly underestimate the true health benefits of the intervention. 
5.3 Methods 
Overall description Transmission dynamic and decision analytic models were combined to simulate the MRSA transmission dynamics and evaluate the impact and cost-effectiveness of hand hygiene interventions. Two ICU settings were considered: a paediatric intensive care unit (PICU) and adult intensive care unit (adult ICU). Epidemiological and economic parameters were derived from detailed local data from a typical tertiary hospital in North-east Thailand. The assumed willingness to pay for health benefits was based on that recommended in Thailand,27 and corresponds to approximately one times GDP per capita. In addition, we also consider a cost-effective threshold of three times GDP per capita as recommended by the WHO.28 
Transmission dynamic model A previously-described deterministic host-vector model was constructed to 
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simulate MRSA transmission dynamics in an ICU.29 (Figure 5.1) Patients can be admitted to the ICU either colonised or uncolonised with MRSA. Uncolonised patients can become colonised or infected by contact with transiently-colonised HCWs. HCWs can be decolonised by performing hand hygiene. Colonized patients have a specified risk of developing MRSA-BSI. The model outputs the number of newly colonized patients, the number of MRSA-BSIs and the number of deaths over one year under different levels of hand hygiene compliance. The 
model	  was	  implemented	  in	  R,	  using	  the	  package	  “deSolve”	  to	  numerically	  solve	  the equations.30,31 Model outcomes were fed into the decision analytic model. Full technical details are given in the appendix. (Appendix C) Model parameters were obtained from a number of sources. (Table 5.1) MRSA carriage data were derived from a previous observational study in North-east Thailand which involved screening patients in a 7-bed PICU and a 10-bed adult ICU.32,33 Estimates of the per contact transmission probability from a colonized HCW to an uncolonized patient and from a colonized patient to an uncolonized HCW were derived using these data,33 combined with previous estimates of the probability of transmission from a colonized patient to HCW (see Appendix C).25 The rates at which colonized patients acquired an MRSA-BSI were estimated from the average number of cases per year at each ward divided by the expected number of colonized bed-days (estimated from the carriage data). Risk of death due to MRSA-BSI was taken from an observation study in the same setting.32 The number of beds, number of HCWs per shift, rates of ICU discharge, ward-specific contact rates, and the baseline hand hygiene compliance were directly observed from the same hospital. 
Economic Evaluation Cost-utility analysis was performed from a healthcare	   provider’s	   perspective.	  The cost of the hand hygiene intervention was estimated over one year. Health benefits were measured with a lifetime horizon with a 3% discounting rate. Costs were adjusted to 2014 values.34 There were two main cost components: cost of hand hygiene promotion; and costs associated with MRSA-BSI. The latter includes costs of additional hospital 
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stay and antibiotic treatment. (Table 5.1) The cost of the hand hygiene campaign accounted for staff time and materials used. We derived this information from a survey conducted in Australia from the national hand hygiene campaign,35 assuming the same time per bed-day requirements but applying Thai pay-scale salaries for registered nurses with two and 10 years experience.36 Costs of alcohol hand rub (AHR) were included in the model; other materials costs were assumed to be negligible. The intervention was assumed to increase AHR use 3·5-fold (range: 2 to 5).37-39 Baseline AHR use was directly observed from all local paediatric and adult ICUs at baseline compliance of 10%. We found similar amount used in both type of ICUs, therefore the average AHR use estimated as 98 litres per ICU, was applied in both wards. Associated costs assumed the market price ($US 2·38 per litre) provided by the national pharmaceutical supplier in Thailand.40 Total hand hygiene intervention costs were estimated to be $US 680 and $US 725 per ward per year in the PICU and adult ICU, respectively. Costs associated with MRSA-BSI were estimated from additional stay and treatment. Hospitalization cost was calculated as the excess length of stay due to MRSA-BSI times cost per bed-day. Retrospective data from routine clinical and microbiological laboratory databases at the local hospital (2003-2010) were used to identify MRSA-BSI cases. Additional stay due to infection was estimated with a multi-state model accounting for time-dependent	   bias	   using	   the	   “etm”	  package within R.41,42 The economic value of a bed-day should reflect the opportunity cost of an occupied bed, a value which could be quantified by asking healthcare providers for their willingness to pay (WTP) for an unoccupied bed-day.43 This opportunity cost is typically much lower than the cost calculated with an accounting approach using the hospital budget divided by the total patient bed-days over the same period.44 In the absence of WTP per ICU bed-day in Thailand, we estimated the accounting cost using local hospital financial data and multiplied this by the ratio of bed-day costs estimated with WTP and accounting approaches reported in a previous study.44  Treatment for MRSA-BSI was assumed to require a 14-day course of Vancomycin with dose regimens following treatment guidelines for hospital-
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acquired MRSA-BSI.45 Drug costs were obtained from the Drug Medical Supply Information Center (DMSIC).46  Estimates of life expectancy amongst post-ICU patients were taken from a previous study using data from North-east Thailand.47 Utility values for patients after ICU discharge were taken from the literature.48-51 The median utility of 0·72 was used in the base case with a range from 0·56 to 0·88. This health utility weight was assumed constant. 
Analyses Four scenarios with different baseline versus post-intervention hand hygiene compliance values were considered: a) 10% vs 20%; b) 10% vs 40%; c) 10% vs 80%; and d) 40% vs 80%. These values were broadly consistent with results from a systematic review where odd ratios were estimated to be 7·4 and 50·1 for WHO-5 and WHO-5 plus other interventions amongst studies using an interrupted-time series design (with a baseline compliance of 10%, these would give post-intervention compliance values of 45 and 85%, respectively).52 In each comparison, point estimates of incremental costs (ΔC) and QALYs gained (ΔQ) due to the intervention and the incremental cost-effectiveness ratio (ICER;	   ΔC/ΔQ) were calculated. The threshold willingness to pay per QALY 
gained	  (λ)	  was	  taken	  as	  gross	  domestic	  product	  (GDP)	  per	  capita	  ($US 4,848),27 and a threshold value of three times GDP per capita was considered in a scenario analysis. The latter threshold essentially corresponds to WHO criteria for a cost-effective intervention and the former to a highly cost-effective intervention.53 Interventions with ICERs below the chosen WTP threshold are, by definition, cost-effective. Probabilistic sensitivity analyses (PSA) were undertaken to capture the effects of parameter using 10,000 Monte Carlo iterations where parameters were sampled from specified distributions. (Table 5.2) Simulation results were used to calculate the monetary net benefit (MNB), which	   is	  defined	  as	  λ*Q-C, for each level of achieved hand hygiene compliance and the distribution of incremental monetary net benefits (IMNB) for each 
comparison	   (λ*ΔQ-ΔC). In addition, the maximum level of investment in the intervention at which it would still be cost-effective was calculated as monetary 
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incremental	   benefits	   (λ*ΔQ) plus the saving in treatment costs from averted infections. A series of hypothetical scenarios with different assumptions about the transmissibility and prevalence of MRSA colonisation at admission were considered in order to generalize the findings. The ward reproduction number (RA), the expected number of MRSA cross transmissions resulting from a single colonised patient during a single ward stay assuming all other patients on the ward are susceptible, was varied between 0·5 and 5 while prevalence of MRSA colonization on ICU admission was varied between 0·01 and 0·15. Changes in costs and health outcomes under different baseline compliance and improvement levels were calculated and combined to evaluate the cost-effectiveness of such interventions in terms of the IMNB. We also determined the maximum level of investment at which the intervention would still be cost-effective, the prevalence reduction and final prevalence in all scenarios. 
5.4 Results Under base case assumptions (with a pre-intervention hand hygiene compliance of 10%) a multimodal hand hygiene intervention (WHO-5) is highly likely to be cost-effective compared with the standard practice in both PICU and adult ICU settings if it increases hand hygiene compliance to 20% or more. (Table 5.2) Conversely, if the baseline compliance is 40%, the expected IMNB is likely to be negative, indicating the intervention is unlikely to be cost-effective solely as a result of reducing MRSA-BSIs. (Figure 5.2) Risk of death due to MRSA-BSI in our study hospital was estimated to be between two and three fold higher than in high-income countries.32,54 However, a scenario analysis showed that the intervention is still highly cost-effective if a mortality risk estimated from high-income settings is used instead. (Table 5.3) When the WTP threshold was three times GDP per capita ($US 14,545), under base case assumptions (with a pre-intervention hand hygiene compliance of 10% and post-intervention compliance of 40%), the IMNBs were $US 14,472 for PICU and $US 20,704 for adult ICU and in case of 40% compliance baseline, the IMNBs were $US 1,256 and $US 1,802, respectively.  
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In hypothetical scenario analyses, the hand hygiene intervention was found to be cost-effective in most scenarios, especially when there was high transmissibility and a high prevalence of MRSA colonized admission. (Figure 5.3) In the situations where the transmissibility is low (RA=0·5), prevalence of MRSA colonization at admission is 5%, and baseline compliance is not greater than 30% in the PICU and 20% in the adult ICU, the intervention is always cost-effective even with only a 10% compliance improvement using the cost estimates in Table 5.1. When the baseline compliance is not greater than 20%, the intervention will always be cost-effective if the intervention cost per year is less than US$ 1,557 in the PICU and $US 888 in the adult ICU providing the intervention increased compliance by 10% or more.




Table 5.1: Deterministic transmission dynamic model parameters. 














  Transmission dynamic model                     
    Proportion of admissions colonised with MRSA  0·063 0·029 0·108 0·087 0·038 0·139 beta 33   
    HCW-Patient transmission probability per contact  0·0065 0·0028 0·0105 0·0113 0·0061 0·0192 beta 25, 33   
    Patient-HCW transmission probability per contact  0·132 0·078 0·194 0·132 0·078 0·194 beta 25   
    Patient/HCW contacts per day (per patient)  8 - - 8 - -  Direct observation   
    HCW/Patient contacts per day (per HCW)  14 - - 9 - -  Direct observation   
    Infection rate from colonized (day-1)  0·0013 0·0007 0·0021 0·0013 0·0008 0·0020 gamma Database   
    Probability of attributable death given MRSA-BSI  0·439 0·338 0·5390 0·439 0·338 0·539 beta 32   
    Removal rate of uncolonised patient (1/LOS) (day-1)  0·164 - - 0·173 - -  Database   
    Removal rate of colonised patients (1/LOS) (day-1)  0·164 - - 0·173 - -   Database   
    Number of beds  7 - - 10 - -   Direct observation   
    Number of HCWs (per shift)  4 - - 9 - -   Direct observation   
    Hand hygiene compliance (baseline)  0·1 - - 0·1 - -   Direct observation   
                          
  Economic model                     
    Cost ($US, 2014)                     
        Hand hygiene intervention (per ward per year)   680·21 283·44 1076·98 724·95 307·19 1142·72 gamma 35, 36, 46 
        ICU bed day (days)   47·6 15·4 72·3 47·6 15·4 72·3 gamma Database, 44    
        General ward bed day (days)  5·5 2·1 10·6 5·5 2·1 10·6 gamma Database, 44    
        Treatment MRSA-BSI  (per case) 143·8 48·2 267·3 215·7 96·3 400·9   gamma 45, 46   
    Excess length of stay due to MRSA-BSI (days per case)  2·2 -0·1 4·6 1·4 -1·3 4·1 normal Database   
    Utility post-ICU (scale 0-1)   0·72 0·56 0·88 0·72 0·56 0·88 beta 48-51 
    QALYs gained per death averted (3% discounted)   17·95 10·48 24·67 10·31 7·92 12·76 gamma Database, 47   
                          
                          
  114 
     
Table 5.2: Results from economic evaluation of hand hygiene promotion in paediatric and adult ICUs (2014).  












Average monetary net benefitsb (95% CI) 
 
Average IMNBb (95% CI) 
 
Paediatric ICU                         
Baseline (HHC 10%)            30,494,582   20,088,985   43,197,023          
 
HHC 20% 0·088 0·197  $ 640·36  0·73  874·56   30,497,252   20,090,217   43,200,550   2,670·41   142·12   7,652·58    
HHC 40% 0·125 0·280  $ 623·73  1·04  600·99   30,498,651   20,090,878   43,202,378   4,068·45   515·20   11,010·90    
HHC 80% 0·141 0·315  $ 616·51  1·17  526·73   30,499,257   20,091,154   43,203,201   4,674·65   700·17   12,405·28    
 
HHC 40% vs HHC 80% 0·016 0·036  $ 673·00  0·13  5,074·55   30,499,257   20,091,154   43,203,201   -73·10  -723·99  861·37    
 
Adult ICU                         
Baseline (HHC 10%) 
           
 21,513,979 
  
 16,832,780  
 
 26,789,135  
         
HHC 20% 0·216 0·303  $ 659·29  1·05  626·61   21,517,994   16,836,229   26,798,861   4,015·61   963·54   9,114·78    
HHC 40% 0·303 0·424  $ 633·41  1·47  431·79   21,519,897   16,838,279   26,801,443   5,918·43   1,688·61   13,072·50    
HHC 80% 0·340 0·475  $ 622·61  1·64  379·66   21,520,701   16,839,232   26,801,808   6,722·64   1,982·44   14,731·19    
 
HHC 40% vs HHC 80% 0·037 0·051  $ 714·16  0·17  4,128·75   21,520,701   16,839,232   26,801,808   77·01   -634·18  1,038·47    
                          
aper ward per year, bMonetary net benefits reported per ward (total admission) assuming a willingness to pay for a QALY of $US 4,840 (160,000 Thai baht, exchange rate; $US 1 = 33 Thai baht). 
MRSA-BSI, methicillin-resistant Staphylococcus aureus bloodstream infection; ICU, intensive care unit; QALY, Quality adjusted life year; ICER, incremental cost effectiveness ratio; IMNB, 
incremental monetary net benefit; HHC, hand hygiene compliance.     
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Costs ($US) QALYsa 
ICER a 
 
Average IMNB a b 
Mean          95% Confidence Interval 
Maximum investment b 
Mean        95% Confidence Interval 
Paediatric ICU, per ward, per year (2014) 
Base case 624 1·04 601 4,068 515 11,011 4,748 1,240 11,683 
Cost of hand hygiene intervention  
(5 folds increase from $US 680 to $US 3,401) 3,345 1·04 3,216 1,328 -2,908 8,632 4,736 1,228 11,678 
QALY gained amongst post-ICU patients  
(Lower bound = 10·48 instead of 17·95) 624 0·61 1,029 2,138 36 6,113 2,819 771 6,799 
No utility weights (LE = 24·93 instead of 17·95)  624 1·44 433 5,982 1,116 15,402 6,663 1,820 16,076 
Low attributable mortality due to MRSA-BSI (at 20%) 624 0·47 1,319 1,526 -112 4,542 2,204 633 5,193 
High attributable mortality due to MRSA -BSI (at 50%) 624 1·18 527 4,781 847 12,210 5,463 1,571 12,909 
Include additional stay in general wards given BSI (12·8 days)54 615 1·04 592 4,134 622 11,020 4,810 1,337 11,682 
          
Adult ICU, per ward, per year (2014) 
Base case 633 1·47 432 5,918 1,689 13,072 6,632 2,411 13,604 
Cost of intervention  
(5 folds increase from $US 725 to $US 3,625) 3,533 1·47 2,409 3,004 -1,867 10,221 6,635 2,431 13,642 
QALY gained amongst post-ICU patients 
(Lower bound = 7·92 instead of 10·31) 633 1·13 562 4,468 1,199 9,729 5,190 1,955 10,453 
No utility weights (LE = 14·32 instead of 10·31) 633 2·04 311 8,592 2,766 17,999 9,316 3,493 18,718 
Low attributable mortality due to MRSA-BSI (at 20%) 633 0·67 947 2,344 355 5,454 3,074 1,160 6,135 
High attributable mortality due to MRSA -BSI (at 50%) 633 1·67 379 6,822 2,103 14,279 7,546 2,853 15,087 
Include additional stay in general wards given BSI (12·8 days)54 610 1·47 415 5,942 1,665 13,149 6,669 2,408 13,863 
          
a QALYs, quality adjusted life years; ICER, incremental cost effectiveness ratio; IMNB, incremental monetary net benefit.  
b Incremental monetary net benefits and maximum investment at which the intervention would still be cost-effective assuming a willingness to pay for a QALY of $US 4,848 (160,000 Thai baht, 
exchange rate; $US 1 = 33 Thai baht). 
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Figure 5.1: Model structure diagram. 
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Figure 5.3: Results from hypothetical scenarios analyses for PICU (left) and adult ICU (right) at WTP per QALY gained of $US 4,848. Incremental monetary net benefit (IMNB) (top); blue for IMNB>0 and red for IMNB<0. Maximum intervention cost at which the intervention would still be cost-effective (bottom). 
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Figure 5.4: Results from hypothetical scenarios analyses for PICU (left) and adult ICU (right). Prevalence reduction of MRSA carriage due to intervention (top) and equilibrium prevalence of MRSA carriage after improved hand hygiene compliance (bottom). 
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5.5 Discussion 
Hand	  hygiene	  promotion	  using	  the	  WHO’s	  five	  moments	  campaign	  is	  likely	  to	  be	  highly cost-effective for ICU settings in Thailand where baseline compliance is 
low	   (≤20%)	   solely	   as	   a	   result	   of	   preventing	  MRSA-BSI. Factors that tended to make the intervention more cost-effective were low baseline compliance, high prevalence of colonization at admission and high transmission. With higher baseline compliance, the intervention may often still be highly cost-effective as a result of reduced MRSA-BSI alone if rates of MRSA carriage on ICU admission or ICU transmission are sufficiently high. Because we ignored impacts of the intervention on other types of HAI (other MRSA infections and infections with other pathogens) our analysis is highly conservative and almost certainly considerably underestimates health benefits.  In particular MRSA-BSIs represent only 5·1% of hospital-acquired BSIs in North-east Thailand, Gram-negatives accounting for 67·6%.55 While the evidence linking increased hygiene with reduced infection rates is less compelling for Gram-negative organisms than it is for MRSA, there are credible reports that such an association exists.56,57 Some of the strongest evidence is found with multi-drug-resistant Acinetobacter spp, where a segmented regression analysis found that a hand hygiene intervention was associated with a substantial change in incidence of infections with extensively drug-resistant 
Acinetobacter spp. in Taiwan.20 Acinetobacter spp. has also been reported to be a frequent contaminant of the hands of HCWs in endemic settings in SE Asia, strengthening the evidence for a causal link between increased hand hygiene and reduced infections.58 Since Acinetobacter spp. are the largest single cause of hospital-acquired BSI in North-east Thailand,55 if infections with these organisms can be reduced substantially by improved hand hygiene the implications for our analysis could be substantial.  While our work provides an analytical framework for such an evaluation, better data on the epidemiology of 
Acinetobacter spp. and the effects of hand hygiene are needed to inform it. To the best of our knowledge, our study is the first economic evaluation of a hand hygiene intervention in a developing country and the first in any setting to 
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make use of a dynamic model.19-22 In previous economic evaluations in high-income countries, Pittet et al. (in Switzerland), and Chen et al. (in Taiwan) used data from observational studies to estimate reductions in infections due to hand hygiene interventions. Pittet et al. concluded that if only 1% of the observed reduction was due to the intervention it would have been cost saving. Chen et al. also concluded that their intervention was likely to be cost saving (assuming that all changes in infection rates could be attributed to the intervention). Huis et al. used data from a cluster-randomized trail of a hand hygiene intervention to inform a cost-effectiveness analysis, assuming a linear relationship between hand hygiene compliance and reduced infections (with a 1% increase in hand hygiene assumed to cause either a 0·3% or 0·15% fall in HAI rates). Under both assumptions the intervention was found likely to be cost-effective if the willingness to pay for a 1% reduction in the HAI rate was about $US 6,000.  A study by the National Patient Safety Association in the United Kingdom also concluded that hand hygiene interventions were likely to be cost saving even if the reduction in rates of hospital acquired infection were as low as 0·1%. As in our study, this report explicitly calculated QALY gains (about 90% of which were due to reduced HAI mortality). However, unlike the other studies, staff time was not accounted for when costing the intervention.  Direct comparison of these findings with ours is difficult for three reasons. First, only one of the previous studies quantified benefits in terms of final health outcomes (QALYs).19 Second, bed-day costs are much greater in high-income settings and account for most of the costs associated with HAIs. In developing country settings costs of antibiotics to treat infections are likely to be the dominant cost which overall will be much lower. Third, there are important differences in aims and methodology. We focused entirely on MRSA-BSI (where we have good data and strong evidence that it can be reduced by hand hygiene) reasoning that if the intervention is cost-effective for this outcome alone then it should certainly be cost-effective overall. We also aimed to make use of important methodological advances, accounting for the expected non-linear association between hand hygiene compliance and infection rates using a mathematical model,17,29,59 avoiding time-dependent biases when estimating 
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increased length of stay,41,60,61 valuing bed-days based on opportunity cost rather than using an accounting approach,43,44 and estimating life years gained by preventing mortality using data from a large linked-database study.47 These approaches will tend to lead to lower estimates of cost-savings and, combined with the much lower bed-day costs, helps explain why our study estimated the cost per infection to be a few hundred dollars, while studies in high income countries estimated it to be a few thousand.20-22  Use of the transmission dynamic model also allowed us to generalize the analysis to scenarios with different levels of transmissibility and admission prevalence. A particular strength of our study is that we were able to make use of extensive local data including direct observations of hand hygiene compliance, historical infection surveillance data from the hospital, and prospectively collected MRSA carriage data to inform this model.   Our study has a number of limitations, the most important of which is that data are not yet available that allow us to include other pathogens in the dynamic model. A further limitation is that we evaluated the intervention over only a one-year post-intervention period. It is unclear how well improvements in hand hygiene will be sustained over a longer time frame. If substantial improvements in hand hygiene persist beyond this period we will again be likely to have substantially underestimated the health benefits of the intervention. 
5.6 Conclusion In conclusion, effective multimodal hand hygiene intervention are likely to be cost-effective in ICU settings in typical middle-income countries as a result of reduced incidence of MRSA-BSI alone under a wide range of circumstances.  When this is not the case the cost-effectiveness of interventions to further improve hand hygiene will depend on the impact on other infections and other pathogens. Further work is needed to quantify this.   
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Panel: Research in context  
Systematic review We searched for articles describing economic evaluations of hand hygiene interventions. We combined manual searches with a search on PubMed using search terms "hand hygiene" OR "hand washing" OR "handwashing" AND "cost" AND "hospital" up to January 2015. There was no systematic review on this topic but we found four studies describing economic evaluations of hand hygiene interventions.19-22 All concluded that the hand hygiene interventions they evaluated are likely to be cost saving. Three of these studies did not consider the intervention benefits in terms of health outcomes, such as deaths averted or quality adjusted life years gained, but focused on cost per infection averted or cost-benefit from investment in promoting hand hygiene. However, all of these were conducted in high-income settings. Little is known about the value for money of such interventions in resource-limited settings. 
Interpretation To our knowledge this is the first study combining a transmission dynamic model with an economic evaluation to assess cost-effectiveness of hand hygiene interventions in a hospital setting. We found that, provided baseline hand hygiene compliance is sufficiently low, in both paediatric and adult ICUs in a typical middle-income country implementing hand hygiene promotion interventions is likely to be cost-effective (but not cost-saving) solely as a result of prevented bloodstream infections with MRSA. This finding is likely to underestimate the benefits of hand hygiene interventions as there may be large benefits in preventing other types of infection, particularly with Gram-negative organisms, which we did not account for. Factors that made hand hygiene interventions more likely to be cost-effective were lower pre-intervention compliance, higher transmissibility, and higher carriage prevalence on admission. We suggest these findings should help encourage decision-makers to ensure more rational levels of investment in hand hygiene interventions in hospitals in developing countries. 
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Chapter 6: General Discussion and Conclusions 
 Chapters 3 - 5 provided the main findings, as well as discussions and conclusions for each study in turn. This chapter summarises the key findings, the strengths and limitations of this thesis and the overall conclusions. Future research recommendations are also considered.  
6.1 Substantive discussion  Unlike other infection control programmes, hand hygiene promotion is relatively simple to implement and is not resource intensive. This makes it well-suited to resource-limited settings, though in practice investment in this intervention appears to have been quite limited in developing countries. This thesis evaluated the value for money of hand hygiene promotion amongst healthcare workers in intensive care units (ICUs) in Thailand and other resource-limited settings.  Because MRSA-BSI is the best-studied infection and there is strong evidence that this can be reduced by hand hygiene, the analysis focused on this outcome when considering health benefits. This is the first economic evaluation of such an intervention conducted in a middle-income country and the first anywhere to make use of a transmission dynamic model.   This research required several connected components. First, in an attempt to quantify life years lost due to mortality arising from HAIs in ICU patients, life expectancy after ICU discharge was considered in Chapter 4. Deaths caused by HAIs are likely to account for a large proportion of the total health burden due to infection. Hand hygiene interventions could potentially reduce this by decreasing HAI rate and consequently preventing death. Health benefits were measured as the number of life years gained if the intervention could prevent one death in an ICU patient. To do this, a retrospective cohort study was performed using hospital data from North-east Thailand linked with the national death registry to assess patient survival time after ICU discharge. These patient-level data were obtained from the hospital electronic database while the national death registry data were obtained from the Bureau of Policy and Strategy, Ministry of Public Health, Thailand. Information in patients’ charts 
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summarised by doctors was recorded in the computer by the medical record department. Internal quality assurance was performed by routine random checks between database and patient charts for accuracy and consistency. Moreover, external audit by the Ministry of Public Health, Thailand, is routinely performed. The results from this study indicated that post-ICU patients had 27.4% lower life expectancy than the general population (age and sex matched). This estimate should also aid policy makers considering the potential health gains and cost-effectiveness of other potential investments for preventing ICU mortality. It was also found that the five-year mortality of post-ICU patients in the Thai population is slightly higher than found in other studies most of which were conducted in high-income settings (35.7% compared with a range from 17.9 to 33.5%).  The effectiveness of different hand hygiene promotion interventions, including the multimodal intervention (WHO-5) recommended by the WHO, was considered in Chapter 3. A systematic review and evidence synthesis was performed to explore all available high quality information on effectiveness of the hand hygiene intervention (for increasing hand hygiene). Costs incurred by the interventions were also summarised. Previous reviews had found only four studies using appropriate study designs, making reliable conclusions impossible and severely limiting the potential for economic evaluation.[25-28] This review made use of previously described search strategies and found 36 high quality studies according to the EPOC criteria, 32 of which were published after 2009 and therefore not included in previous reviews.[90] In total there were six RCTs, 26 interrupted time series and an additional four quasi-experimental studies (only four of these had been included in the previous Cochrane review).[25] However, only two of the RCTs and 11 of ITS studies were eligible for quantitative synthesis. Different combinations of hand hygiene intervention components were compared in different studies. Network meta-analysis accounting for both direct and indirect effects was carried out to quantify the effect size amongst different strategies where direct head to head studies are not available.[139, 140] This evidence synthesis framework is increasingly used in health technology assessment in many different areas.[141-143] Results indicated 
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that the WHO-5 hand hygiene campaign is effective at increasing hand hygiene compliance in healthcare workers. In addition, the evidence also showed that when adding extra components including goal setting, reward incentives, and accountability, compliance is further improved.  However, it was not possible to quantify the relationship between improvement in compliance and change in infection rates or mortality. In addition, it was found that information about resources used for the interventions was largely lacking. Only a few studies collected and reported such resource-use properly and, therefore, conclusions about the relationship between level of investment and improvement in compliance could not be made.  In chapter 5, costs and effectiveness of hand hygiene intervention were evaluated using a transmission dynamic model and economic analysis. To account for the dynamics of nosocomial organisms and the impact of hand hygiene interventions in hospital wards, a host-vector model was developed (where HCWs correspond to the vector) and parameterized using data from two ICU wards, paediatric and adult ICUs. MRSA carriage data from a previous study conducted at the same hospital and other useful parameters from the same source were used to simulate the situation in those settings. Unlike a static model, a dynamic mechanistic model aims to capture the interaction between patients and HCWs to reflect mechanisms of cross contamination.[38] In the model the force of infection (the rate at which a susceptible patient becomes infected) was dependent on the level of contamination on HCWs’	  hands	  which	  in	  turn depended on the level of colonization pressure (point prevalence of colonization amongst patients) at the wards.[38, 130, 144] Increasing hand hygiene compliance would tend to interrupt this chain.[20, 23, 145] As a result, a relationship between the level of hand hygiene compliance and the infection rates could be derived from the model. A non-linear relationship was found between the increased compliance and reduction of infection rate. Results indicated that at low pre-intervention hand hygiene compliance the intervention will be very effective but that there will be diminishing marginal returns as the baseline hand hygiene compliance increases. For example, in the adult ICU, when the hand hygiene increases from 10% to 20%, the number of 
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MRSA-BSI avoided is 0.59 cases per 10,000 bed-day while when the compliance increases from 20% to 40% and 40% to 80%, 0.23 and 0.10 cases of MRSA-BSI per 10,000 bed-day are avoided, respectively. The benefits of hand hygiene for reducing infections also increased with higher transmissibility and higher prevalence of colonization of patients at admission. One of the benefits of using such a model-based analysis is that it allows such scenario analyses.  The main outputs from the transmission dynamic model, including the number of infections and deaths averted due to the hand hygiene intervention were used in the decision analytic model. Cost-utility analysis was performed using economic data, evidence on effectiveness and health benefits from Chapter 3 and Chapter 4 as parameter inputs. As there was a wide range of uncertainty in the effectiveness of the intervention, outcomes were compared for different levels of achieved hand hygiene compliance with a fixed observed baseline compliance of 10% (based on ward observations). The findings showed that a hand hygiene intervention is likely to be cost-effective in ICU settings in Thailand where the baseline hand hygiene compliance is low (less than 20%) solely as a result of preventing MRSA-BSI.[93, 146] In the hypothetical scenario analyses, the results indicated that the intervention is very important in settings where the transmission is high (with high colonization pressure) as an improvement in compliance provides large benefits. However, as the baseline hand hygiene increases, the likelihood of the hand hygiene intervention being cost-effective decreases.  Although performing expected value of perfect information (EVPI) analysis could be very useful to explore the potential benefit of collecting more information in order to reduce uncertainty, results from the probabilistic sensitivity analysis (PSA) showed a low level of uncertainty about whether the intervention was cost-effective when the baseline compliance was at 10%. This suggests that funding for further research on effectiveness of hand hygiene promotion should focus on areas other than the immediate effectiveness of hand hygiene interventions, for example by considering how improvements in hand hygiene could be best sustained.  
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In the model, the improved hand hygiene compliance was assumed to be constant over one year of the intervention period. This analysis did not incorporate uncertainty of the improved hand hygiene compliance in the PSA or enable the improved compliance to change over time in the dynamic model. However, deterministic analyses with lower and upper values from the confidence interval of the odds ratios when implementing WHO-5 obtained from Chapter 3 was performed and showed robust results.  If the actual ceiling threshold is less than the figure commonly used in Thailand (~ 1 gross domestic product (GDP) per capita) by 50% or approximately $US 2,500 per QALY gained, the costs per QALY gained would still be far below the threshold when the compliance baseline is 10%.[147] However, with a fixed healthcare budget, adopting an intervention that would be classed as cost-effective according to the standard ceiling threshold might still cause an opportunity loss if the healthcare budget is not sufficient to  fund interventions with lower cost per QALY gained. In general, therefore, interventions with lower cost per QALY gain should be prioritised. The work in this thesis has shown that under plausible assumptions, the cost per QALY gained with a hand hygiene promotion intervention is likely to be far below the ceiling threshold suggesting that it should be highly prioritised, at least in ICU settings in Thailand. 
 
6.2 Implications of the research findings  These findings provide the first evidence that investments in hand hygiene campaigns in hospitals in middle-income countries are likely to represent good value for money. The also call attention for the need for appropriately resourced national campaigns in developing countries. Because only the health benefits obtained by preventing MRSA-BSI in ICU wards were considered, the analysis is likely to be very conservative: real health benefits are likely to be greater than estimated. The findings suggest that policy decision makers in Thailand and other countries where hand hygiene compliance is low should consider prioritising patient safety concerns by investing more resources in evidence-based hand hygiene promotion interventions. There is a high chance this would 
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lead to substantial improvements in hand hygiene compliance and, as a result, HAI rate reduction. 
 In Thailand, were this intervention to be implemented at all ICU wards across the country, the total budget was estimated to be $US 336,631 with a minimum of 727.97 QALYs gained annually. This calculation assumes a total of 5,080 ICU beds owned by the government across the country with 80% of these for adults.[148] This figure is relevant to the Ministry of Public Health, who are responsible for most healthcare services for the population. As a centralised healthcare financing system, the government could consider efficiently allocating the budget to improve the national healthcare service.   The research findings are also relevant for other tertiary referral or teaching hospitals providing intensive care services in Thailand.[93, 146] Local hospital management could encourage their HCWs to improve compliance by adding goal-setting, reward incentives, accountability strategies in additional to WHO-5 as the evidence from meta-analysis showed further improvement. This could be initially focused on ICUs where patients are more likely to acquire HAI and more likely to die as a result. Hospital-wide programs could then be performed at a later stage.  Finally, the findings are likely to generalize to other low-middle income countries. As resources in these settings are limited, other interventions could be considered as additional options complementary to well-maintained hand hygiene compliance.  There are a number of difficulties in determining the implications of these research findings for non-ICU settings. In most cases, the burden of HAI is lower in non-ICU wards as patients are usually less severely ill and therefore less susceptible to HAI. This suggests that health benefits obtained from the improved compliance would be lower than that seen in ICU settings. However, the cost of intervention would also be lower as staff to patient ratios are lower in non-ICU settings and therefore proportionately less staff time would be spent for hand hygiene training, promotion and implementation activities. 
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Conclusions about the value for money of this intervention in non-ICU settings would also require setting-specific data about transmission dynamics and other parameters to be used in the analysis.   
6.3 Limitations of this thesis  6.3.1 Limited to ICU settings The scope of the analysis is limited to ICU settings. Due to the fact that all available carriage data came from ICU settings, the analysis could not be extended to cover general ward settings without a large amount of guesswork. Although implementing the intervention at non-ICU settings would also obtain benefits, the magnitude is still unknown. Such information and more complex transmission models capturing	  patients’	  movement	  between	  wards	  would allow a hospital wide analysis. This would provide useful information for policy decision makers.[134, 149]   6.3.2 Failure to capture all costs and benefits In addition, the analysis did not capture all costs and benefits arising from the HAIs. Other cost components such as extra laboratory tests and healthcare services apart from the treatment and bed-day costs as well as other possible 
indirect	   costs	   including	   patients’	   productivity	   loss	   were neglected. Further analysis would be required to justify this. A consequence of this is that the results may underestimate the magnitude of cost reduction due to the decreased HAI cases. In addition, the impacts of the intervention on other types of HAI (other MRSA infection and infections with other pathogens) were ignored. Because of both of these factors, this analysis is highly conservative and likely to considerably underestimate the benefits of the interventions.  6.3.3 Using non-local data A number of parameters in this model-based evaluation were not derived from local data. Resource use incurred by the intervention and utility weights amongst post-ICU patients were derived from the literature. These parameters may therefore be different from those directly collected from local data due to differences in the settings. However, scenario analyses were performed to 
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investigate uncertainty of these parameters. It was found that the results were robust; even the cost of the intervention increased five-fold or if utility weights at the low value of the plausible range were used, the general conclusions did not change.  6.3.4 Short time horizon A further limitation is that the intervention was evaluated over only a one-year time horizon. It is unclear how well improvements in hand-hygiene will be sustained over a longer timeframe. If substantial improvements in hand hygiene persist beyond this period the analysis will again be likely to have substantially underestimated the health benefits of the intervention.  
6.4 Strengths of this thesis  The evidence synthesis of hand hygiene interventions overcame key limitations of previous reviews. [25-28] First, a much greater number of relatively high quality studies were found when compared with reviews including only papers published before 2009. Also, by using a network-meta analysis within a Bayesian framework amongst interrupted time series designs, it was possible to estimate the pooled effect size of different interventions even when direct head-to-head comparisons were absent. This made it possible to quantify relative efficacy of a series of different intervention strategies with different baseline interventions.[140] These findings are useful in determination of effectiveness of different hand hygiene promotion interventions.  This thesis also contains one of the first attempts to estimate long-term post-ICU survival conducted in a developing country context. It makes use of data in routinely collected databases combining hospital patient-level data and the national death registry. These findings are not only valuable for measuring the final health benefits from an infection control intervention but are also likely to be useful for quantifying health benefits from other quality improvement programs in hospital settings that could prevent unnecessary death in the ICU.  
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A particular strength of this research is that it made use of extensive local data including direct observations of hand hygiene compliance, historical infection surveillance data from the hospital, and prospectively collected MRSA carriage data to inform the model. Use of the transmission dynamic model also made it possible to generalize the analysis to scenarios with different levels of transmissibility and admission prevalence.  Importantly, this study is the first economic evaluation of a hand hygiene intervention conducted in a resource-limited setting where improving hand hygiene is most needed. Previous studies were all conducted in high-income settings.[40-43] In addition, this study contains a number of methodological advances. For example, estimates of the excess LOS were made using an approach that avoids time dependent bias;[69, 71] values of bed days were adjusted to reflect opportunity cost (not based on the accounting approach alone); [72] and use of the dynamic model made it possible to account for the expected non-linear association between hand hygiene compliance and infection rates.[129, 130] The findings should not only be relevant for Thai settings, but are also likely to generalize to other similar settings. 
 
6.5 Future research directions   The limitations arising from this work presented in Section 6.3 are evident areas for further examination. Parameters that derived from literature could be prospectively collected from local settings. It is not uncommon in economic evaluation to adopt some parameters from non-local settings. However, setting-specific estimates would be preferable. Two of the potential parameters are the cost of hand hygiene intervention and the economic value of WTP per bed day by health care providers. A survey of resource use, HCWs’ time and materials, alongside a well-design intervention trial could be performed to obtain the cost of hand hygiene intervention while an interview session asking hospital management for their WTP for an unoccupied bed-day would therefore be of value.[11]   
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Collecting more data on other HAIs should also be ranked as a high priority. This economic evaluation represents a very conservative analysis as it accounted for the benefits of preventing MRSA-BSI alone. More information on incidence of other types of MRSA infections and other pathogens will give more realistic estimate of the value of hand hygiene interventions. In the Thai context, potential future research could prioritise the prospective collection of 
Acinetobacter spp. data as this has been recently found to be the largest single cause of hospital-acquired BSI in North-east Thailand.[150] However, better information on the effects of hand hygiene on the epidemiology of Acinetobacter 
spp. are also needed to inform such an analysis.  In addition, a well-structured surveillance system in hospital care would be of value. The poor quality of many reporting systems is an urgent issue in developing countries,[48] and is probably a cause of under-reporting of the incidence of HAI and therefore underestimating the burden of HAI. Closely monitoring the medical chart and making use of laboratory data could lead to better HAI case detection. An improved system with better data would not only enable more accurate estimates of the burden of HAI for the national healthcare monitoring system but would also will provide good information to accurately quantify the benefits of a particular infection control interventions.  An expanded dynamic model to include non-ICU settings should also be considered. Although this research showed hand hygiene interventions are likely to be cost-effective in ICU settings, this might not be the case in general wards. There might be several differences between these two settings and it is probable that general wards have a lower burden of disease due to HAIs than ICUs as patients tend to have better health and are less susceptible to nosocomial infection. However, more research in this area is required. In addition, carriage data of other pathogens is also needed and a more complex mathematical model	   capturing	   patients’	  ward	  movement	  would allow a more comprehensive analysis.  Other infection control interventions could also be considered as complementary measures. Interventions with relatively low resource 
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intensivity such as ward cleaning, universal decolonization, and care bundles are areas that should be considered for prioritization for future cost-effectiveness analyses. High resource intensive interventions such as isolation precautions and screening and decolonization could be included in the later stage.  
6.6 Conclusions  This thesis highlights the importance of hand hygiene promotion as follows.  Multimodal hand hygiene intervention (WHO-5) is effective at increasing hand hygiene compliance in healthcare workers. There is evidence that adding goal-setting, reward incentives and accountability strategies can lead to greater improvements. Reporting of resources required for such intervention remains inadequate.  Effective multimodal hand hygiene interventions are likely to be very cost-effective in ICU settings in typical middle-income countries as a result of reduced incidence of MRSA-BSI alone under a wide range of circumstances. When this is not the case the cost-effectiveness of interventions to further improve hand hygiene will depend on the impact on other infections and other pathogens. Further work is needed to quantify this.  This economic evaluation of hand hygiene promotion assessed under what circumstances these initiatives represent good value for money. However, when an acceptable and stable level of hand hygiene compliance has been achieved, other supplementary interventions including care bundles, ward cleaning, and screening and decolonization may be considered to complement the hand hygiene promotion. Such interventions represent important subjects for future research. 
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Appendices 
Appendix A: Chapter 3 Supplementary 
Appendix A1: Electronic search strategy 
 Databases Adapted from Gould et al. Adapted from Huis et al. MEDLINE  1 Handwashing/  2 (hand antisepsis or handwash$ or hand wash$ or hand disinfection or hand hygiene or surgical scrub$).tw. 3 1 or 2  4 exp Hand/  5 exp Sterilization/  6 4 and 5  7 3 or 6  8 randomized controlled trial.pt.  9 controlled clinical trial.pt.  10 intervention studies/  11 experiment$.tw.  12 (time adj series).tw.  13 (pre test or pretest or (posttest or post test)).tw.  14 random allocation/ 15 impact.tw.  16 intervention?.tw.  17 chang$.tw.  18 evaluation studies/  19 evaluat$.tw.  20 effect?.tw. 21 comparative study/  22  animal/  23  human/  24 22 not 23 25  or/8-21  26 25 not 24  27 7 and 26  
28	  limit	  27	  to	  yr=“2009	  -Current”	   29 exp hospitals/ 30 hospital$.tw. 31 exp inpatients/ 32 inpatient$.tw. 33 exp health care/ 34 health care$.tw. 35 healthcare$.tw. 36 infirmary$.tw. 37 nosocomial$.tw. 38 intensive care unit$.tw. 39 ward$.tw. 40 OR/29-39 41 28 and 40 
1 Randomized controlled trial/ 2 random$.tw. 3 experiment$.tw. 4 (time adj series).tw. 5 (pre test or pretest or post test or posttest).tw. 6 impact.tw. 7 intervention$.tw. 8 chang$.tw. 9 evaluat$.tw. 10 effect?.tw. 11 compar$.tw. 12 control$.tw. 13 or/1-12 14 limit 13 to humans 15 (hand washing or handwashing or hand hygiene) 16 14 and 15  17 limit 16 to yr="2009 - Current" 18 exp hospitals/ 19 hospital$.tw. 20 exp inpatients/ 21 inpatient$.tw. 22 exp health care/ 23 health care$.tw. 24 healthcare$.tw. 25 infirmary$.tw. 26 nosocomial$.tw. 27 intensive care unit$.tw. 28 ward$.tw. 29 OR/18-28 30 17 and 29 
 *EPOC Methodological filter Randomized Controlled Trial [publication type] OR Controlled Clinical Trial [publication type] OR Comparative Study 
OR	  Evaluation	  Studies	  OR	  ‘comparative	  
study’	  OR	  ‘effects’	  OR	  ‘effect’	  OR	  
‘evaluations’	  OR	  ‘evaluating’	  OR	  
‘evaluation’	  OR	  ‘evaluates’	  OR	  ‘changing’	  
OR	  ‘changes’	  OR	  ‘change’	  OR	  ‘interventions’	  
OR	  ‘intervention’	  OR	  ‘impact’	  OR	  ‘random	  
allocation’	  OR	  ‘post	  test’	  OR	  ‘posttest’	  OR	  
‘pre	  test’	  OR	  ‘pretest’	  OR	  ‘time	  series’	  OR	  
‘experimental’	  OR	  ‘experiments’	  OR	  
‘experiment’	  OR	  ‘intervention	  studies’	  OR	  
‘intervention	  study’	  OR	  ‘controlled	  clinical	  
trial’	  OR	  ‘randomised	  controlled	  trial’	  	  OR	  
‘randomized	  controlled	  trial’ 
 EMBASE  1 Handwashing/  2 (hand antisepsis or handwash$ or hand wash$ or hand disinfection or hand hygiene or surgical scrub$).tw. 3 1 or 2  4 exp Hand/  5 exp Sterilization/  
1 Randomized controlled trial/  2 random$.tw. 3 experiment$.tw.  4 (time adj series).tw.  5 (pre test or pretest or post test or posttest).tw.  6 impact.tw. 
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6 4 and 5  7 3 or 6  8 randomized controlled trial/ 9 randomi$.tw. 10 exp controlled clinical trial/ 11 controlled clinical trial$.tw. 12 intervention studies/ 13 experiment$.tw. 14 (time adj series).tw. 15 (pre test or pretest or (posttest or post test)).tw. 16 random allocation/ 17 impact.tw. 18 intervention?.tw. 19 chang$.tw. 20 evaluation studies/ 21 evaluat$.tw. 22 effect?.tw. 23 comparative study/ 24 animal/ 25 human/ 26 24 not 25 27 or/8-23 28 27 not 26 29 7 and 28 30 limit 29 to yr="2009 -Current" 31 exp hospitals/ 32 hospital$.tw. 33 exp hospital patient/ 34 inpatient$.tw. 35 exp health care/ 36 health care$.tw. 37 healthcare$.tw. 38 infirmary$.tw. 39 nosocomial$.tw. 40 intensive care unit$.tw. 41 ward$.tw. 42 or/31-41 43 30 and 42 












CINAHL  1 (MH "Handwashing+") 2 (hand antisepsis OR handwash* OR hand wash* OR hand disinfection OR hand hygiene OR surgical scrub*) 3 1 OR 2  4 Hand* 5 Sterilization* 6 4 AND 5  7 3 OR 6  8 (MH "Clinical Trials+") 9 clinical trial* 10  randomi* 11 controlled clinical trial* 12 intervention studies* 13 experiment*  14 "time series" 15 (MH "Pretest-Posttest Design+") 16 random allocation* 17 impact* 18. intervention? 19. chang* 
1(MH "Clinical Trials+") 2 clinical trial* 3 "comparative studies" 4 "experimental studies" 5 "time series" 6 impact* 7 evaluat* 8 effect* 9 (MH "Pretest-Posttest Design+") 10 (MH "Quasi-Experimental Studies+") 11 or/1-10 12 (MH "Handwashing+") 13 (handwashing OR hand hygiene)  14 or/12-13 15 11 and 14 16 limit 15 to yr="2009 - Current" 17 (MH "Hospitals+") 18 (MH "Hospital Units+") 19 Intensive Care Units 20 (MH "Inpatients") 21 (MH "Child, Hospitalized") 22 (MH "Adolescent, Hospitalized")  
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20. (MH "Evaluation Research+")  21. evaluat* 22. effect? 23. comparative study* 24.(MH "Animals+") 25.(MH "Human+") 26. 24 NOT 25 27. OR/8-23 28. 27 NOT 26 29. 7 and 28 30. limit 29 to yr="2009 -Current" 31 (MH "Hospitals+") 32 (MH "Hospital Units+") 33 hospital* 34 Intensive Care Units 35 (MH "Inpatients") 36 (MH "Child, Hospitalized") 37 (MH "Adolescent, Hospitalized")  38 (MH "Aged, Hospitalized") 39 (hospitalized OR hospitalised) 40 (health care OR healthcare) 24 healthcare$.tw. 25 infirmary$.tw. 26 nosocomial$.tw. 27 intensive care unit$.tw. 28. ward$.tw. 41 or/31-40 42 30 AND 41 
23 (MH "Aged, Hospitalized") 24 (hospitalized OR hospitalised) 25 (health care OR healthcare) 24 healthcare$.tw. 25 infirmary$.tw. 26 nosocomial$.tw. 27 intensive care unit$.tw. 28. ward$.tw. 26 or/17-25 27 16 AND 26 
BNI  1 handwash* (137) 2 hand wash* (170) 3 hand antisep* (22) 4 hand disinfection (39) 5 hand hygiene (369) 6 hand decontamination (43) 7 hand cleansing (29) 8 hand cleaning  (27) 9 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 (599) 10 hand (1438) 11 strilization (106) 12 9 OR 11 (702) 
13	  limit	  12	  to	  “2009	  to	  Current” 
n/a 
CRD Database  n/a 1 MeSH DESCRIPTOR Clinical Trial EXPLODE ALL TREES 2 Clinical Trial* 3 control* 4 random* 5 comparative stud* 6 experimental stud* 7 time series* 8 impact* 9 intervention* 10 evaluat* 11 effect* 12 Chang* 13 Compar* 14 Experiment* 15 (pretest OR pre test OR posttest OR post test) 16 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 17 MeSH DESCRIPTOR Handwashing EXPLODE ALL TREES 
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18 (hand washing OR handwashing OR hand hygiene)  19 #17 OR #18 20 #15 AND #19 21 (#20) FROM 2009 TO 2013  22 MeSH DESCRIPTOR Hospitals EXPLODE ALL TREES (MH  23 MeSH DESCRIPTOR Hospital Units EXPLODE ALL TREES (MH  24 hospital* 25 Intensive Care Unit* 26 MeSH DESCRIPTOR Inpatients EXPLODE ALL TREES 27 MeSH DESCRIPTOR Adolescent, Hospitalized EXPLODE ALL TREES 28 MeSH DESCRIPTOR Adolescent, Institutionalized EXPLODE ALL TREES 29 MeSH DESCRIPTOR Child, Hospitalized EXPLODE ALL TREES 30 MeSH DESCRIPTOR Child, Institutionalized EXPLODE ALL TREES 31 (hospitalised OR hospitalized OR healthcare OR health care) 32 #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 33 #21 AND #32   Cochrane Library  
  
1 MeSH descriptor: [Hand hygiene] explode all trees 2 (hand antisepsis OR handwash* OR hand wash* OR hand disinfection OR hand hygiene OR surgical scrub*) 3 1 OR 2  4 Hand* 5 Sterilization* 6 4 AND 5  7 3 OR 6  8 MeSH descriptor: [Clinical Trial] explode all trees 9 clinical trial* 10 randomi* 11 controlled clinical trial* 12 intervention studies* 13 experiment*  14 time series* 15 (pretest OR pre test OR posttest OR post test) 16 random allocation* 17 impact* 18 intervention? 19 chang* 20 evaluat* 21 effect* 22 comparative study* 23 OR/8-22 24 7 and 23 25 limit 24 to yr="2009 -Current" 26. MeSH descriptor: [Hospitals] explode all trees 27 MeSH descriptor: [Hospital Units] explode all trees 28 hospital* 29 Intensive Care Unit* 30 MeSH descriptor: [Inpatients] explode all trees  
1 MeSH descriptor: [Clinical Trial] explode all trees 2 Clinical Trial* 3 control* 4 random* 5 comparative stud* 6 experimental stud* 7 time series* 8 impact* 9 intervention* 10 evaluat* 11 effect* 12 Chang* 13 Compar* 14 Experiment* 15 (pretest OR pre test OR posttest OR post test) 16 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 17 MeSH descriptor: [Hand hygiene] explode all trees 18 (hand washing OR handwashing OR hand hygiene)  19 #17 OR #18 20 #16 AND #19 21 (#20) FROM 2009 TO 2013    22 MeSH descriptor: [Hospitals] explode all trees 23 MeSH descriptor: [Hospital Units] explode all trees  24 hospital* 25 Intensive Care Unit* 26 MeSH descriptor: [Inpatients] explode all trees  27 MeSH descriptor: [Adolescent, Hospitalized] explode all trees 28 MeSH descriptor: [Adolescent, 
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31 MeSH descriptor: [Adolescent, Hospitalized] explode all trees 32 MeSH descriptor: [Adolescent, Institutionalized] explode all trees 33 MeSH descriptor: [Child, Hospitalized] explode all trees 34 MeSH descriptor: [Child, Institutionalized] explode all trees 35 (hospitalised OR hospitalized OR healthcare OR health care) 36 #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 37 #25 AND #36  
Institutionalized] explode all trees 29 MeSH descriptor: [Child, Hospitalized] explode all trees 30 MeSH descriptor: [Child, Institutionalized] explode all trees 31 (hospitalised OR hospitalized OR healthcare OR health care) 32 #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 32 #21 AND #32   
Current Clinical Control Trial  
n/a  ("hand hygiene" OR "hand washing" OR "handwashing" OR "hand sanitizer" OR "hand rubbing" OR "hand rubs") AND ("hospital" OR "healthcare" OR "inpatients" OR "intensive care unit" OR "hospitalised" 
OR	  "hospitalized"	  OR	  “nosocomial”) ACP journal   ("hand hygiene" OR "hand washing" OR "handwashing" OR "hand sanitizer" OR "hand rubbing" OR "hand rubs") AND ("hospital" OR "healthcare" OR "inpatients" OR "intensive care unit" OR "hospitalised" 
OR	  "hospitalized"	  OR	  “nosocomial”) 
n/a 
Evidence-Based Medicine Reviews    
1 handwashing.sh. 2 handwash$.tx. 3 hand wash$.tx.  4 hand disinfection.tx. 5 hand hygiene.tx.  6 surgical scrub$.tx.  7 hand decontamination.mp. [mp=ti, to, ab, tx, kw, ct, sh, hw] 8 hand cleansing.mp. [mp=ti, to, ab, tx, kw, ct, sh, hw]  9 hand cleaning.mp. [mp=ti, to, ab, tx, kw, ct, sh, hw]  10 1or2or3or4or5or6or7or8or9  11 from 10 keep 1-249  12 10 
13	  limit	  12	  to	  yr=”2005	  Current”	   
n/a 
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Appendix A2: Classification for level of information on resources use 
 
Level of information on resources use for interventions  
High: Stated clearly what the interventions were and how they were implemented and described clearly what materials were used and how much time for each person was spent as well as the duration of the implementation period.  
 
Moderate: Stated what the interventions were and how they were implemented but lacking a clear description of materials used and person-time involved as well as time spent for each intervention. 
 
Low: Stated only what the interventions were and how they were implemented. Largely lacking any details on materials used, person involved as well as the time spent. 
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Appendix A3: Analysis of interrupted time series data 
 
Data from interrupted time series were re-analysed when data on the number of 
opportunities and hand hygiene compliance at different time points could be 
obtained.  
 
If n(t) represents the number of hand hygiene opportunities in a study at time t and 
y(t) represents the number of occasions where compliance was observed, then we 
used the following generalized linear model to evaluate the effect of the intervention: 
 
y(t)  ~  binomial(π(t), n(t))        [1] 
 
ln(π(t)/(1- π(t))= a + but +cu1t≥t.int  + du1t≥t.intu(t-t.int)     [2] 
 
where  π(t) is the probability of hand hygiene at time t, t.int is the time of the 
intervention, 1t≥t.int is a function of t taking the value 1 if t≥t.int and zero otherwise. In 
this expression the parameter a measures baseline compliance, b the initial pre-
intervention trend, c the step (level) change associated with the intervention, and d 
corresponds to the change in trend associated with the intervention. These parameters 
were estimated for each study that was re-analysed. In this model an intervention can 
increase hand hygiene either through a step increase in compliance at the time of the 
intervention (c > 0) or through a trend for increased compliance (d > 0). 
 
It is also useful to obtain a statistic that summarizes the effectiveness of the 
intervention, accounting for both changes in trend and level. There are several 
possibilities and we consider two: the mean percentage change in hand hygiene 
compliance in the post-intervention period attributed to the intervention (an absolute 
measure of change in compliance) and the mean log odds ratio of hand hygiene 
associated with the intervention (a relative measure).  
 
The first statistic, the mean percentage change in hand hygiene compliance, is given 
by 100 times the mean  difference  between  the  value  of  π(t) predicted by equation [2] 
and  the  value  of  π(t)  that would be expected if the terms c and d were set to zero (i.e. 
the expected compliance probability if the intervention had not occurred), where the 
mean is taken over the post-intervention interval [t.int, t.end], where t.end is the time 
of the end of post-intervention period. This is equivalent to 100/(t.end – t.int) 
multiplied by the area between the following two curves (representing the hand 
hygiene compliance probability given the intervention and the hand hygiene 
compliance probability that would be expected without the intervention, 
respectively) for t.int ≤  t ≤    t.end: 
 
    [3] 
         [4] 
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This is given by    where the areas A1 and A2 are found by integrating 
[3] and [4] over this range: 
 
 










An associated standard error was obtained using the delta method making use of the 
covariance matrix obtained by fitting the full generalized linear model described by 
equations [1] and [2]. 
 
The relative measure of hand hygiene change associated with the intervention is the 
mean log odds ratio for hand hygiene. This is defined as the mean value of the 
logarithm of ratio of the odds of hand hygiene compliance in the post-intervention 
period given by equation [2] to the odds of hand hygiene given by equation [2] but 




and the associated variance is given by  
 
var(c) + var(d) u ((t.end – t.int)/2)2  + 2 u cov(c, d) u (t.end – t.int)/2. 
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Appendix A4: WINBUGs code for network meta-analysis 
 
a) Base case analysis # Trial-level data given as treatment differences # Random effects model  
model{                                # *** PROGRAM STARTS 
  for(i in 1:ns) {                    # LOOP THROUGH STUDIES 
    y[i] ~ dnorm(delta[i],prec[i])    # normal likelihood for trials 
    var[i] <- pow(se[i],2)       # calculate variances 
    prec[i] <- 1/var[i]          # set precisions 
    #Trial-specific mean diff distributions 
    delta[i] ~ dnorm(md[i],bytau.sq[c[i]]) 
    #Mean of random effects distributions 
    md[i] <-  d[t[i,2]] - d[t[i,1]] 
    #Deviance contribution 
    dev[i] <- (y[i]-delta[i])*(y[i]-delta[i])*prec[i]     
    #summed residual deviance contribution for this trial 
    resdev[i] <- sum(dev[i]) 
  }  
totresdev <- sum(resdev[])     #Total Residual Deviance 
 d[1]<-0    #Treatment effect is zero for reference treatment
  
 for (k in 2:nt){d[k] ~ dnorm(0,.0001) 
    }  
     for ( i in 1:nc){   
      tau.sq[i]<-max(0.01,t.s[i]) 
      t.s[i]~dnorm(2,10) 
       bytau.sq[i]<- 1/tau.sq[i] 
      } 
 #Ranking  
 for (k in 1:10) { 
 rk[k] <- 11-rank(d[],k) 
 best[k] <- equals(rk[k],1)} 
 
}                                    # *** PROGRAM ENDS                                                                      
                                             
# ns= number of studies; 
# nt=number of treatments; 
 
#Data 
list(ns=14, nt=10, nc=10)  
c[]  t[,1] t[,2] y[]  se[] 
1 1 5 0.4711 0.1647 
2 1 8 2.4499 0.1691 
3 3 6 5.8455 0.5953 
4 3 9 0.7974 0.4078 
5 9 10 1.0656 0.1131 
6 1 7 2.2700 0.3041 
1 1 5 5.4996 1.4148 
8 4 5 0.3847 0.1541 
1 1 5 1.9448 0.8245 
9 1 9 2.8740 0.1402 
1 1 5 1.3230 0.8183 
10 5 5 -1.8738 0.6183 
7 2 5 0.6408 0.4910 
10 5 5 -0.5222 1.2273 
END  
Dbar  =  post.mean  of  -2logL;  Dhat  =  -2LogL  at  post.mean  of  stochastic  nodes 
 Dbar Dhat pD DIC  
test Ř.ŘŘŘ Ř.ŘŘŘ -Ř.ŘŘŘ Ř.ŘŘŘ  
y řś.Šřş ř.ŚŚŚ řŚ.ŝšŝ ŚŞ.ŜřŚ  
total řś.Šřş ř.ŚŚŚ řŚ.ŝšŝ ŚŞ.ŜřŚ 
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b) Sensitivity analysis  Code and results for sensitivity analysis exclude the multiple time implementation studies including Helms et al., Kirkland et al., Al-Tawfiq et al., and Crews et al.  
# Trial-level data given as treatment differences 
# Random effects model 
model{                               # *** PROGRAM STARTS 
  for(i in 1:ns) {                    # LOOP THROUGH STUDIES 
    y[i] ~ dnorm(delta[i],prec[i]) # normal likelihood for trials 
    var[i] <- pow(se[i],2)   # calculate variances 
    prec[i] <- 1/var[i]      # set precisions 
  # trial-specific mean diff distributions 
    delta[i] ~ dnorm(md[i],bytau.sq[c[i]]) 
  # mean of random effects distributions, with multi-arm 
trial correction 
    md[i] <-  d[t[i,2]] - d[t[i,1]] 
 
    #Deviance contribution 
    dev[i] <- (y[i]-delta[i])*(y[i]-delta[i])*prec[i]     
    #summed residual deviance contribution for this trial 
    resdev[i] <- sum(dev[i]) 
  } 
 totresdev <- sum(resdev[])            #Total Residual Deviance 
 d[1]<-0      #treatment effect is zero for reference treatment 
 for (k in 2:nt){  d[k] ~ dnorm(0,.0001)  
    } 
     for ( i in 1:nc){   
      tau.sq[i]<-max(0.01,t.s[i]) 
      t.s[i]~dnorm(2,10) 
       bytau.sq[i]<- 1/tau.sq[i] 
      } 
 #Ranking  
 for (k in 1:8) { 
 rk[k] <- 9-rank(d[],k) 
 best[k] <- equals(rk[k],1)}                              
}                                     # *** PROGRAM ENDS                                                                                                                  
 
# ns= number of studies; 
# nt=number of treatments;  
 
#Sensitivity anslysis: exclude Crews, Kirkland, Helms and Al-Tawfiq. 
list(ns=10, nt=8, nc=8)  
c[]  t[,1] t[,2] y[]  se[] 
1 1 5 0.4711 0.1647 
2 3 7 0.7974 0.4078 
3 7 8 1.0656 0.1131 
4 1 6 2.2700 0.3041 
5 4 5 0.3847 0.1541 
6 1 7 2.8740 0.1402 
1 1 5 1.3230 0.8183 
7 5 5 -1.8738 0.6183 
8 2 5 0.6408 0.4910 
7 5 5 -0.5222 1.2273 
END 
 
Dbar  =  post.mean  of  -2logL;  Dhat  =  -2LogL  at  post.mean  of  stochastic  nodes 
 Dbar Dhat pD DIC  
test Ř.ŘŘŘ Ř.ŘŘŘ -Ř.ŘŘŘ Ř.ŘŘŘ  
y řś.Šřş ř.ŚŚŚ řŚ.ŝšŝ ŚŞ.ŜřŚ  
total řś.Šřş ř.ŚŚŚ řŚ.ŝšŝ ŚŞ.ŜřŚ 
Results 
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Appendix A5: Excluded studies with reason by EPOC criteria.  
 







Reason for exclusion a 
1 Abela 2012 Y N UBA with no control 
2 Aboumatar 2012 Y N ITS with inadequate data collection points 
3 Alemagno 2010 Y N UBA with no control 
4 Allegranzi 2010 Y N UBA with no control 
5 Allegranzi 2013 Y N UBA with no control 
6 Ananda-Rajah 2010 Y N ITS with inadequate data collection points 
7 Apisarnthanarak 2010 Y N UBA with no control 
8 Apisarnthanarak 2010 Y N CBA with uncomparable control 
9 Ardizzone 2013 Y N UBA with no control 
10 Barahona-Guzman 2014 Y N ITS with inadequate data collection points 
11 Barbut 2013 Y N UBA for AHR use/ ITS for HAI rate 
12 Barrera 2011 Y N ITS with inadequate data collection points 
13 Bessesen 2013 Y N UBA with no control 
14 Bingham 2010 Y N UBA with no control 
15 Biswal 2013 Y N UBA with no control 
16 Boog 2013 Y N ITS with inadequate data collection points 
17 Borges 2012 Y N UBA with no control 
18 Bouadma 2010 Y N UBA with no control 
19 Buffet-Bataillon 2010 Y N UBA with no control 
20 Bukhari 2011 Y N UBA, no baseline data 
21 Caniza 2009 Y N UBA with no control 
22 Chen 2011 Y N UBA with no control 
23 Cheng 2010 Y N UBA for AHR use/ ITS for HAI rate 
24 Costers 2012 Y N UBA with no control 
25 Cumbler 2013 Y N ITS with inadequate data collection points 
26 Davis 2010 Y N UBA with no control 
27 de Macedo 2012 Y N UBA with no control 
28 di Martino 2011 Y N UBA with no control 
29 DiDiodato 2013 Y N UBA with no control 
30 Dierssen-Sotos 2010 Y N UBA with no control 
31 Dierssen-Sotos 2010 Y N UBA with no control 
32 Dilek 2012 Y N UBA with no control  
33 Dos Santos 2013 Y N ITS with inadequate data collection points 
34 El-Kafrawy 2013 Y N UBA with no control 
35 Eveillard 2011 Y N UBA with no control 
36 Fakhry 2012 Y N UBA with no control 
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37 Fitzpatrick 2011 Y N UBA with no control 
38 Forrester 2010 Y N UBA with no control 
39 Garcia-Rodriguez 2013 Y N UBA with no control 
40 Garcia-Vazquez 2011 Y N UBA with no control 
41 Gill 2009 Y N CBA with only 1 control 
42 Graf 2013 Y N UBA with no control 
43 Grant 2011 Y N UBA with no control 
44 Grayson 2011 Y N ITS with inadequate data collection points 
45 Helder 2010 Y N UBA with no control 
46 Helder 2012 Y N UBA, no baseline data 
47 Henderson 2012 Y N UBA with no control 
48 Homa 2011 Y N ITS with inadequate data collection points 
49 Jaggi 2013 Y N UBA with no control 
50 Jamal 2012 Y N ITS with inadequate data collection points 
51 Jeong 2013 Y N UBA with no control 
52 Kanj 2013 Y N UBA with no control 
53 KelcÃkova 2012 Y N UBA, no baseline data 
54 Kim 2013 Y N UBA with no control 
55 Kindness 2010 Y N UBA, no baseline data 
56 Kowitt 2013 Y N ITS with inadequate data collection points 
57 Langston 2011 Y N UBA with no control 
58 Leblebicioglu 2013 Y N UBA with no control 
59 Leblebicioglu 2013 Y N UBA with no control 
60 Levchenko 2011 Y N UBA with no control 
61 Linam 2011 Y N UBA with no control 
62 Ling 2012 Y N UBA with no control 
63 Lobo 2010 Y N UBA with no control 
64 Marra 2013 Y N UBA, no baseline data 
65 Mathai 2011 Y N UBA with no control 
66 Mazi 2013 Y N ITS with inadequate data collection points 
67 Molina-Cabrillana 2010 Y N UBA with no control 
68 Monistrol 2012 Y N UBA with no control 
69 Monistrol 2013 Y N UBA with no control 
70 Mukerji 2013 Y N UBA with no control 
71 Pontivivo 2012 Y N ITS with inadequate data collection points 
72 Prospero 2010 Y N UBA with no control 
73 Rahim 2009 Y N UBA with no control 
74 Rees 2013 Y N ITS with inadequate data collection points 
75 Reichardt 2014 Y N UBA with no control 
76 Rello 2013 Y N UBA with no control 
77 Roberts 2012 Y N ITS with inadequate data collection points 
78 Rogers 2010 Y N UBA with no control 
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a UBA; uncontrolled before and after study, CBA; controlled before and after study, ITS; interrupted time series study, AHR; alcohol based hand rub, and HAI; healthcare associated infection.
79 Rosenthal 2010 Y N UBA with no control 
80 Rosenthal 2013 Y N UBA with no control 
81 Rosenthal 2012 Y N UBA with no control 
82 Rosenthal 2012 Y N UBA with no control 
83 Rosenthal 2012 Y N UBA with no control 
84 Rosenthal 2012 Y N UBA with no control 
85 Sahud 2012 Y N ITS with inadequate data collection points 
86 Saint 2009 Y N UBA with no control 
87 Salama 2013 Y N UBA with no control 
88 Santos 2013 Y N UBA with no control 
89 Saramma 2011 Y N UBA with no control 
90 Scheithauer 2012 Y N UBA, no baseline data 
91 Scheithauer 2013 Y N UBA with no control 
92 Scheithauer 2013 Y N UBA with no control 
93 Scheithauer 2013 Y N UBA with no control 
94 Seirafian 2013 Y N UBA with no control 
95 Seto 2013 Y N ITS with inadequate data collection points 
96 Simmons 2013 Y N UBA with no control 
97 Son 2011 Y N UBA with no control 
98 Song 2013 Y N ITS with inadequate data collection points 
99 Tromp 2012 Y N UBA with no control 
100 van den Hoogen 2011 Y N UBA with no control 
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CRCT  Not done but 
available as part of 
the national 
campaign 
Not done but available as 
part of the national 
campaign 
Observation and feedback  
by "Ward Coordinator" performed 
one repeating 4-week cycle. The 
tasks were hand hygiene 
observation of an individual health 
care worker, and immediate 
feedback as well as preparing an 
action plan to feed back at a ward 
meeting.  
Training program for observers is 
required (Total 62 training visits, 1 
to 1.5 hour) 
Not done but available as part 
of the national campaign 
Not done but available as 
part of the national 
campaign 
Goal-setting: Ward coordinators 
were asked to fill out a form to 
record, observations, feedback, 
goals and action plans. 
National "Cleanyourhands" 
 campaign as routine 




CRCT Adequate product 
and facilities 
 
Education for improving 
relevant knowledge and 
skills. 
 
Distribution of educational 
material/written 









Distribution of posters replace 
every 12 weeks 
Interviews and messages in 
newsletters or hospital 
magazines 
General reminders by opinion 
leaders/ward management 
Gaining active commitment 
and initiative of ward 
manager. 
Modelling by informal 
leaders at the ward; 
demonstrating good hand 
hygiene behavior, 
instructing and stimulating 
their colleagues 
Goal-setting: Setting norms and 
targets within the team 
Three interactive team sessions 
(1–1.5 hour each) 
Analysis of barriers and 
facilitators to determine how 
nurses could best adapt their 
behaviour in order to reach their 
goal 
Nurses address each other in 
case of undesirable hand 
hygiene behavior 
All managers received a 4-hr 
training before the start of the 
intervention 
State of the art strategy 
(SAS) implemented 




CRCT Sink and AHR 
dispensers were 
available 
Small group teaching 
seminars 
Meeting of clinical manager and 
staff on the intervention units and 
the later meeting provide the 
specific performance feedback  
(biweekly meeting for 6 months) 
Posters and pamphlets Not done Not done System change was done 
Sink and AHR dispensers 
were available before the 
intervention period in both 
control and intervention 
arm 
M 
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Huang 
(2002) 
CRCT Not done Educational intervention 
(Universal precaution 
training) provided by 3 
trained investigator: 
including a) a 2-hr lecture, 
b) a 1-hr demonstration, 
and c) 30 min discussion 
Not done Not done Not done Not done No intervention  
but received training after 




RCT AHR dispensers and 
basins were 
available at point of 
care 
Not done Quantified individual feedback by 
receiving confidential and weekly 
written feedback reports of hand 
hygiene compliance 
Real-time reminders (audible 
beeps) using a wireless hand 
hygiene monitoring system 
Not done Not done AHR dispensers and basins  




RCT AHR dispensers and 
basin  
were available at 
point of care 
Hand hygiene education 
was performed by an 
infection control nurse via a 
2 hours lecture; the lecture 
session was repeated a few 
times in such a way as to 
cover all the personnel 
working in different shifts. 
Motivational Interview; five 
sessions of interviewing with 
maximum of 15 participants for 90 
minutes. 
Not done Not done Not done AHR dispensers were 
available at point of care 




ITS Not done Education sessions Direct feedback after observation 
and  
Monthly feedback of local 
compliance rates is provided to 
wards to guide the content of each 
local hand hygiene program. 
Visual reminders (no details) Not done Not done Reminder as posters 
L 
Lee (2013) ITS AHR at point of care Training and education of 
healthcare worker 
Observation and feedback of hand 
hygiene practices 
Reminders in the workplace 
(e.g. posters) 
Improving the safety climate 
in the institution with 
management support for 
the initiative 
Not done One unit was no 
intervention and another 
unit was system change 
changing AHR formulation. 
The other two were WHO-5. 
L 
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Marra 
(2013) 




position of AHR 
dispensers, 
recommending a 
change in the 
pressure of the tap 
water and added the 
dispensers in the 
corridors. 
 
*PDs were defined 
as those HCWs who 
wanted to change, 
to think, to develop 
new ideas for 
improving HH and 
who stimulated 
other HCWs. 
Positive Deviants (PD) 
meeting with all HCWs 
twice monthly 
The hospital PD 
coordinators provided PD 
training for all HCWs 
including nurses, physicians, 
physical therapists, speech 
pathologists, and 
nutritionists who used the 
dispensers and provided the 
opportunities to express 
feelings about hand 
hygiene. 
PDs showed the HHC% and 
discussed their performance in 
every meeting.  
Some ideas and strategies were 
related to the reminders such 
as preparing badges for doctors 
who perform HH and noting 
them as examples and 
preparing a short theater 
presentation discussing "My 5 
Moments for Hand Hygiene" 
with their peers. 
PD initiated engaging 
people to involve by inviting 
another PD in the next 
meeting 
Not done No intervention 




ITS Increase availability 
of hand sanitizers 
(AHR) 
Education 




Posting data on intranet 
Compliance criteria shared with 
health care professionals 
Inclusion in dashboard with goal-
setting 
Devotion of activity to low 
performing units  
Face-to-face feedback during 
weekly tracer rounds 
Frequent audit and feedback and 
discussed the feedback findings 
with each unit supervisor and 
fostering ways to improve 
Promotion 
Flashing  pins  “Wash  your  
hands  stay  healthy” 
Ask  me  “have  you washed your 
hands”  pins   
Hand hygiene banners 
throughout the organization 
Magnetic door posters 
promoting hand hygiene 
Leadership commitment  
Senior leadership 
engagement included 
monthly tracking of the 
compliance rates and 
communicating to 
management and hospital 
staff during monthly 
meeting and through the 
dashboard 
Goal-setting: 
Setting compliance goals  
Increased the stated goal to 75%  
Increased the goal to 85% 
No intervention 




ITS Not done Not done Feedback metrics tabulated by a 
central server database delivered 
back to the HCWs through 
electronic light emitting diode 
boards, electronic mail summaries, 
and weekly performance reports. 
Not done Not done 24 video cameras and motion 
sensors at handwashing sinks 
and sanitizer dispensers to 
record hand hygiene 
opportunities 
Goal-setting: Setting the 
targeted compliance as >=95% 
Video cameras were 
installed during baseline 
period as well but without 
feedback. M 
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Armellino 
(2012) 
ITS Not done Not done Feedback metrics tabulated by a 
central server database delivered 
back to the HCWs through 
electronic light emitting diode 
boards, electronic mail summaries, 
and weekly performance reports. 
Not done Not done 24 video cameras and motion 
sensors at hand washing sinks 
and sanitizer dispensers to 
record hand hygiene 
opportunities 
Goal-setting: Setting the 
targeted compliance as >=95% 
Video cameras were 
installed during baseline 




ITS 38 AHR dispensers 
were installed 
and changed the 
location 
Not done Not done Not done Not done Not done No intervention 










Annual educational training 
for clinical staff including 
physician and hospital staff 
Routine feedback to HCWs Marketing committee launched 
a campaign that emphasized 
branding hand hygiene with a 
positive image.  
Slogan and child-friendly 
posters and signs with the 
message were displayed at 
strategic locations. 
Additional items containing the 
message, including pens, 
buttons, calendars, and 
coloring books, were widely 
distributed. 
Not done Goal-setting: Hand hygiene goal 
added to employee  
Three goals related to quality or 
patient safety 
 
Reward incentives: If the goals 
are achieved, every employee 
receives a financial reward. 
Multiple unit-based 
educational  
initiatives and use of a gel-




ITS Not done Hand hygiene auditor 
training program based on 
the WHO "My 5 moments 
for hand hygiene" in the 
orientation program for 
final year nursing students,  
1- hour session including 
lecture and practical 
auditing using WHO video 
tools and 398 nursing 
students from 3 nursing 
schools involved. 
Not done Not done Not done Not done No intervention/routine 
practice 
M 





As part of the 
bundle of readiness 
assessment and 
planning program 
Expanded HH direct 
observation program 
Observation program was 
expanded to include all 
inpatient and outpatient 
locations. The observers 
attended required training 
on a standardized 
observation methodology  
Readiness assessment and planning 
The project bundle focused 
planners on addressing the 
following: defining the problem, 
ensuring project alignment with the 
organization’s  mission,  securing  
financial support, defining 
performance and measurement 




Poster messaging and targeted 
talks aimed to increase HH 
awareness and its importance 
in preventing HAIs. 
Leadership goal-setting  
Improved HH adherence 
was adopted as an 
institutional quality 
improvement goal and the 
performance related to the 
goal immediately became a 
factor in annual 
performance evaluations 
and incentive compensation 
for medical center leaders. 
Goal-setting:  
Modest HH adherence goals 
were set in the first year of the 
program (adherence of 65% as a 
threshold goal, 75% as a target 
goal, and 85% as a reach goal) 
with the intent of increasing 
performance requirements each 
year. 
Reward incentive: 
Financial incentives via a self-
insurance trust allocation rebate 
program. The component of the 
allocation rebate was worth up 
to 25% of the total rebate 
dollars (2.5% of yearly 
premiums). For example, for a 
physician whose yearly premium 
was $10,000.00, the rebate 
amounted to $250.00. 
Phase I: Hand hygiene 
annual faculty and staff 
training 
M 
  Phase II Same as Phase I 
above 
Same as Phase I above Same as Phase I above Same as Phase I above Hand Hygiene executive 
committee   
The committee consisted of 
key physician and nursing 
leaders was established to 
review location 
performance monthly and 
direct interventions. 
Goal-setting and Reward 
incentive 





Units with low adherence were 
identified for interventions on 
the basis of a system-wide hand 




Observers provided direct 
feedback when a hand hygiene 
opportunity was missed. System 
leadership monitored event 
reporting and acted as 
necessary, consistent with 
organizational policies 
concerning behaviors that 
undermine a culture of safety. 
Phase II: Intervention 
Implemented in Phase I. 
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Higgins 
(2013) 
ITS Increased supplies of 
hand AHR, dispenser 
at bedside. 
Adenosine triphosphate 
(ATP) monitoring system, a 
mobile stand-alone 
computer system, was 
purchased and used in the 
clinical area during spot 
audits and also at regular 
intervals outside the staff 
canteen to measure 
handwashing technique. 
 
HCWs were selected at 
random and asked to wash 
their hands with soap and 
water. Once the hands were 
completely dry, the swab 
was rubbed against the tips 
of each finger, in between 
each finger and then in an S-
shape along the palm of one 
hand. 
Monthly hand hygiene audit and 
verbal feedback provided directly 
to staff during the audits. 
Posters displaying hand 
hygiene technique and 
information of "WHO 5 
moments" placed at the key 
area of the hospital. 
 
Advertising campaign was 
carried out in the hospital 
through e-mails and general 
hospital mail. An information 
leaflet was designed and copies 
were left in the canteen, at 
nurses’  stations,  in  staff  
meeting rooms etc. 
Commitment from 
management, hand hygiene 
audit results were provided 
to the hospital executive 
team and board. 
Reward incentive: 
Fob watches were provided as 
spot prizes 
No intervention 




ITS Not done Not done Not done Screen servers for 6 computer 
screens, 2 per unit, were 
involved to emphasize the 
need for improved adherence 
to hand hygiene protocols and 
were designed according to 
theoretical principles of 
message framing. The 
messages on the screen servers 
were replaced by a newly 
designed 2-screen series every 
2 weeks. 
Not done Not done AHR dispensers were 
available at point of care.  
However, five months 
before the study present, a 
multidisciplinary infection 
prevention education 




availability of hand 
sanitiser 
Education and training 
Developed electronic 
learning module and 
training video that provided 
hand hygiene education for 
all staff. It was accessible 
through the hospital 
intranet.  A  ‘certification’  
program was also available 
by which staff 
demonstrated HH 
competency. 
Measurement and feedback 
Routine HH audits 
Monthly unit specific data 
published on an intranet site 
available to all staff, and reported 
to executive leadership, clinical 
leaders and board members 
Marketing and communication 
Marketing staff created a series 
of posters and screen savers, 
stories in medical center 
publications and local news 
outlets, and direct 
communication with staff 
about expectations and 




emphasised the importance 
of hand hygiene 
Not done No intervention 
(but the AHR was available) 
M 
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Morgan 
(2012) 
ITS Installed multiple 
automated, 
networked, touch 
free AHR and soap 
dispensing units at 
the entrance to each 
room and the sink in 
each room 
Infection control and 
research staff monthly 
visited each unit to present 
the poster, remind staff 
about the importance of 
hand hygiene, and answer 
any questions about the 
study. The WHO 5 Moments 
for Hand Hygiene were 
discussed in training. 
Feedback compliance was provided 
for entry and exit based on human 
observation. 
Two posters in each unit to 
display unit-specific monthly 
and quarterly hand hygiene 
compliance rate also included 
infection control reminders to 
link hand hygiene with 
infection prevention (e.g. unit 
infection rates, photos of unit 
staff performing hand hygiene, 
general HAI education) 
Not done Not done No intervention 




ITS Alcohol hand rub at 
bedside 
Not done Regular audit and feedback of 
compliance 
Posters reminding HCWs to 
clean their hands 
Empowering patients to 
remind HCWs 




ITS Not clear Not clear Not clear Not clear Not clear Identify key area of 
improvement 
 











All HCWs received 
continuing education and 
pre-service  
education on hand hygiene 
issues by experienced 
infection control nurses 
(ICN) 
Monitoring and feedback of hand 
hygiene compliance monthly by 
infection control nurses 
Posters Not done HCWs were encouraged to 
educate their patients and 







ITS AHRs were placed at 
all bedsides on high 
risk areas (ER, ICUs) 
Theoretical and practical 
workshop to all HCWs and 
practical sessions 
Audit by a hand hygiene monitor 
team 
8 HCWs direct observation with 2 
evaluation periods and 25 days of 
monitoring 
 
Feedback through informal 
interactive session on every ward at 
the end of evaluation periods (2 
sessions)  
Posters and handout, replaced 
monthly 
Commitment by 
administrative and nursing 
director 




Promotion of hand hygiene 
such as staff education, 
reminders, and six months 
hand hygiene audit was 
performed during baseline 
period but it was neither 
structured nor sustained on 
time. 
H 
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AHRs were placed at 
all bedsides in 
conventional wards 
while maintaining 
those at corridors. 
 
Maintain as above Audit by a hand hygiene monitor 
team  
8 HCWs carried out direct 
observation with 17 evaluation 
periods and 51 days of monitoring. 
3 randomized days every 3 weeks 
("3/3 strategy") 
 
Feedback using control charts on 
every ward at institutional and 
individual level. 
Maintain as above Maintain as above 
 
Corrective actions: 
Modification of incorrect HH 
habits, clarification of 
doubts and positive 
reinforcement were 
conducted 
Not done Phase II: Intervention 
Implemented in Phase I. 
Koff 
(2011) 
ITS Not done A personalized hand 
hygiene device was worn by 
HCWs used for recording 
the frequency of hand 
disinfection event. 
Feedback was provided to both 
individuals and the entire 
group. 







in all public non-
patient care areas  
Educational program; online 
teaching, grand rounds 
lectures and nurses 
Close observation with feedback Promoting campaign by 
email to introduce the 
campaign to employees 
Posters; large size to introduce 
to patients and families, small 
size for the walls in various 
places) 
Handout for new patients 
Stickers and pins with positive 
and humorous messages 
A private advertising firm was 
contracted to develop a 
professional marketing 
campaign for the hospital. 
Leadership commitment  
Chief medical officer and 
CEO spoke about HH at 
every given opportunity  
Heads of department and 
ICU directors were asked to 
make hand hygiene an 
educational priority and to 
personally carry out hand 
hygiene observation 
Not done During 2007 to July 2008 
(baseline period), 
intervention component 1 
to 4, including placement of 
hand sanitizers, reminder 
signs, education, and 
feedback with observed 
compliance, was 
implemented but reinforced 
with a new strategy 
together with component 5 








ITS Changing the 
position of alcohol 
gel dispensers in the 
patient rooms and 
to put more in the 
corridors. 
Positive deviants (PD) 
meeting with all SDU HCWs 
twice monthly, 1.5 hour 
each, attendance about 35-
40 to discuss and provide 
training for all HCWs 
including nurses, physicians, 
physical therapists, speech 
pathologists, and 
nutritionists who used the 
dispensers and provide the 
opportunities to express 
feelings about hand 
hygiene. 
PD showed the hand hygiene 
compliance and discussed their 
performance in every meeting.  
Incorporated laminated sheets 
on "My Five Moments for Hand 
Hygiene" as the first page in all 
of SDU patient medical records. 
PD initiated engaging 
people to involve by inviting 
another PD in the next 
meeting 
Not done No intervention (but the 




ITS Alcohol hand 
disinfection at every 
bed together with 
pictures and posters, 
and instruction. 
Meeting monthly (reporting, 
evaluation, feedback and 
discussion) and continuous 
education program 
(Department level) 
Feedback of hand hygiene 
performance during the meeting 
Not done Not done Goal-setting: 
The goal was a 40% reduction in 
healthcare associated infections 
in ventilated patients. 
Process objective 
The process objective was 100% 
of staff to implement basic 
hygiene routines. 
No intervention (but the 




ITS Alcohol foam 
dispenser installed 





container for all staff 
 
Hand sanitizing 
station in the main 
lobby, emergency 




Implementation of "You 
bugged me" program, staff 
member presenting another 
employee with a card if they 
witnessed them not 
washing their hand 
properly. 
 
The infection control 
coordinator attended all the 
staff meeting in all 
departments and provided 
educations on proper hand 
hygiene technique. One part 
of the program is the use of 
the fluorescent lotion to see 
effects of handwashing 
Direct feedback when staffs forget 
to perform hand hygiene via "You 
bugged me" program. 
Signs to remind the staff to 
wash their hands. 
 
Flyers to educate patients' 
visitors 
 
The patients were educated on 
admission to remind the staff 
to wash their hands. 
Chief executive Officer 
(CEO) and Chief Nurse 
Officer (CNO) involved in 
activity for the penalty of 
non compliance 
Not done No intervention (but the 
AHR was available) 
M 
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Chou 
(2010) 
ITS Adding AHR 
dispensers in each 
patient room 




material includes added 
interactive demonstration 
"fluorescent germs" and 
bacterial cultures of hands 
before and after hand 
hygiene to hospital-wide 
educational programs to 
impress the important of 
hand hygiene and posters 
contest 
Hand hygiene liaison (at least one 
staff each department) responsible 
for review in HH policy, ensuring 
availability of HH product, 
observing HH at least 20 opp. each 
month) 
 
Feedback in hand hygiene 
compliance 
Posters from the contest 
displayed in the key areas. 
Hospital wide support; the 
bundle of this intervention 
was introduced to hospital 
administration for their 
support and approval and 
presented to multiple 
leadership committees 
consisting of physicians, 
nursing directors and 
managers and other leaders 
 
A violation letter was sent 
to managerial personnel of 
noncompliant individuals to 
take corrective action with 
violators.  
Goal-setting and Reward 
incentive: 
Nursing units were rewarded 
with pizza parties if they 
achieved and sustained the 
targeted hand hygiene 
compliance. 
No intervention (but the 






AHR were available 
during baseline and 
intervention) 
Not clear Not clear Not clear Not clear Spring 2003: Applying social 
marketing theory to promote 
standard precautions and 
isolation precautions mentioned 
hand hygiene as an element of 
standard precautions (did not 
target the promotion of AHR in 
particular) 
 
Autumn 2005: Swiss national 
hand hygiene promotion 
campaign and the global patient 
safety challenge entitled  'Clean 
your hand is safer care' with an 
exclusive focus on the frequent 
and proper of AHR. 











AHR placed at the 
end of each bed, 
chart trolleys and in 
medication 
preparation areas.  
Liquid soap provided 
at handwashing 
basin.  
(Pre intervention: 1 
month)  
Pre intervention: 4 months 
A series of meetings led by 
seniors and attended by all 
clinical and non-clinical staff  
 
Intervention phase 1: 2 
months 







Intervention phase 1: 2 months 
Staff developed talking-wall 
promotional cartoons with prizes 
awarded and the additional 







Intervention phase 1: 2 months 
Information in accordance with 
CDC’s  guidelines  was  provided  







Intervention phase 2: 3 
months 
"Walk-arounds" by 
executive medical and 
nursing members and 
photograph of senior staff 
with speech balloons at 







Large photographs of the 
hospital executive were 
positioned throughout the 
wards 
No intervention (but the 
AHR was available) 
M 
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AHR placed at the 
end of each bed, 
chart trolleys and in 
medication 
preparation areas  
Liquid soap provided 
at handwashing 
basin.  
(Pre intervention: 1 
month) 
Pre intervention: 5 months 
Clinician-led meetings, 
semi-structured format all 






Not done  
Intervention phase 1: 2 months 
Posters and Screen savers 
 
 
Intervention phase 2: 5 
months 
"Walk-arounds" by 
executive medical and 
nursing members AND 
Photograph of senior staff 
with speech balloons at 
each ward in the last month 
Not done No intervention (but the 
AHR was available) 
 













AHR placed at the 
end of each bed, 
chart trolleys and in 
medication 
preparation areas.  








Not done Not done Not done Not done Not done No intervention (but the 









providing standardized unit 
in-service presentations 
prepared by infection 
preventionist, the hospital 
epidemiologist, physician 
groups, and infection 
control personnel and 
clinical staff.  
Ongoing audit with monthly 
feedback by infection  
preventionist 
Not done Not done Not done No intervention/routine 
practice 
H 




providing standardized unit 
in-service presentations 
prepared by infection 
preventionist, the hospital 
epidemiologist, physician 
groups, and infection 
control personnel and 
clinical staff. 
 
Ongoing audit with monthly 




Posters with catchy phrases 
were placed throughout the 
hospital. 




managers, service directors 
and hospital epidemiologist 
to encourage staff 
involvement and to provide 
unit specific feedback. 
Reward incentive: through 
“Positive  reinforcement” 
The hand hygiene committee 
generated new motivational 
campaign themes to maintain 
interest.  
An example of a group 
motivator  theme  was  the  “War  
on  Germs”  to  encourage  unit  
teamwork. 
Publicizing that the unit with the 
best hand hygiene compliance 
would win a pizza party  
Individual incentives theme, in 
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caught in the act of performing 
hand hygiene were entered into 




CCT Not done Hand washing self-study 
module 
and additional education 
sessions about 
microorganisms 
Not done Posters (bugs and agar plates) 
placed and rotated the location  
Not done Not done Hand washing self-study 
module 
M 
    Not done Hand washing self-study 
module 
Not done Not done Not done Goal-setting and Reward 
incentive: hand hygiene 
adherence goal and reward with 
pizza party. Unit-based 
recognition by peers on a sticker 
poster and rewarding some 
incentives, e.g. movie ticket, gift 
card, unit recognition and pizza 
party. 





CBA Make AHR available 
at the bedside 
Not done Not done Posters on wards updated 
monthly 
Encouraged patients to ask 
staff to clean their hands 
Not done Control: no intervention but 
"cleanyourhands" campaign 
implemented during 2004-





CBA Not done Educational program by 
experienced nurse teachers 
with specific expertise (5 
different sessions, 30 min 
each) 
Not done Not done Not done Not done No intervention/routine 
practice 
M 
* AHR: alcohol based hand rub, CRCT: cluster randomised controlled trial, RCT: randomised controlled trial, ITS: Interrupted time series study, CCT: controlled clinical trial, CBA: controlled before and after study.
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Appendix A7: Reasons for exclusion from network meta-analysis. 
 4 studies were excluded from the network meta-analysis. The reasons were: i.) Conducted in only nursing students (Salmon 2013) ii.) Hand hygiene intervention and control period unclear (Jaggi 2012) iii.) Reporting compliance only at entry and exit from the patients room  (Armellino 2012, 2013) 
 
   Salmon S, Wang XB, Seetoh T, Lee SY, Fisher DA. A novel approach to improve hand hygiene compliance of student nurses. Antimicrob Resist Infect Control 2013;2:16.  Jaggi N, Sissodia P. Multimodal supervision programme to reduce catheter associated urinary tract infections and its analysis to enable focus on labour and cost effective infection control measures in a tertiary care hospital in India. J Clin Diagn Res 2012;6:1372-76.  Armellino D, Trivedi M, Law I, Singh N, Schilling M, Hussain E, et al. Replicating changes in hand hygiene in a surgical intensive care unit with remote video auditing and feedback. Am J of Inf Control 2013;41:925-27.  Armellino D, Hussian E, Schilling ME, Senicola W, Eichorn A, Dlugacz Y, et al. Using high-technology to enforce low-technology safety measures: the use of third-party remote video auditing and real-time feedback in healthcare. Clin Infect Dis 2012;54:1-7.
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Appendix A8: Funnel plots  Funnel plots of RCT studies, WHO5 VS WHO5+GOAL Random effects model  
    
  179 
Funnel plot of ITS studies, no intervention compared to WHO5  Random effects model  
  
  180 
Funnel plot of all ITS studies   Random effects model 
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Appendix B: Chapter4 Supplementary 
Three main phrases used in the systematic literature search 1. Intensive care unit (ICU) 2. Long term follow up 3. Low and middle income countries Key words: 
(“intensive	  care	  unit”	  or	   “critical	  care	  unit”	  or	  “intensive	  therapy	  unit”	  or	  “intensive	  treatment	  
unit”)	  and	  ("post-discharge" or "post discharge" or "post-ICU discharge" or "post ICU discharge" or "after discharge" or "long-term outcome" or "long term outcome" or "long-term follow up" or "long term follow up" or "long-term survival" or "long term survival" or "five-year survival" or "five year survival" or "five years survival" or "five years" or "two-year survival" or "two year survival" or "one-year survival" or "one year survival") and ("low income" or "developing country" or "middle income" or "low-middle" or "upper-middle-income" or "lower-middle-income" or "Afghanistan" or "Gambia" or "Mozambique" or "Bangladesh" or "Guinea" or "Myanmar" or "Benin" or "Guinea-Bisau" or "Nepal" or "Burkina Faso" or "Haiti" or "Niger" or "Burundi" or "Kenya" or "Rwanda" or "Cambodia" or "Korea, Dem Rep" or "Republic of Korea" or "Sierra Leone" or "Central African Republic" or "Kyrgyz Republic" or "Somalia" or "Chad" or "Liberia" or "Tajikistan" or "Comoros" or "Madagascar" or "Tanzania" or "Congo, Dem. Rep" or "Congo" or "Malawi" or "Togo" or "Eritrea" or "Mali" or "Uganda" or "Ethiopia" or "Mauritania" or "Zimbabwe" or "Albania" or "Indonesia" or "Samoa" or "Armenia" or "India" or "São Tomé and Principe" or "Belize" or "Iraq" or "Senegal" or "Bhutan" or "Kiribati" or "Solomon Islands" or "Bolivia" or "Kosovo" or "South Sudan" or "Cameroon" or "Lao" or "Sri Lanka" or "Cape Verde" or "Lesotho" or "Sudan" or "Congo, Rep." or "Marshall Islands" or "Swaziland" or "Côte d'Ivoire" or "Micronesia" or "Syrian" or "Djibouti" or "Moldova" or "Timor-Leste" or "Egypt" or "Mongolia" or "Tonga" or "El Salvador" or "Morocco" or "Ukraine" or "Fiji" or "Nicaragua" or "Uzbekistan" or "Georgia" or "Nigeria" or "Vanuatu" or "Ghana" or "Pakistan" or "Vietnam" or "Guatemala" or "Papua New Guinea" or "West Bank and Gaza" or "Guyana" or "Paraguay" or "Yemen" or "Honduras" or "Philippines" or "Zambia" or "Angola" or "Ecuador" or "Palau" or "Algeria" or "Gabon" or "Panama" or "American Samoa" or "Grenada" or "Peru" or "Antigua and Barbuda" or "Iran" or "Romania" or "Argentina" or "Jamaica" or "Russia" or "Azerbaijan" or "Jordan" or "Serbia" or "Belarus" or "Kazakhstan" or "Seychelles" or "Bosnia and Herzegovina" or "Latvia" or "South Africa" or "Botswana" or "Lebanon" or "St. Lucia" or "Brazil" or "Libya" or "St. Vincent and the Grenadines" or "Bulgaria" or "Lithuania" or "Suriname" or "Chile" or "Macedonia" or "Thailand" or "China" or "Malaysia" or "Tunisia" or "Colombia" or "Maldives" or "Turkey" or "Costa Rica" or "Mauritius" or "Turkmenistan" or "Cuba" or "Mexico" or "Tuvalu" or "Dominica" or "Montenegro" or "Uruguay" or "Dominican Republic" or "Namibia" or "Venezuela") Pubmed search: 
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(("intensive care units"[MeSH Terms] OR ("intensive"[All Fields] AND "care"[All Fields] AND "units"[All Fields]) OR "intensive care units"[All Fields] OR ("intensive"[All Fields] AND "care"[All Fields] AND "unit"[All Fields]) OR "intensive care unit"[All Fields]) OR ("intensive care units"[MeSH Terms] OR ("intensive"[All Fields] AND "care"[All Fields] AND "units"[All Fields]) OR "intensive care units"[All Fields] OR ("critical"[All Fields] AND "care"[All Fields] AND "unit"[All Fields]) OR "critical care unit"[All Fields]) OR (intensive[All Fields] AND ("therapy"[Subheading] OR "therapy"[All Fields] OR "therapeutics"[MeSH Terms] OR "therapeutics"[All Fields]) AND unit[All Fields]) OR (intensive[All Fields] AND ("therapy"[Subheading] OR "therapy"[All Fields] OR "treatment"[All Fields] OR "therapeutics"[MeSH Terms] OR "therapeutics"[All Fields]) AND unit[All Fields])) AND ("post-discharge"[All Fields] OR "post discharge"[All Fields] OR "post-ICU discharge"[All Fields] OR "post ICU discharge"[All Fields] OR "after discharge"[All Fields] OR "long-term outcome"[All Fields] OR "long term outcome"[All Fields] OR "long-term follow up"[All Fields] OR "long term follow up"[All Fields] OR "long-term survival"[All Fields] OR "long term survival"[All Fields] OR "longterm survival"[All Fields] OR "five-year survival"[All Fields] OR "five year survival"[All Fields] OR "five years survival"[All Fields] OR "five years"[All Fields] OR "two-year survival"[All Fields] OR "two year survival"[All Fields] OR "one-year survival"[All Fields] OR "one year survival"[All Fields]) AND ("low income"[all fields] or "developing country"[all fields] or "middle income"[all fields] or "low-middle"[all fields] or "upper-middle-income"[all fields] or "lower-middle-income"[all fields] or "afghanistan"[all fields] or "gambia"[all fields] or "mozambique"[all fields] or "bangladesh"[all fields] or "guinea"[all fields] or "myanmar"[all fields] or "benin"[all fields] or "guinea-bisau"[all fields] or "nepal"[all fields] or "burkina faso"[all fields] or "haiti"[all fields] or "niger"[all fields] or "burundi"[all fields] or "kenya"[all fields] or "rwanda"[all fields] or "cambodia"[all fields] or "korea dem rep"[all fields] or "republic of korea"[all fields] or "sierra leone"[all fields] or "central african republic"[all fields] or "kyrgyz republic"[all fields] or "somalia"[all fields] or "chad"[all fields] or "liberia"[all fields] or "tajikistan"[all fields] or "comoros"[all fields] or "madagascar"[all fields] or "tanzania"[all fields] or ("congo, dem. rep"[all fields]) or "malawi"[all fields] or "togo"[all fields] or "eritrea"[all fields] or "mali"[all fields] or "uganda"[all fields] or "ethiopia"[all fields] or "mauritania"[all fields] or "zimbabwe"[all fields] or "albania"[all fields] or "indonesia"[all fields] or "samoa"[all fields] or "armenia"[all fields] or "india"[all fields] or "sao tome and principe"[all fields] or "belize"[all fields] or "iraq"[all fields] or "senegal"[all fields] or "bhutan"[all fields] or "kiribati"[all fields] or "solomon islands"[all fields] or "bolivia"[all fields] or "kosovo"[all fields] or "south sudan"[all fields] or "cameroon"[all fields] or "lao"[all fields] or "sri lanka"[all fields] or "cape verde"[all fields] or "lesotho"[all fields] or "sudan"[all fields] or "congo, rep."[all fields] or "marshall islands"[all fields] or "swaziland"[all fields] or "cote d'ivoire"[all fields] or "micronesia"[all fields] or "syrian"[all fields] or "djibouti"[all fields] or "moldova"[all fields] or "timor-leste"[all 
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fields] or "egypt"[all fields] or "mongolia"[all fields] or "tonga"[all fields] or "el salvador"[all fields] or "morocco"[all fields] or "ukraine"[all fields] or "fiji"[all fields] or "nicaragua"[all fields] or "uzbekistan"[all fields] or "georgia"[all fields] or "nigeria"[all fields] or "vanuatu"[all fields] or "ghana"[all fields] or "pakistan"[all fields] or "vietnam"[all fields] or "guatemala"[all fields] or "papua new guinea"[all fields] or "west bank and gaza"[all fields] or "guyana"[all fields] or "paraguay"[all fields] or "yemen"[all fields] or "honduras"[all fields] or "philippines"[all fields] or "zambia"[all fields] or "angola"[all fields] or "ecuador"[all fields] or "palau"[all fields] or "algeria"[all fields] or "gabon"[all fields] or "panama"[all fields] or "american samoa"[all fields] or "grenada"[all fields] or "peru"[all fields] or "antigua and barbuda"[all fields] or "iran"[all fields] or "romania"[all fields] or "argentina"[all fields] or "jamaica"[all fields] or "russia"[all fields] or "azerbaijan"[all fields] or "jordan"[all fields] or "serbia"[all fields] or "belarus"[all fields] or "kazakhstan"[all fields] or "seychelles"[all fields] or "bosnia and herzegovina"[all fields] or "latvia"[all fields] or "south africa"[all fields] or "botswana"[all fields] or "lebanon"[all fields] or "st. lucia"[all fields] or "brazil"[all fields] or "libya"[all fields] or "st. vincent and the grenadines"[all fields] or "bulgaria"[all fields] or "lithuania"[all fields] or "suriname"[all fields] or "chile"[all fields] or "macedonia"[all fields] or "thailand"[all fields] or "china"[all fields] or "malaysia"[all fields] or "tunisia"[all fields] or "colombia"[all fields] or "maldives"[all fields] or "turkey"[all fields] or "costa rica"[all fields] or "mauritius"[all fields] or "turkmenistan"[all fields] or "cuba"[all fields] or "mexico"[all fields] or "tuvalu"[all fields] or "dominica"[all fields] or "montenegro"[all fields] or "uruguay"[all fields] or "dominican republic"[all fields] or "namibia"[all fields] or "venezuela"[all fields])  Inclusion criteria: a). Populations are the patients who had been admitted to adults intensive care units (ICUs) including specialised ICUs; medicine/coronary care ICUs, surgical/neurosurgical ICUs, trauma ICUs, and cardiothoracic ICU. Studies confined to certain underlying or specific diseases such as sepsis, transplantations, and cardiac surgery will be excluded. b). Follow-up period must be at least one year from ICU/hospital admission or ICU/hospital discharge. c). No restrictions regarding language or year of publication. Results: 201 abstracts Accessed: 15 June 2013 
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Appendix C: Chapter 5 Supplementary 
Appendix C1: Model description and parameter estimation 
List of parameters and definition 
Parameters Definition 
  𝑈௣௔௧ Number of MRSA (-ve) patients on ward at one time 
  𝐶௣௔௧ Number of MRSA (+ve) patients on ward at one time 
  𝑛௣௔௧ Number of beds (U_pat+C_pat) 
  𝑈ு஼ௐ Number of MRSA (-ve) HCWs per shift 
  𝐶ு஼ௐ Number of MRSA (+ve) HCWs per shift 
  𝑛ு஼ௐ Number of total HCWs per shift (U_HCW+C_HCW) 
   
𝜇 Removal rate of uncolonised patient (1/mean length of stay) (day-1) 
𝛾 Removal rate of colonised patients (1/ mean length of stay) (day-1) 
𝜋 Proportion of admission with colonized 
c Patient-HCW contact per day (per patient) 
𝑃ு௉ Transmission probability from HCW to Patient per contact 
c’ HCW-patient contact per day (per HCW) 
𝑃௉ு Transmission probability from Patient to HCW per contact 
𝐻𝐻𝐶 Hand hygiene compliance 
𝜆 
 





ௗ௧ =   −  𝜇 ∗ 𝑈௣௔௧ − 𝑐 ∗ 𝑃ு௉ ∗ 𝑈௣௔௧ ∗
஼ಹ಴ೈ
௡ಹ಴ೈ
+ (1 − 𝜋) ∗ (𝜇 ∗ 𝑈௣௔௧ + 𝛶 ∗ 𝐶௣௔௧)  (1) 
ௗ஼೛ೌ೟  
ௗ௧ =   −  𝛶 ∗ 𝐶௣௔௧ + 𝑐 ∗ 𝑃ு௉ ∗ 𝑈௣௔௧ ∗
஼ಹ಴ೈ
௡ಹ಴ೈ
+   𝜋 ∗ (𝜇 ∗ 𝑈௣௔௧ +   𝛶 ∗ 𝐶௣௔௧)  (2) 
ௗ௎ಹ಴ೈ  
ௗ௧ =   − ቀ𝑐
′ ∗ 𝑃௉ு ∗ 𝐶௣௔௧ ∗
௎ಹ಴ೈ
௡ಹ಴ೈ
ቁ +   𝜆 ∗ 𝐶ு஼ௐ      (3) 
ௗ஼ಹ಴ೈ  
ௗ௧ =    ቀ𝑐
′ ∗ 𝑃௉ு ∗ 𝐶௣௔௧ ∗
௎ಹ಴ೈ
௡ಹ಴ೈ




Estimates of transition probability from HCWs to patient (𝑷𝑯𝑷) and the ward reproduction 
number (RA) 
 
From Worby et al.,[1] we have an estimate from our data of the force of infection,  𝛽,  arising from  a 
single colonised patient.  
 
Assuming the number of colonized HCWs can be approximated by the quasi-equilibrium values, we 
can use equation (1)-(4) to derive the expression for  𝑃ு௉ in terms of 𝛽 and other parameters. 
 
  𝑃ு௉ =
ఉ∗൫௖ ′∗௉ುಹା  ఒ∗୬_ୌେ୛൯
௖∗௖′∗௉ುಹ
     
 
We used directly observed values of 𝑐, 𝑐 ′, nୌେ୛, n୮ୟ୲, and  𝐻𝐻𝐶 while 𝑃௉ு was adopted from 
elsewhere, estimated by McBryde et al.[2] 
 
The ward reproduction number (RA), the number of secondary cases arising from one primary case in 
a completely susceptible population, is given by  
 
   𝑅஺ =   
௖∗௉ಹು∗௖ ′∗௉ುಹ∗(୬_୮ୟ୲ିଵ)
ఊ∗(ఒ∗୬_ୌେ୛ା௉ುಹ∗௖ ′)
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Appendix(C2:(Plot of all iterations from four comparisons in probability 














HHC 10 vs 20% 
HHC 10 vs 40% 
HHC 10 vs 80% 
HHC 40 vs 80% 
HHC 10 vs 20% 
HHC 10 vs 40% 
HHC 10 vs 80% 
HHC 40 vs 80% 
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Appendix D: Peer reviewed publications arising directly from the thesis 
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Comparative efficacy of interventions to promote hand hygiene 
in hospital: systematic review and network meta-analysis
Nantasit Luangasanatip,1, 2 Maliwan Hongsuwan,1 Direk Limmathurotsakul,1, 3 Yoel Lubell,1, 4  
Andie S Lee,5, 6 Stephan Harbarth,5 Nicholas P J Day,1, 4 Nicholas Graves,2, 7 Ben S Cooper1,  4 
ABSTRACT
OBJECTIVE
To evaluate the relative efficacy of the World Health 
Organization 2005 campaign (WHO-5) and other 
interventions to promote hand hygiene among 
healthcare workers in hospital settings and to 
summarize associated information on use of 
resources.
DESIGN
Systematic review and network meta-analysis.
DATA SOURCES
Medline, Embase, CINAHL, NHS Economic Evaluation 
Database, NHS Centre for Reviews and Dissemination, 
Cochrane Library, and the EPOC register (December 
2009 to February 2014); studies selected by the 
same search terms in previous systematic reviews 
(1980-2009).
REVIEW METHODS
Included studies were randomised controlled trials, 
non-randomised trials, controlled before-after trials, 
and interrupted time series studies implementing 
an intervention to improve compliance with hand 
hygiene among healthcare workers in hospital 
settings and measuring compliance or appropriate 
proxies that met predefined quality inclusion criteria. 
When studies had not used appropriate analytical 
methods, primary data were re-analysed. Random 
effects and network meta-analyses were performed 
on studies reporting directly observed compliance 
with hand hygiene when they were considered 
sufficiently homogeneous with regard to 
interventions and participants. Information on 
resources required for interventions was extracted 
and graded into three levels.
RESULTS
Of 3639 studies retrieved, 41 met the inclusion criteria 
(six randomised controlled trials, 32 interrupted time 
series, one non-randomised trial, and two controlled 
before-after studies). Meta-analysis of two randomised 
controlled trials showed the addition of goal setting to 
WHO-5 was associated with improved compliance 
(pooled odds ratio 1.35, 95% confidence interval 1.04 
to 1.76; I2=81%). Of 22 pairwise comparisons from 
interrupted time series, 18 showed stepwise increases 
in compliance with hand hygiene, and all but four 
showed a trend for increasing compliance after the 
intervention. Network meta-analysis indicated 
considerable uncertainty in the relative effectiveness 
of interventions, but nonetheless provided evidence 
that WHO-5 is effective and that compliance can be 
further improved by adding interventions including 
goal setting, reward incentives, and accountability. 
Nineteen studies reported clinical outcomes; data 
from these were consistent with clinically important 
reductions in rates of infection resulting from 
improved hand hygiene for some but not all important 
hospital pathogens. Reported costs of interventions 
ranged from $225 to $4669 (£146-£3035; €204-
€4229) per 1000 bed days.
CONCLUSION
Promotion of hand hygiene with WHO-5 is effective at 
increasing compliance in healthcare workers. Addition 
of goal setting, reward incentives, and accountability 
strategies can lead to further improvements. Reporting 
of resources required for such interventions remains 
inadequate.
Introduction
At any point in time more than 1.4 million patients 
around the world experience healthcare associated 
infections.1 2  Such infections cause excess morbidity 
and are associated with increased mortality.2 3  Direct 
contact between patients and healthcare workers who 
are transiently contaminated with nosocomial patho-
gens is believed to be the primary route of transmission 
for several organisms and can lead to patients becom-
ing colonised or infected. Although hand hygiene is 
widely thought to be the most important activity for the 
prevention of nosocomial infections, a review of hand 
hygiene studies by the World Health Organization 
(WHO) found that baseline compliance with hand 
hygiene among healthcare workers was on average only 
38.7% (range 5-89%).4
In 2005, the WHO World Alliance for Patient Safety 
launched a campaign, the First Global Patient Safety 
Challenge—“Clean Care is Safer Care”—aiming to 
improve hand hygiene in healthcare.4 This campaign 
WHAT IS ALREADY KNOWN ON THIS TOPIC
Hand hygiene among healthcare workers is possibly one of the most effective 
measures to reduce healthcare associated infections, but compliance remains poor 
in many hospital settings
In 2005 WHO launched a campaign to improve hand hygiene in healthcare settings 
by promoting a multimodal strategy consisting of five components: system change, 
training and education, observation and feedback, reminders in the hospital, and a 
hospital safety climate
WHAT THIS STUDY ADDS
These meta-analyses provide evidence that the WHO campaign is effective at 
increasing compliance with hand hygiene in healthcare workers
There is evidence that additional interventions (used in conjunction with the WHO 
campaign elements), including goal setting, reward incentive, and accountability, 
can lead to further improvements
Reporting on resource implications of such interventions is limited
doi: 10.1136/bmj.h3728 | BMJ  2015;351:h3728 | the bmj
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(WHO-5) promotes a multimodal strategy consisting of 
five components: system change, training and educa-
tion, observation and feedback, reminders in the hospi-
tal, and a hospital safety climate. More recently, 
additional strategies for improving hand hygiene have 
been evaluated, including those based on behavioural 
theory.
We assessed the relative eﬀectiveness of WHO-5 and 
other strategies for improving compliance with hand 
hygiene in healthcare workers in hospital settings. Eval-
uation of the evidence for the eﬀectiveness of diﬀerent 
interventions is complicated by three factors: firstly, 
most evaluations of interventions to promote hand 
hygiene use non-randomised study designs, and in 
many cases the reported analysis is inappropriate or 
methodological quality is too low to allow meaningful 
conclusions to be drawn;5-8  secondly, there is wide vari-
ation between studies in the activities to promote hand 
hygiene used in the comparison group; thirdly, direct 
head-to-head comparisons of most interventions are 
lacking.7
We aimed to overcome these problems by restricting 
attention to randomised trials and high quality 
non-randomised studies, re-analysing data when nec-
essary; explicitly accounting for activities to promote 
hand hygiene in the comparison group in each study; 
and using network meta-analysis to allow indirect com-
parison between interventions.
We also summarise information on changes in clini-
cal and microbiological outcomes associated with inter-
ventions when this was reported. Information on 
resources used in diﬀerent interventions is essential for 
those wanting to implement such interventions or eval-
uate their cost eﬀectiveness.9 10 An additional aim was 
therefore to document information on resources used in 
interventions to promote hand hygiene.
Methods
We developed a protocol and used systematic methods 
to identify relevant studies, screen study eligibility, and 
assess study quality. This protocol was not registered. 
This review is reported according to the Preferred 
Reporting Items for Systematic Reviews and Meta-Anal-
yses (PRISMA) guidelines.11
Search strategy
We used a two stage search strategy. Firstly, we obtained 
all studies considered in two previous reviews (covering 
the period up to November 2009), including those that 
had been reported as failing to meet inclusion criteria.5 6 
Secondly, we extended the search from these studies 
from December 2009 to February 2014. We searched 
Medline, Embase, Cumulative Index to Nursing and 
Allied Health (CINAHL), Database of Abstracts of 
Reviews of Eﬀects (DARE), National Health Service Eco-
nomic Evaluation Database (NHS-EED), National 
Health Service Centre for Reviews and Dissemination 
(NHS-CRD) and British Nursing Index (BNI), Cochrane 
Library (Cochrane database of systematic reviews, 
Cochrane central register of controlled trials, Cochrane 
methodology register, Health Technology assessment 
database), Clinical Trial.gov, Current Clinical Control 
trial, Cochrane Eﬀective Practice and Organisation of 
Care Group (EPOC) register, American College of Physi-
cians journal, and reviews of evidence based medicine. 
Results were limited to peer reviewed publications. To 
validate previous search results we also repeated the 
electronic search for three earlier years (1980, 1995, and 
2009). The complete search strategy is provided in 
appendix 1.
Inclusion and exclusion
Studies were included if they met all the following ini-
tial criteria: they evaluated one or more interventions 
intended to improve hand hygiene compliance among 
healthcare workers in a hospital setting; they measured 
compliance with hand hygiene using opportunities 
with prespecified indications or using proxies linked to 
compliance (such as consumption of soap and alcohol 
hand rub); they were either randomised controlled tri-
als, non-randomised trials, controlled before-after 
studies, or used an interrupted time series design.
We placed no restrictions on promotion of hand 
hygiene in the comparison group. Studies were 
excluded if they were not reported in peer reviewed 
publications or not written in English.
We applied a methodological filter by excluding stud-
ies that failed meet minimal quality criteria specified by 
the Cochrane Eﬀectiveness Practice and Organisation of 
Care Group (EPOC). Acceptable study designs were ran-
domised controlled trials and non-randomised trials 
(with at least two intervention and two control sites); 
controlled before-after studies (with outcome measures 
before and after the intervention from at least two inter-
vention and two comparable control sites); and inter-
rupted time series (with a clearly defined point in time 
for the intervention and outcome measures from at least 
three time points in both baseline and intervention 
periods).12 13
Patient involvement
No patients were involved in setting the research ques-
tion or the outcome measures, nor were they involved in 
the design and implementation of the study. There are 
no plans to involve patients in dissemination.
Data extraction and assessment of quality 
Two reviewers (NL and BSC) independently screened 
the titles and abstracts of the citations obtained from 
the search to assess the eligibility. Consensus was 
reached by discussion if initial assessments diﬀered. NL 
evaluated the full text and abstracted data, which was 
checked by BSC.
The reviewers abstracted data including study design 
and duration, population, activities to promote hand 
hygiene in both intervention and comparison groups, 
hand hygiene outcomes, clinical and microbiological 
outcomes, measurement methods, and settings. When 
possible, we classified hand hygiene promotion activi-
ties according to WHO guidelines on hand hygiene in 
healthcare.4  We grouped activities into eight compo-
nents: system change, education, feedback, reminders, 
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safety climate, incentives, goal setting, and account-
ability (table 1). Results and raw compliance data from 
each study were extracted for further re-analyses. In 
addition, we extracted the costs of hand hygiene inter-
ventions or data on use of resources (materials and time 
spent on interventions) when appropriate. Additional 
information was obtained from the authors if it was not 
clear from the manuscript. For all included studies we 
used prespecified definitions to record the level of infor-
mation (high, moderate, or low) about resources used 
for promotion of hand hygiene (see appendix 2).
Assessment of risk of bias in included studies
We used the Cochrane Collaboration’s tool to assess risk 
of bias.14 Nine standard criteria for randomised con-
trolled trials, non-randomised trials, and controlled 
before-after studies and seven standard criteria for 
interrupted time series were applied and used to clas-
sify each study’s risk of bias as low, high, or unclear.
Data synthesis and statistical analysis
Data synthesis was performed separately for diﬀerent 
study designs. The primary evidence synthesis was 
based on studies that used direct observation to mea-
sure compliance with hand hygiene. We restricted our 
analysis to this outcome because it reflects the opportu-
nities for hand hygiene.
For randomised controlled trials, we used Cochrane 
Review Manager (RevMan; version 5.1) to calculate the 
natural logarithm of the odds ratio and associated vari-
ance to estimate the pooled odds ratio with a random 
effects model.15 The same method was applied to 
non-randomised trials, and controlled before-after 
studies if applicable. Heterogeneity between studies 
was assessed with the I2 statistic. Risk of publication 
bias was evaluated with an enhanced contour funnel 
plot.16  17
For interrupted time series, if re-analysis was 
required, we used a generalised linear segmented 
regression analysis to estimate the stepwise change in 
level and change in trend associated with the interven-
tion.18  This approach is similar to that proposed by 
Ramsey and colleagues19  and Vidanapathirana and col-
leagues,20  except that it accounts for the binomial 
nature of the data, appropriately weighting each data 
point by the number of observations. We accounted for 
any evidence of autocorrelation by using Newey-West 
standard errors.21 Analysis was performed with Stata 13 
(Statacorp LP, College Station, TX). We then estimated 
two summary measures that combined both stepwise 
and trend changes. Firstly, we calculated the mean nat-
ural logarithm of the odds ratio for hand hygiene asso-
ciated with the intervention, a measure of relative 
improvement. Secondly, we calculated the mean per-
centage change in compliance in the period after the 
intervention (compared with that expected if there had 
been no intervention), an absolute measure of improve-
ment in compliance. Standard errors were derived with 
the delta method by using the emdbook package in 
R.22 23 Appendix 3 provides full details.
Network meta-analysis
Network meta-analysis aims to combine all of the 
 evidence, both direct and indirect, to estimate the 
 comparative eﬃcacy of all the interventions.24 Each 
intervention strategy is represented by a node in the 
network. If a study directly compares two interventions 
they are directly connected by a link on the network and 
a direct comparison is possible. If two interventions are 
connected indirectly (for example, if there are studies 
comparing each with a third intervention), then indi-
rect comparison is possible.
We used network meta-analysis to compare the rela-
tive eﬀectiveness of four diﬀerent strategies: no promo-
tion of hand hygiene, single component interventions, 
WHO-5, and WHO-5 and others (table 2 ). We included in 
the network meta-analysis those studies that included 
only these strategies and permitted a segmented regres-
sion analysis and directly observed compliance with 
hand hygiene.25 26
The eﬀect sizes obtained from each comparison were 
combined in a network meta-analysis with a random 
eﬀects model.25  Eﬀect sizes were taken as the mean of 
the natural logarithm of the odds ratio for the hand 
hygiene intervention as estimated with the segmented 
regression model. Intervention rankings and associ-
ated credible intervals were obtained. Model fitting for 
the meta-analysis was carried out within a Bayesian 
Table 1 | Description of eight components of interventions to promote hand hygiene in healthcare workers
Component Description
System change* Ensuring necessary infrastructure is available including access to water, soap and towels and alcohol based 
handrub at point of care
Education and training Providing training or educational programme on importance of hand hygiene and correct procedures for 
hand hygiene for healthcare workers
Feedback Monitoring hand hygiene practices among healthcare workers while providing compliance feedback to staff
Reminders at workplace Prompting healthcare workers either through printed material, verbal reminders, electronic communications or 
other methods, to remind them about importance of hand hygiene and appropriate indications and procedures
Institutional safety climate Active participation at institutional level, creating environment allowing prioritisation of hand hygiene
Goal setting Setting of specific goals aimed at improving compliance with hand hygiene, which can both apply at 
individual and group level and can include healthcare associated infection rates
Reward incentives Interventions providing any reward incentive for participants completing a particular task or reaching a 
certain level of compliance. Both non-financial and financial rewards are included
Accountability Interventions involved with improving healthcare workers’ accountability both at individual and unit level
*If the intervention period included changing the location or formulation of alcohol based handrub or installing more handrub dispensers, the baseline 
intervention was counted as no intervention or standard practice (no system change component), even if alcohol based handrub had been used during 
the baseline period.
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framework using WinBUGS.26  Inconsistency checks 
were performed for closed loops in the network.27 Full 
model details are provided in appendix 4.
We performed a sensitivity analysis by excluding 
studies that implemented multicomponent strategies in 
a stepwise manner without suﬃcient data to evaluate 




Figure 1 shows a summary of the review process . Of 
3639 studies screened, 142 studies met initial inclusion 
criteria and 41 of these met EPOC criteria. Among these 
41 studies, six were randomised controlled trials 
(including three cluster randomised controlled tri-
als),31-36  32 were interrupted time series,28-30  37-65  one 
was a non-randomised trial,66  and two were controlled 
before-after studies.67 68 Appendix 5 give details of the 
reasons for exclusion. Applying our search strategy to 
three years covered by previous reviews did not yield 
any studies meeting our inclusion criteria that had not 
already been included.
Seventeen studies applied interventions to the whole 
hospital, while 21 studies enrolled hospital wards. 
Three studies allocated interventions to specific 
healthcare workers.31 33 36  Twenty five studies were con-
ducted in either a hospital-wide setting or combined 
intensive care units and general wards, while 11 were 
conducted in intensive care units or general wards 
alone. Of 10 studies conducted in more than one hospi-
tal, three included two or more countries.42 48 50  Only 
five of the 41 studies were conducted in low or middle 
income countries.33 36 46 50 51
Study periods ranged from two months to six years. 
In 11 studies the period was up to one year; in 17 studies 
it was more than a year and up to three years; and in 13 
it was more than three years. Among the 32 interrupted 
time series, only 11 were longer than 12 months.
In 34 studies hand hygiene was observed in all types 
of healthcare workers with patient contact, while six 
studies considered only nurses and/or nursing assis-
tants.33 34 36 60 64 68  One study recruited only nursing stu-
dents as participants.54  One study also included 
patients’ relatives.39
Six studies used a single faceted intervention: four 
implemented education alone33 46 54 68  and two applied 
system change or reminders.39 44  Seventeen studies 
used interventions equivalent to WHO-5, and six of 
these added supplemental interventions including goal 
setting, incentives, and accountability.28 34 40 45 56 66  Nine-
teen studies implemented interventions with two to 
four components; four of these applied components not 
in WHO-5, including goal setting and incentives.37 38 41 59
Thirty studies (four randomised controlled trials, 25 
interrupted time series, and one non-randomised trial) 
used direct observation to measure compliance with 
hand hygiene. Two of these used a combination of video 
recorders and external observers.37 38  Proxy measures 
were assessed in 19 studies including the rate of hand 
hygiene events, consumption of hand hygiene products 
(alcohol hand rub or soap), and a hand hygiene score 
checklist (two randomised controlled trials, 15 inter-
rupted time series, and two controlled before and after 
studies). Clinical outcomes were reported in 19 stud-
ies.28-30 35 42 46-52 55-57 59 62 63 66 67 69 Appendix 6 provides full 
study characteristics including study design, setting, 
intervention, and comparison groups.
Examination of funnel plots (appendix 7) did not pro-
vide any clear evidence of publication bias, though evi-
dence for or against such bias was limited by the fact 
that there were no more than four studies for any pair-
wise comparison of strategies.
Quality assessment
Ten studies were considered to have a high risk of bias. 
Thirty one had either low or unclear risk. High risk of 
bias was present in all three non-randomised trials or 
controlled before-after studies but only in seven out of 
Table 2 | Mean odds ratios with 95% credible intervals for interventions strategies to 
promote hand hygiene. Results are from random effects network meta-analysis model
Strategies* Description Mean OR (95% credible interval)
None/current practice No intervention or current practice Reference
Single intervention Single intervention (system change 
or education)
4.30 (0.43 to 46.57)
WHO-5† WHO-5 components 6.51 (1.58 to 31.91)
WHO-5* + others WHO-5 plus incentives, goal setting, 
or accountability
11.83 (2.67 to 53.79)
*Model fit statistic: posterior mean residual deviance=10.40 and deviance information criterion (DIC)=23.86.
†Contained five components: system change, education, feedback, reminders, and institutional safety climate 
(see table 1 for details).
Studies identified by Gould et al or
Huis et al and meeting EPOC criteria
(1980 to Nov 2009) (n=10 studies)
Potentially relevant citations identified
after searching from electronic database
(Dec 2009 to Feb 2014) (n= 7615 records)
Records screened after duplicates removed (n=3639)
Relevant studies included in systematic review (n=41):
  Randomised controlled trials (n=6)
  Interrupted time series (n=32)
Studies included in quantitative synthesis (n=10):
  Randomised controlled trials (n=2) Interrupted time series studies (n=8)
Non-randomised trials (n=1)
Controlled before and after trials (n=2)
Full text articles assessed for eligibility (n=202)
Studies met initial inclusion criteria; of these, 41 studies met EPOC inclusion criteria (n=142)
Full text articles excluded (n=60):
  No hand hygiene outcome (n=21)
  No intervenion or not hand hygiene promotion (n=15)
  Not healthcare workers (n=1)
  Not hospital settings (n=5)
  Not intervention studies/ not peer reviewed (review, protocol, conference
    proceeding, economic evaluation (n=12)
  Non-English literature (n=6)
Records excluded by title and abstract screening (n=3437)
Records excluded by EPOC inclusion criteria (n=101):
  Controlled before and after with appropriate control (n=3)
  Uncontrolled before and after design (n=80)
  Interrupted time series trials with inadequate data collection points (n=18)
Fig 1 | Flow chart of study identification in systematic review of interventions to promote 
hand hygiene in healthcare workers
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32 interrupted time series. No randomised controlled 
trials or cluster randomised controlled trials were 
thought to have a high risk of bias (fig 2).
The two controlled before-after studies67 68  had high 
risks for inadequate allocation sequence and conceal-
ment, while one non-randomised trial66 had high risk of 
dissimilarity in baseline outcome between experimen-
tal and control groups.
Fourteen studies (34%) had a low risk of bias due to 
the knowledge of allocated intervention, as these stud-
ies either measured objective outcomes (such as alco-
hol consumption or output from electronic counting 
devices) or stated that the observers were blinded to 
the intervention. The rest of the studies had unclear 
risk as they did not report whether the observers were 
blinded.
Risk of selective outcome reporting was unclear in 33 
studies as pre-specified protocols were reported only in 
three randomised controlled trials.32 34 35  Two of the 
interrupted time series had a high risk of selective out-
come reporting as they reported on a non-periodical 
basis.28 59  Among the interrupted time series, six had a 
high risk that outcomes were aﬀected by other interven-
tions such as a universal chlorhexidine body washing 
programme,42 63  reinforcement of standard precau-
tions,42  screening and decolonisation for multidrug-re-
sistant micro-organisms,48 quality improvement 
program,46  59  and antibiotic use and healthcare associ-




Four of six randomised controlled trials measured com-
pliance with hand hygiene by direct observation with 
indications similar to WHO-5.32-35  Two of these studies 
compared WHO-5 with WHO-5 combined with goal set-
ting (WHO-5+).32 34  Huis and colleagues performed a 
cluster randomised trial in 67 wards from three hospi-
tals in the Netherlands.34  Compliance immediately after 
the intervention increased from 23% to 42% in the 
WHO-5 arm and from 20% to 53% in the WHO-5+ arm; in 
both arms improvements were sustained six months 
later. Fuller and colleagues used a three year stepped 
wedge design in 16 intensive care units and 44 acute 
care of the elderly wards and reported an absolute 
increase in compliance of 13-18% and 10-13%, respec-
tively, in implementing wards.32 Only 33 of 60 enrolled 
wards, however, implemented the intervention (22 out 
of 44 elderly wards and 11 out of 16 intensive care units), 
and the intention to treat analysis did not show 
increased compliance in the elderly wards while com-
pliance in intensive care units increased by 7-9%. 
Meta-analysis (with intention to treat results) provided 
evidence favouring the WHO-5+ strategy. The pooled 
odds ratio was 1.35 (95% confidence interval 1.04 to 1.76; 
I2=81%) (fig 3 ). The large heterogeneity seemed to be 
caused by the low fidelity to intervention in acute care 
of the elderly wards. Per protocol analyses gave similar 
odds ratios for compliance to the study by Huis and col-
leagues (1.67 (95% confidence interval 1.28 to 2.22) for 
elderly wards and 2.09 (1.55 to 2.81) for intensive care 
units). Two other randomised controlled trials directly 
reported observed compliance with hand hygiene. An 
individually randomised trial of an education pro-
gramme versus no intervention for nurses in China 
reported an absolute improvement in compliance of 
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Fig 2  | Assessment of risk of bias in included studies of interventions to promote hand 
hygiene in healthcare workers
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32.7% (95% confidence interval 15.6% to 49.7%) for 
opportunities before contact with patients and 20.4% 
(5.6% to 35.2%) for opportunities after contact (baseline 
compliance before and after contact was about 25% and 
37%, respectively, in both arms).33  In Canada, a cluster 
randomised trial of a bundle of education, performance 
feedback, and visual reminders in 30 hospital units 
where alcohol hand rub was available at point of care in 
both arms (but with no other interventions in the con-
trol arm) reported a higher adherence after the interven-
tion in the intervention arm (mean diﬀerence 6.3%, 
95% confidence interval 4.3% to 8.4%).35 In both arms 
baseline compliance was low (16%).
Fisher and colleagues randomised individuals to 
either a control group where hand hygiene was not 
actively promoted or an intervention arm that used 
audio reminders and individual feedback.31  They 
assessed compliance using an automated system at 
entry to and exit from patients’ rooms. The interven-
tion was associated with a 6.8% (95% confidence 
interval 2.5% to 11.1%) improvement in compliance. 
Salamati and colleagues randomised nursing person-
nel to either a motivational interviewing intervention 
(a behaviour modification approach initially devel-
oped to treat patients with alcoholism) or a control 
group.36 Both arms also received an educational inter-
vention. The outcome measure was a composite hand 
hygiene score, which was found to increase in the 
intervention arm. The scoring details, however, were 
unclear.
Interrupted time series
Of 32 interrupted time series, 25 measured hand 
hygiene compliance. Only 18 studies with direct 
observation, however, reported the number of obser-
vations at each time point, making them eligible for 
re-analysis.28-30 37  38 40-46 48 50 54 56 60 64 65  As some of these 
studies were conducted at multiple sites48  or had multi-
ple intervention phases,56  22 pairwise comparisons 
from these 18 studies were available for re-analysis (fig 4 ). 
In four studies there was evidence of positive first order 
autocorrelation.37 38 40 56
The baseline compliance ranged from 7.6% to 91.3%. 
Twelve of 22 comparisons showed a declining trend in 
compliance during the period before intervention; 
seven of these did not report any activities to promote 
hand hygiene before intervention, while another four 
used only education or reminders. Fifteen pairwise 
 contrasts showed a positive change in trend for com-
pliance with hand hygiene after the intervention 
(table 3 ). All but four contrasts showed both stepwise 
increases in compliance with hand hygiene associated 
with the intervention and increases in mean compli-
ance in the period after intervention compared with 
that expected in the absence of the intervention. The 
range was wide: the mean change in hand hygiene 
attributed to the intervention varied between a 
decrease of 14.8% and an increase of 83.3% (table 3 ). 
Two studies had an intervention period lasting at least 
two years; neither showed evidence for any decline in 
compliance over this period.40 41  In only one study was 
there a net trend for decreasing compliance after the 
intervention (fig 4).45
Non-randomised trials and controlled before-after 
studies
Mayer and colleagues compared WHO-5 and reward 
incentives (WHO-5+) with a combination of system 
change, education, and feedback using a staggered 
introduction of an intervention bundle, across four out 
of six patient units.66 The WHO-5+ intervention was 
associated with improved compliance, which increased 
from 40% to 64% in one two-unit cohort and from 34% 
to 49% in the other. 
Benning and colleagues reported a hospital-wide 
trend of increased soap and alcohol consumption in 
both intervention (package of system change, remind-
ers, and safety climate) and control (no intervention) 
groups but found no evidence of an increased eﬀect in 
the intervention group.67  Gould and colleagues found 
no evidence of improvement in frequency of hand 
decontamination in surgical intensive care wards 
resulting from a series of educational lectures com-
pared with no intervention (control).68
Analysis of interrupted time series and network 
meta-analysis
Among the 22 pairwise comparisons from interrupted 
time series, 18 had clear details about interventions and 
similar indications for compliance with hand hygiene 
among qualified healthcare workers. In 16 of these the 
intervention period included additional intervention 
components alongside measures to promote hand 
hygiene used in the baseline period, and all outcome 
data favoured the intervention (fig 5 ). In the two com-
parisons where there was no improvement in hand 
  Fuller 2012 (acute care of elderly wards)
  Fuller 2012 (intensive care units)
  Huis
Total (95% CI)
Test for heterogeneity: τ2=0.04,
  χ2=10.63, df=2, P=0.005, I2=81%
Test for overall effect: z=2.27, P=0.02
1.06 (0.88 to 1.27)
1.44 (1.18 to 1.76)
1.64 (1.33 to 2.02)


























Fig 3 | Forest plot of the associations between WHO-5 and goal setting compared with WHO-5 alone and compliance with 
hand hygiene from randomised controlled trials using intention to treat results
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Fig 4 | Re-analysis of studies involving interrupted time series where the outcome was hand hygiene compliance. Points represent observations, solid 
lines show expected values from fitted segmented regression models, and broken lines represent extrapolated trends before intervention. SYS=system 
change; EDU=education; FED=feedback; REM=reminders; SAF=institutional safety climate; INC=incentives; GOAL=goal setting; ACC=accountability; 
WHO-5=combined intervention strategies including SYS, EDU, FED, REM, and SAF
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Fig 5 | Forest plot showing effect size as mean log odds ratios for hand hygiene compliance for all direct pairwise comparisons 
from interrupted time series studies. Lee and colleagues48 was a multi-centre study. In hospitals 8 and 9 baseline strategy was 
already equivalent to WHO-5. SYS=system change; EDU=education; FED=feedback; REM=reminders; SAF=institutional safety 
climate; INC=incentives; GOAL=goal setting; ACC=accountability; WHO-5=combined intervention strategies including SYS, 
EDU, FED, REM, and SAF






for change in 
trend
Coefficient (SE) 
for change in 
level
Mean (95% CI)* % 
change in 
compliance% compliance Coefficient (SE)
Lee48
 Hospital 4 No intervention v WHO-5 44.6 −0.215 (0.30) −0.081 (0.10) 0.130 (0.10) 0.606 (0.26) 29.9 (3.5 to 56.4)
 Hospital 7 WHO-5 v WHO-5 53.8 0.154 (0.29) 0.281 (0.07) −0.151 (0.08) −1.042 (0.25) −11.5 (−13.5 to −9.5)
 Hospital 8 SYS v WHO-5 44.6 −0.215 (0.26) 0.059 (0.06) 0.014 (0.06) 0.563 (0.19) 13.3 (−9.2 to 35.8)
 Hospital 9 WHO-5 v WHO-5 62.3 0.503 (0.33) 0.088 (0.13) −0.094 (0.13) −0.007 (0.51) −9.7 (−63.6 to 44.3)
Derde42 REM v EDU+FED+REM 52.8 0.112 (0.04) −0.015 (0.01) 0.133 (0.02) 0.346 (0.05) 16.3 (13.6 to 19.1)
Higgins45 No intervention v WHO-5+INC 37.2 −0.428 (0.17) −0.009 (0.25) −0.030 (0.03) 2.448 (0.25) 48.8 (45.4 to 52.3)
Doron43 SYS+EDU+FED+REM v WHO-5 70.7 0.204 (0.12) 0.187 (0.10) −0.040 (0.03) 0.586 (0.01) 4.7 (2.3 to 7.1)
Chou40† No intervention v WHO-5+INC+GOAL 54.9 0.198 (0.03) −0.039 (0.00) 0.151 (0.01) 0.453 (0.17) 56.4 (53.1 to 59.8)
Marra50 No intervention v WHO-5 45.7 −0.173 (0.07) 0.020 (0.06) 0.063 (0.03) 0.218 (0.06) 11.5 (3.4 to 19.6)
Helms30 No intervention v WHO-5 91.3 2.350 (0.42) −0.297 (0.18) 0.354 (0.19) 0.706 (0.33) 35.9 (−5.8 to 77.7)
Kirkland29 No intervention v WHO-5 51.3 0.052 (0.14) −0.097 (0.04) 0.111 (0.04) 4.443 (1.03) 83.3 (77.0 to 89.6)
Al-Tawfiq28 No intervention v WHO-5+GOAL 41.3 −0.350 (0.09) −0.014 (0.02) 0.081 (0.07) 2.328 (0.21) 49.9 (42.8 to 57.0)
Crews41 EDU v SYS+EDU+FED+REM+INC+GOAL 50.7 0.028 (0.12) −0.070 (0.02) 0.103 (0.02) 3.679 (0.22) 38.2 (35.5 to 40.9)
Talbot  
(phase I)56†





81.1 1.455 (0.45) −0.020 (0.01) 0.060 (0.01) 0.464 (0.05) 15.0 (10.6 to 19.5)
Dubbert60 No intervention v EDU+FED 69.5 0.822 (0.34) 0.636 (0.39) 2.908 (1.57) −0.753 (0.75) 0.7 (−10.0 to 11.4)
Tibballs65 SYS v SYS+EDU 23.4 −1.186 (0.53) 0.187 (0.10) −0.040 (0.03) 0.453 (0.57) 11.9 (−18.4 to 42.1)
Khatib64 EDU v EDU+FED 86.2 1.836 (0.17) −2.051 (0.26) 2.185 (0.52) 2.549 (0.29) 65.8 (58.6 to 73.0)
Jaggi46 Unclear intervention details 19.5 −1.420 (0.26) 0.080 (0.02) −0.006 (0.03) −0.586 (0.34) −14.8 (−33.1 to 3.6)
Armellino38† No intervention v FED+GOAL 7.6 −2.493 (0.15) −0.088 (0.133) 0.849 (0.235) 3.046 (0.68) 45.4 (38.5 to 52.3)
Armellino37† No intervention v FED+GOAL 29.0 −0.895 (0.04) 0.122 (0.10) −0.109 (0.08) 2.267 (0.14) 74.9 (65.5 to 84.4)
Salmon54‡ No intervention v EDU 42.7 −0.295 (0.17) 0.003 (0.02) 0.021 (0.02) 0.485 (0.22) 17.9 (−0.3 to 36.2)
SYS=system change; EDU=education; FED=feedback; REM=reminders; SAF=institutional safety climate; INC=incentives; GOAL=goal setting; ACC=accountability; WHO-5=combined 
intervention strategies including SYS, EDU, FED, REM, and SAF.
*Mean change in hand hygiene compliance during period after intervention period attributed to intervention accounting for baseline trends (see appendix 3 for details).
†Evidence of autocorrelation; Newey-West standard errors reported.
‡Hand hygiene compliance measured in student nurses.
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hygiene, all components of the intervention were 
already in place in the baseline period.48
Twelve pairwise comparisons met the criteria for net-
work meta-analysis, and included direct comparisons 
between all pairs of strategies except WHO-5 versus 
WHO-5+ and no intervention versus single intervention 
(fig 6 ). The network meta-analysis showed that 
although there was large uncertainty in eﬀect sizes 
among the pairwise comparisons, point estimates for 
all intervention strategies indicated an improvement in 
compliance with hand hygiene compared with no inter-
vention (fig 7 ). When two strategies, WHO-5 and WHO-
5+, were compared with no intervention there was 
strong evidence that they were eﬀective (table 2 ). The 
WHO5+ strategy also showed additional improvement 
compared with single intervention strategies and 
WHO-5 alone. For the latter comparison, which 
depended only on indirect comparisons, the estimated 
eﬀect size was similar to that seen in the randomised 
controlled trials, though uncertainty was much larger 
(odds ratio for WHO-5 versus WHO-5+ was 1.82, 95% 
credible interval 0.2 to 12.2). WHO-5+ had the highest 
probability (67%) of being the best strategy in improv-
ing compliance (fig 8).
After we excluded studies with multiple stepwise 
interventions in the sensitivity analysis, there was a 
decrease in the eﬀect size of all intervention strategies 
(appendix 4).
Clinical outcomes
Nineteen studies reported clinical or microbiological 
outcomes alongside hand hygiene outcomes. Six of 
these were multicentre studies,35 42 48 55 62 67  and 13 were 
based in a single hospital.28-30 46 47 49 52 56 57 59 63 66 69 All 
reported that improvements in hand hygiene were asso-
ciated with reductions in at least one measure of hospi-




Fig 6 | Network structure for network meta-analysis of four 
hand hygiene intervention strategies from interrupted time 
series studies. Intervention strategies were: none (no 
intervention); single intervention; WHO-5; and WHO-5+ 
















Fig 7 | Box-and-whiskers plot showing relative efficacy of 
different hand hygiene intervention strategies compared 
with standard of care estimated by network meta-analysis 
from interrupted time series studies. Lower and upper 
edges represent 25th and 75th centiles from posterior 
distribution; central line median. Whiskers extend to 5th 
and 95th centiles. Intervention strategies were single 
intervention; WHO-5; and WHO-5+ (WHO-5 with incentives, 
goal-setting, or accountability). Appendix 9 shows results 
from sensitivity analysis that excluded studies where 






























Fig 8 | Rankograms showing probabilities of possible rankings for each intervention strategy (rank 1=best, rank 4=worst)
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case, however, either appropriate analysis was lacking, 
denominators were not reported, time series data were 
not shown (making interrupted time series designs vul-
nerable to pre-existing trends), or numbers were too 
small to draw firm conclusions.
There were, however, three single centre studies that 
did not have these limitations.49 57 63  Two of these stud-
ies, which lasted about seven years, used time series 
analysis to study associations between use of alcohol 
hand rub and clinical outcomes, with adjustment for 
changing patterns of antibiotic use.49 57 Lee and col-
leagues found strong evidence (P<0.001) that increased 
use of alcohol hand rub was associated with reduced 
incidence of healthcare associated infection and evi-
dence that it was associated with reduced healthcare 
associated methicillin resistant Staphylococcus aureus 
(MRSA) infection (P=0.02).49  Vernaz and colleagues 
found strong evidence that increased use of alcohol 
based hand rub was associated with reduced incidence 
of MRSA clinical isolates per 100 patient days 
(P<0.001), reporting that 1L of hand rub per 100 patient 
days was associated with a reduction in MRSA of 0.03 
isolates per 100 patient days.57 No association was 
found between increased use of alcohol based hand 
rub and clinical isolates of Clostridium diﬃcile. John-
son and colleagues reported that an intervention in an 
Australian teaching hospital associated with a mean 
improvement of compliance with hand hygiene from 
21% to 42% was also associated with declining trends 
in clinical MRSA isolates (by 36 months after the inter-
vention clinical isolates per discharge had fallen by 
40% compared with the baseline before the interven-
tion), declining trends in MRSA bacteraemias (57% 
lower than baseline after 36 months), and declining 
trends in clinical isolates of extended spectrum β lact-
amases (ESBL) producing E coli and Klebsiella (>90% 
below baseline 36 months after intervention), though 
there was no evidence of changes in patient MRSA col-
onisation at four or 12 months after the intervention.63 
In addition to hand hygiene, however, the intervention 
included patient decolonisation and ward cleaning, 
and the relative importance of these measures cannot 
be determined.
Among the multicentre studies, Grayson and col-
leagues described a similar hand hygiene intervention 
(but without additional decolonisation or ward clean-
ing) initially introduced to six hospitals as a pilot study 
and, later, to 75 hospitals in Victoria, Australia, as part 
of a state-wide roll out.62 Both the pilot and roll out 
were associated with large improvements in compli-
ance (from about 20% to 50%) and similar clinically 
important trends after the intervention for reduced 
MRSA bacteraemias and MRSA clinical isolates per 
patient discharge (though in the state-wide roll out 
hospitals there was also a decline in MRSA clinical iso-
lates before the intervention that continued after the 
intervention).
Roll out of a similar hand hygiene intervention (the 
Cleanyouhands campaign, based on WHO-5) in England 
and Wales was reported to be associated with reduced 
rates of MRSA bacteraemia (from 1.9 to 0.9 cases per 
10 000 bed days) and C diﬃcile infection (from 16.8 to 
9.5 cases per 10 000 bed days), but no association was 
found with methicillin-sensitive S aureus (MSSA) bacte-
raemia.55 This study also reported independent associ-
ations between procurement of alcohol hand rub and 
MRSA bacteraemias; in the last 12 months of the study, 
MRSA bacteraemias were estimated to have fallen by 1% 
(95% confidence interval 5% to 15%) for each additional 
mL of hand rub used per bed day (adjusted for other 
interventions and hospital level mupirocin use, a surro-
gate marker for MRSA screening and decolonisation). 
Similarly, each additional mL of soap used per bed day 
was associated with a 0.7% (0.4%, 1.0%) reduction in 
C diﬃcile infection.
Benning and colleagues described the evaluation of a 
separate but contemporaneous patient safety interven-
tion that included a hand hygiene component in nine 
English hospitals with nine matched controls.67 Both 
intervention and control sites experienced large 
increases in consumption of soap and alcohol hand rub 
between 2004 and 2008 and substantial falls in rates of 
MRSA and C diﬃcile infection, though in all cases (soap, 
hand rub, and infections) there was no evidence that 
diﬀerences between intervention and control sites 
resulted from anything other than chance.
In a two year study in 33 surgical wards in 10 Euro-
pean hospitals, Lee and colleagues found that, after 
adjustment for clustering, potential confounders, and 
temporal trends, enhanced hand hygiene alone was not 
associated with a reduction in MRSA clinical cultures 
and MRSA surgical site infections, and neither was a 
strategy of screening and decolonisation, but in wards 
where both interventions were combined, there was a 
reduction in the rate of MRSA clinical cultures of 12% 
per month (adjusted incidence rate ratio 0.88, 95% con-
fidence interval 0.79 to 0.98).48
Among the randomised controlled trials, Mertz and 
colleagues found similar rates of hospital acquired 
MRSA colonisation in intervention and control groups 
(0.73 v 0.66 events per 1000 patient days, respectively; 
P=0.92), though adherence to hand hygiene was only 
6% higher in the intervention arm.35  Finally, in a study 
in 13 European intensive care units, Derde and col-
leagues reported a declining trend in acquisition of 
antimicrobial resistant bacteria (weekly incidence rate 
ratio 0.976, 95% confidence interval 0.954 to 0.999) 
associated with a hand hygiene intervention that 
increased compliance from about 50% to over 70%.42 
The decline was largely because of reduced MRSA 
acquisition. The intervention also included universal 
chlorhexidine body washing, and it is not possible to 
establish the relative importance of hand hygiene.
Level of information on resource use
Reporting of information on cost and resource use was 
limited, with 3, 26, and 12 studies classified as having 
high, moderate, and low information, respectively 
(appendix 8). Three studies reported costs associated 
with both materials and person time34 52 66 ; in two cases 
these reports were in separate papers.70 71  Table 4 sum-
marises the reported costs of interventions.





A multi-faceted hand hygiene intervention—WHO-5—
and single interventions including system change, 
training and education, or reminders alone are associ-
ated with improved compliance with hand hygiene 
among healthcare workers in hospital compared with 
standard practice. Results from both randomised con-
trolled trials and interrupted time series designs pro-
vide consistent evidence that adding supplemental 
interventions including goal setting, reward incentives, 
and accountability to the WHO-5 strategy lead to addi-
tional improvements in compliance. Information about 
resources used in the interventions was not well 
reported.
Comparison with other studies
We are aware of four previous systematic reviews of 
interventions for hand hygiene in healthcare settings.5-8 
One of these found only four studies of suﬃcient meth-
odological quality to reliably evaluate interventions to 
promote hand hygiene and was unable to reach firm 
conclusions.5  Overlap between included studies in the 
other three and our review is small: respectively four 
(9.8%),8  three (7.3%),6  and five (12.2%)7  of studies 
included in our review were included in previous 
reviews, while 17 (80.1%), 38 (92.7%), and 40 (88.9%) of 
the studies in these reviews failed to meet the minimum 
quality threshold in ours.12 13  While high quality 
non-randomised studies can potentially play an import-
ant role in the evaluation of interventions if they are 
analysed with appropriate methods, there are many 
reasons for thinking that simple before-after studies (a 
design used by most of the studies included in previous 
reviews) do not provide a reliable basis for evaluating 
interventions.72-74 While an interrupted time series 
study (where multiple outcome measures are taken 
before and after the intervention) represents a strong 
quasi-experimental design, a before-after study com-
pares a single outcome measure before and after the 
intervention and is vulnerable to distorting eﬀects of 
pre-existing trends.
We found an increasing number of “high quality” 
studies on interventions for hand hygiene after 2009. 
From two previous systematic reviews5  6 examining the 
literature from 1980 to November 2009, we found only 
10 studies meeting the EPOC criteria (one randomised 
controlled trial, eight interrupted time series, and one 
controlled before-after study). With the same criteria, 
our review found 31 studies (five randomised controlled 
trials, 24 interrupted time series, one non-randomised 
trial, and one controlled before-after study) published 
between December 2009 and February 2014.
Reporting on resource implications for interventions 
was generally limited with some notable exceptions. 
Most included studies reported only part of the 
resources used, and methods for collecting cost data 
were unclear. Such information on resource use is 
important both for those wishing to implement similar 
strategies and for economic evaluation of diﬀerent 
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data has also been proposed.76  Cost eﬀectiveness anal-
ysis of promotion of hand hygiene is required to assess 
under what circumstances these initiatives represent 
good value for money and when resources might be bet-
ter directed at supplemental interventions, including 
care bundles,77  ward cleaning,78  and screening and 
decolonisation,79 to complement well maintained com-
pliance with hand hygiene.
Strengths and limitations of study
A particular strength of our study is that the network 
meta-analysis allowed us to quantify the relative eﬃ-
cacy among a series of diﬀerent intervention strategies 
with diﬀerent baseline interventions, even where the 
direct head-to-head comparisons were absent.
This study also has several limitations. Firstly, 
details on implementation of components of the inter-
vention varied substantially. For example, personal 
feedback and group feedback were classified together, 
but, in practice, the impacts of these strategies can 
vary. Moreover, diﬀerent studies might implement the 
same programme with diﬀerent quality of delivery and 
level of adherence, so called intervention fidelity or 
type III error.80  Both issues are common to many inter-
ventions to improve the quality of care in hospital set-
tings and are likely to be responsible for much of the 
unexplained heterogeneity between studies.81 82  Sec-
ondly, direct observation of compliance with hand 
hygiene might induce an increase in compliance unre-
lated to the intervention (the Hawthorne effect). 
Recent research suggests that such Hawthorne eﬀects 
can lead to substantial overestimation of compli-
ance.83 84  Such eﬀects, however, should not bias esti-
mates of the relative eﬃcacy of diﬀerent interventions 
from randomised controlled trials and interrupted 
time series unless the eﬀects vary between study arms/
intervention periods. Thirdly, it is possible that it is the 
novelty of the intervention itself that leads to improve-
ments in compliance and that any suﬃciently novel 
intervention would do the same regardless of the com-
ponents used. This clearly cannot be ruled out and is 
not necessarily inconsistent with our findings that 
interventions with more components tend to perform 
better. At present, however, there are too few high 
quality studies to evaluate whether individual compo-
nents of interventions show consistent diﬀerences 
that cannot be explained by novelty alone. Fourth, 
results might be distorted by publication bias. Fifth, 
there might also be a low level of language bias 
because we excluded studies in languages other than 
English. The magnitude of such bias, however, is likely 
to be small.85 86
Finally, linking improved compliance to clinical out-
comes such as number of infections prevented would 
provide more direct evidence about the value of such 
interventions.10  Such direct evidence is still limited in 
hospital settings, although the association is supported 
by a growing body of indirect evidence as well as bio-
logical plausibility. Moreover, findings from studies 
included in our review that reported clinical or microbi-
ological outcomes are consistent with substantial 
reductions in infections for some pathogens, such as 
MRSA, resulting from large improvements in hand 
hygiene.87 88  The lack of a measureable effect of 
improved hand hygiene on MSSA infections might seem 
paradoxical but can be partly explained by the fact that 
MSSA infections are much more likely to be of endoge-
nous origin, whereas MRSA is more often linked to nos-
ocomial cross transmission. Moreover, predictions from 
modelling studies that hand hygiene will have a dispro-
portionate eﬀect on the prevalence of resistant bacteria 
in hospitals (provided resistance is rare in the commu-
nity) seem to have been borne out in practice.89
Conclusions
While there is some evidence that single component 
interventions lead to improvements in hand hygiene, 
there is strong evidence that the WHO-5 intervention 
can lead to substantial, rapid, and sustained improve-
ments in compliance with hand hygiene among health-
care workers in hospital settings. There is also evidence 
that goal setting, reward incentives, and accountability 
provide additional improvements beyond those 
achieved by WHO-5. Important directions for future 
work are to improve reporting on resource implications 
for interventions, increasingly focus on strong study 
designs, and evaluate the long term sustainability and 
cost eﬀectiveness of improvements in hand hygiene.
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Abstract
Introduction: Economic evaluations of interventions in the hospital setting often rely on the estimated long-term
impact on patient survival. Estimates of mortality rates and long-term outcomes among patients discharged alive
from the intensive care unit (ICU) are lacking from lower- and middle-income countries. This study aimed to assess
the long-term survival and life expectancy (LE) amongst post-ICU patients in Thailand, a middle-income country.
Methods: In this retrospective cohort study, data from a regional tertiary hospital in northeast Thailand and the
regional death registry were linked and used to assess patient survival time after ICU discharge. Adult ICU patients
aged at least 15 years who had been discharged alive from an ICU between 1 January 2004 and 31 December 2005
were included in the study, and the death registry was used to determine deaths occurring in this cohort up to
31st December 2010. These data were used in conjunction with standard mortality life tables to estimate annual
mortality and life expectancy.
Results: This analysis included 10,321 ICU patients. During ICU admission, 3,251 patients (31.5%) died. Of 7,070
patients discharged alive, 2,527 (35.7%) were known to have died within the five-year follow-up period, a mortality
rate 2.5 times higher than that in the Thai general population (age and sex matched). The mean LE was estimated
as 18.3 years compared with 25.2 years in the general population.
Conclusions: Post-ICU patients experienced much higher rates of mortality than members of the general
population over the five-year follow-up period, particularly in the first year after discharge. Further work assessing
Health Related Quality of Life (HRQOL) in both post-ICU patients and in the general population in developing
countries is needed.
Introduction
Hospital mortality amongst intensive care unit (ICU) pa-
tients is high throughout the world, typically ranging
from 14 to 44% [1-6]; in Thailand the reported range is
between 24 and 40% [5-7]. Interventions to improve the
quality of ICU care have the potential to reduce this
mortality. Examples of such interventions include devel-
opment of clinical guidelines [8,9], improvements to in-
fection control practices [10], and appropriate use of
medical devices [11].
There is growing interest not just in the effectiveness
of such interventions at reducing mortality, but in their
cost-effectiveness, and formal economic evaluation is in-
creasingly used to aid decisions about allocation of
scarce health care resources in these settings [12]. Such
analyses consider both costs of the interventions and the
associated health benefits. Outcomes such as the num-
ber of life years (LYs) or quality adjusted life years
(QALYs) gained or disability adjusted life years (DALYs)
averted are commonly used to represent the benefit of
particular interventions. However, to estimate the change
in LYs caused by preventing a single ICU death, estimates
of post-ICU survival are needed. A number of studies have
assessed long-term survival (defined as survival for at least
one year post-ICU discharge) [2,13-29]. All but one of
these studies were conducted in high-income countries
and high quality data are lacking from lower and middle
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income countries [26]. The aim of this study was to quan-
tify the long-term survival of post-ICU patients in Thailand
and to estimate life expectancy (LE) in this population.
Materials and methods
Setting and facilities
Sappasithiprasong Hospital is a 1,100-bed tertiary refer-
ral hospital located in rural northeast Thailand. In 2004
and 2005 it had a catchment of 1.8 million people,
predominantly rice farmers and their families. Universal
health coverage has been operating in Thailand since
2002, ensuring access to this hospital for the entire
population in the catchment area [30]. In 2004,
Sappasithiprasong Hospital had 36 general wards and 16
ICUs (4 pediatric and 12 adult), representing 6 ICU beds
per 100,000 people. These wards provided care for critic-
ally ill patients and patients recovering from major
surgery. Adult ICUs comprised four medical ICUs
(including one respiratory ICU), two surgical ICUs, two
neurosurgical ICUs, one trauma ICU, two coronary care
units, and one cardiovascular and thoracic ICU. ICUs
contained a median of 8 beds (range 8 to 16) and the
mean nurse-to-patient ratio was 1:1.5 (including both
registered nurses and practical nurses). All of these ICUs
could be defined as Level II open ICUs according to the
guidelines from the American College of Critical Care
Medicine [31] since there were no intensivists accredited
by the Royal College of Physicians of Thailand working
at Sappasithiprasong Hospital in 2004. Further details
about the ICUs in this hospital have been described else-
where [32].
Data
Retrospective patient-level data from January 2004 to
December 2005 were obtained from Sappasithiprasong
Hospital. Adult patients, aged at least 15 years, who had
been admitted to an adult ICU and discharged alive
from the ICU between 1 January 2004 and 31 December
2005 were included in this retrospective cohort analysis.
For patients who were subsequently readmitted to an
ICU during this period, only the time since the end of
the first ICU episode was considered. The regional death
registry for northeast Thailand from 2004 to 2010 was
obtained from the Thai Ministry of Public Health and
linked to the patient data using the national identification
number (ID). We verified the validity of each patient’s ID
number using the checksum digit and cross-checked the
name and date of birth between hospital data and the
regional death registry to validate the data.
Use of these data was approved by ethical committees
from 1) the Faculty of Tropical Medicine, Mahidol
University, 2) Sappasithiprasong Hospital, Ubon Ratchatani,
and 3) the Ministry of Public Health, Thailand [33]. No
patient consent was required as this study was retrospect-
ive and did not use patient identifiable data.
Patients with a recorded date of death during the ICU
admission period were classified as ICU deaths. It is not
uncommon practice in Thailand and other Southeast
Asian countries to discharge moribund patients to die at
home [33]. We, therefore, also classified deaths occur-
ring within two days of ICU discharge as ICU deaths.
Survival time for discharged patients was assessed for
five years after hospital discharge. Patients were assumed
Figure 1 Patient flow from intensive care unit admission to discharge and until five-year follow-up.
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to be alive if no death was recorded within five years of
ICU discharge in the death registry.
Analysis
The primary outcome was survival time after ICU dis-
charge. A Kaplan-Meier survival curve showing the
estimated proportion of post-ICU patients alive at each
time point was plotted over the five-year follow-up
period. To quantify the potential impact of differential
mortality following year five, we fitted an exponential
curve to the annual risk of death from years two to five.
From year eight onwards, the extrapolated post-ICU
mortality differed by less than 1% from that in the gen-
eral population matched for age and sex. Therefore,
mortality from year eight was assumed to be equal to
that in the general Thai population which we took from
standard mortality life tables [34]. In the base case analysis
we assumed that in years six and seven post-discharge the
relative risk of death for former ICU patients compared to
the general population was the same as that observed in
year five (relative risk of 1.35). Since this assumption may
underestimate post-ICU survival, we performed a sensitiv-
ity analysis in which we assumed that mortality rates in
years six and seven post-discharge were the same as those
in the general population matched for age and sex (that is,
a relative risk of one). The life expectancy (LE) amongst
patients discharged from the ICU was taken as the area
under the lifetime survival curve. The LE was calculated
for the overall ICU population and for each age group.
Survival analysis stratified according to major diagnostic
categories for ICU admission from the International Stat-
istical Classification of Diseases, 10th revision (ICD10) [35]
was also performed. The diagnostic groups were: a.)
Cerebrovascular diseases (ICD10 codes: I60 to I69); b.)
Cardiovascular diseases except Cerebrovascular diseases
(ICD10 codes: I00 to I99 except I60 to I69); c.) Digestive
system (ICD10 codes: K00 to K93); d.) Neoplasms (ICD10
codes: C00 to D48); e.) Respiratory system (ICD10 codes:
J00 to J99); and f.) Injury, poisoning and other external
causes (ICD10 codes: S00 to T98). The analysis was
performed using STATA 11 (Stata Corp., College Station,
TX, USA) and Microsoft Excel 2010, (Redmond, WA,
USA).
We also performed a systematic search in order to re-
view the related literature investigating long-term sur-
vival amongst post-ICU patients in low and middle







N = 3,251 N = 7,070
Age (Med [IQR]) 57.6 [42.6, 71.1] 54.5 [38.2, 67.8]
Age group (number of patients)
15 to 29 408 (12.6%) 1,132 (16.1%)
30 to 44 492 (15.1%) 1,298 (18.4%)
45 to 59 879 (27.0%) 1,821 (25.8%)
60 to 74 901 (27.7%) 1,914 (27.1%)
>75 571 (17.6%) 905 (12.8%)
Length of hospital stay 3.0 [1,7] 7.0 [3,12]
(Med [IQR])
Sex (% female) 1,241 (38.2%) 2,700 (38.2%)
ICD10 (Top five, by %)




- Other forms of heart disease
(I30 to I52)
179 615
- Ischemic heart diseases
(I20 to I25)
152 886
- Chronic rheumatic heart diseases
(I05 to I09)
86 441
Injury, poison and other external
causes (S00 to T98)
751 (23.1%) 1,598 (22.6%)
- Injury (S00 to T14) 715 1,490
- Poisoning and certain other
consequences of external causes
(T15 to T98)
36 108
Digestive system (K00 to K93) 328 (10.1%) 789 (11.2%)
- Other diseases of the digestive
system (K90 to K93)
106 125
- Diseases of oesophagus, stomach
and duodenum (K20 to K31)
48 225
- Disorders of gallbladder, biliary
tract and pancreas (K80 to K87)
43 166
Respiratory system (J00 to J99) 248 (7.6%) 376 (5.3%)
- Influenza and pneumonia
(J09 to J18)
145 129
- Chronic lower respiratory diseases
(J40 to J47)
35 82
- Suppurative and necrotic
conditions of lower respiratory
tract (J85 to J86)
10 61




- Neoplasms of uncertain or
unknown behaviour (D37 to D48)
22 128
Table 1 Demographic data for ICU patients (Continued)
- Benign neoplasms (D10 to D36) 4 27
Hospital mortality (%) N/A 139 (2.0%)
Five-year mortality (%) N/A 2,527 (35.7%)
1Includes patients who died within two days of ICU discharge.
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income countries. The search strategy and inclusion cri-
teria are provided in Additional file 1.
Results
There were 11,985 adult patients admitted to an ICU in
Sappasithiprasong Hospital between 2004 and 2005 and
discharged before 1 January 2006. After verifying the
hospital dataset, 1,664 patients (13.9%) were not eligible
for this analysis due to missing data, incomplete or in-
valid ID numbers, or coming from other countries (and
therefore not recorded in the regional mortality records).
As a result, 10,321 patients were included in this
analysis. There were 7,223 patients who were discharged
alive from the ICU; 153 of these died within two days
and were counted as ICU deaths. Of these 61 (39.9%)
died at the hospital and 92 (60.1%) died at home. We
studied five-year survival in the remaining 7,070 patients
who were discharged from the ICU alive (31.5% ICU
fatality rate). Patient-flow is shown in Figure 1. Demo-
graphics and ICD10 codes in the group of patients who
Table 2 Demographic data for post-ICU patients
Post-ICU patients dying within
five years of ICU discharge
Post-ICU patients alive five
years after ICU discharge
N = 2,527 N = 4,543
Age (Med [IQR]) 64.6 [52.6, 74.0] 47.46 [32.6, 62.2]
Age group (number of patients)
15 to 29 127 (5.0%) 1,005 (22.1%)
30 to 44 256 (10.1%) 1,042 (22.9%)
45 to 59 618 (24.5%) 1,203 (26.5%)
60 to 74 949 (37.6%) 965 (21.2%)
>75 577 (22.8%) 328 (7.2%)
Length of hospital stay 8.0 [4,15] 7.0 [3,11]
(Med [IQR])
Sex (% female) 1,041 (41.2%) 1,659 (36.5%)
ICD10 (Top five, by %)
Circulatory system (I00 to I99) 1,023 (40.5%) 1,604 (35.3%)
- Cerebrovascular diseases (I60 to I69) 337 549
- Other forms of heart disease (I30 to I52) 225 390
- Ischemic heart diseases (I20 to I25) 216 188
- Chronic rheumatic heart diseases (I05 to I09) 114 327
Neoplasms (C00 to D48) 324 (12.8%) 164 (3.6%)
- Malignant neoplasms (C00 to C99) 249 82
- Neoplasms of uncertain or unknown behaviour (D37 to D48) 70 58
- Benign neoplasms (D10 to D36) 5 22
Digestive system (K00 to K93) 321 (12.7%) 468 (10.3%)
- Other diseases of the digestive system (K90 to K93) 86 139
- Diseases of oesophagus, stomach and duodenum (K20 to K31) 67 99
- Disorders of gallbladder, biliary tract and pancreas (K80 to K87) 60 65
Injury, poison and other external causes (S00 to T98) 215 (8.5%) 1,383 (30.4%)
- Injury (S00 to T14) 182 1,308
- Poisoning and certain other consequences 33 75
of external causes (T15 to T98)
Respiratory system (J00 to J99) 190 (7.5%) 186 (4.1%)
- Influenza and pneumonia (J09 to J18) 75 54
- Chronic lower respiratory diseases (J40 to J47) 58 46
- Suppurative and necrotic conditions 15 24
of lower respiratory tract (J85 to J86)
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were discharged alive differed slightly from those in pa-
tients who died within the ICU (Table 1). In contrast,
the group of post-ICU patients who died within five
years of discharge tended to be older and much less
likely to have ICD10 codes relating to injury, poison and
other external causes than those who were alive after
five years (Table 2). Of the 7,070 patients who were
discharged alive, 79.3% survived the first year, then
74.0%, 70.3%, 66.9% and 64.2% survived each subsequent
year (Figure 2). Overall, within five years, 2,527 of the
original 7,070 (35.7%) had died. The Kaplan-Meier sur-
vival curve indicated a greatly elevated risk of death in
the first year post-ICU discharge, with 9.5% (241 of
2,527) of all deaths occurring within seven days. Of
these, 67 (27.8%) died at the hospital and 174 (72.2%)
died at home. Of the total 2,527 deaths over five years,
21.4% (540) occurred within the first month, 35.5% (896)
within three months, 46.0% (1,162) within six months,
and 57.9% (1,464) within the first year. Mortality rates
became close to those in the general population between
years two to five after ICU discharge. The annual risks
of death for each year during these periods were 0.21,
0.07, 0.05, 0.05 and 0.04, respectively. In the general
population, the annual risk of death (matched for age
and sex with those discharged alive from the ICU) was
0.03. Overall, half of the post-ICU patients would have
Figure 2 Kaplan-Meier survival estimates for post-ICU patients and survival for the general population in Thailand.
Figure 3 The extrapolated lifetime survival curve of post-ICU patients and survival for the general population.
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been expected to die within 12.1 years of ICU discharge
under base case assumptions. In a sample of the general
population matched for age and sex, half would be
expected to die within 21.2 years (Figure 3). The LE
under base case assumptions and the sensitivity analysis
are presented in Table 3. The overall LE amongst post-
ICU patients was estimated to be 18.3 years while the
LE in the general population (matched for age and sex)
was estimated to be 25.2 years. The sensitivity analysis
yielded estimates of LE 1.6% higher than under the base
case assumption.
Survival categorised by specific diagnostic categories is
presented in Figure 4 and Table 4. The lowest survival
within six months of discharge was seen in patients ad-
mitted with cerebrovascular disease, though at five years
post-discharge the lowest survival (33.6%) was seen in
patients with neoplasms. The highest survival rates were
consistently seen in those admitted due to injury, poi-
soning or other external causes; 86.5% of patients in this
group survived at least five years.
In the systematic search for studies of long-term sur-
vival amongst post-ICU patients in low and middle
income countries, we found only one study evaluating
post-ICU survival across all diagnostic categories [26].
This study followed up 187 post-ICU patients in
Malaysia for two years. It was reported that 97 of 105
post-ICU patients (92.4%) who responded to a question-
naire survived for two years. However, the high loss to
follow-up in this study (43.8%, 82 from 187) makes
interpretation of these findings difficult.
Discussion
This study found that post-ICU patients had a substan-
tially higher mortality rate (and substantially reduced
LE) compared to the general population, with most of
the difference seen in the first year post-discharge. Over-
all, the LE among the post-ICU patients was estimated
to be seven years lower than in the general population
and the number of life years gained from preventing one
ICU death was found to be about two-thirds that from
preventing one death in the general population (matched
for age and sex).
Results from this study are broadly consistent with
those from previous studies conducted elsewhere in
high-income countries [2,13,14,16-18,36-38]. Our esti-
mate that cumulative mortality over the five years was
35.7% (or 2.5 times higher than in an age- and
sex-matched general population) is slightly higher but
comparable with estimates from previous studies which
found that the five years cumulative mortality rate
ranged from 17.9 to 33.5% [2,13,14,16-18,36-38]. Our
estimate of the risk of death in year five, 0.04, is at the
upper end of the range estimated in studies conducted
in high-income countries (0.01 to 0.04) [14,36,37]. The
mortality rates among post-ICU patients in our study
were high in the first 12 months, then decreased rapidly,
and were projected to closely approximate those of the
general population by year eight post-ICU discharge.
Studies conducted in Finland, Norway and Scotland
[13,36,37] also demonstrated substantially greater risk of
death during the first year, but these became similar to
the general population within one to four years. On the
other hand, studies conducted in the United Kingdom
[16] and Australia [38] found that the mortality rate
amongst former ICU patients was higher than the gen-
eral population over a 5-year and 15-year follow-up
period, respectively.
There are several possible reasons for differences in
the time for post-ICU mortality rates to approach those
in the general population. Firstly, there was considerable
variation between the studies in the frequency of differ-
ent diagnostic categories. Our study had a relatively high
proportion of patients with ICD10 codes relating to in-
jury, poisoning and other external causes (23% compared
Table 3 Life expectancy among post-ICU patients





†Base case *Sensitivity analysis ◊General population
15 to 29 43.16 43.80 48.97
30 to 44 28.87 29.56 36.01
45 to 59 16.41 16.98 24.03
60 to 74 8.72 8.96 13.66
≥75 4.75 4.61 6.36
Overall 18.26 18.56 25.15
†Base case analysis: we assumed that from year five to year seven post-discharge
the relative risk of mortality amongst post-ICU patients was the same as that in
year five. From year eight onwards, the relative risk was assumed to be 1.
*Sensitivity analysis: we assumed the mortality rates among the post-ICU
patients after five years post-discharge to be the same as those in the general
population matched for age and sex.
◊General population: we applied the mortality rate of the Thai general
population age- and sex-matched to all post-ICU patients since ICU discharge.
Figure 4 Kaplan-Meier survival estimates for post-ICU patients
stratified by diagnostic group.
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to a range of 7 to 15% in other studies) [18,36-38]. Con-
versely, there was a low proportion of patients with
ICD10 codes relating to the respiratory system (5% com-
pared with a range of 8 to 36%) [13,36,37]. Figure 4 sug-
gests that these differences are likely to be associated
with both a shorter period for post-ICU mortality to ap-
proach that in the general population and a relatively
high five-year post-ICU survival rate.
Quality of care in different settings [39,40] is another
possible factor that could impact on long-term survival
rates. Higher quality of care should reduce ICU mortal-
ity, but could potentially either increase or decrease the
long-term survival in patients discharged alive from
ICU. The latter could occur if higher quality of care pre-
vents ICU deaths in patients with poor long-term prog-
nosis (where some of these patients would have died in
the ICU if in lower quality of care settings). Quantifying
such competing effects is challenging, but important for
evaluating the cost-effectiveness of interventions to
improve quality of ICU care in low and middle income
countries.
Currently, however, there are few studies of long-term
survival following ICU stays in lower and middle income
countries. While the systematic search identified a
small number of studies evaluating long-term survival
following ICU discharge in specific diagnostic categor-
ies (liver transplants, myocardial infarction, metastatic
solid cancer, chronic obstructive pulmonary disease)
[41-45], long-term follow-up of representative ICU cohorts
was lacking.
Our analysis accounted for the common practice in
Southeast Asia of discharging moribund patients to die
at home by classifying deaths occurring within two days
of discharge as ICU deaths. The two-day cut-off was
chosen because post-ICU mortality showed a clear spike
on day two post-discharge (with 116 deaths, or 1.12% of
total ICU patients) but showed a gradual decline from
day three (48 (0.47%), 46 (0.45%), 36 (0.35%), 28 (0.27%)
and 29 (0.28%) for days three to seven, respectively).
This resulted in only slightly higher ICU mortality than
would have been obtained had we only considered deaths
occurring during the admission (31.5% versus 30.0% mor-
tality, or 153 more deaths), and consequently, slightly lower
cumulative five-year mortality amongst the non-ICU deaths
(37.1% versus 35.7%).
The mortality rates during years six and seven post-ICU
discharge are likely to be somewhat lower than assumed
in the base case (which assumed the same relative risk for
death as in year five), but somewhat higher than assumed
in the sensitivity analysis (which assumed a relative risk of
one). However, these two assumptions yielded estimates
of LE that differed by less than 2% (Table 3) indicating that
improved estimates of mortality in years six and seven
would have negligible impact on the results.
Interestingly, among individuals over 75 years of age,
the mortality rate was higher in the post-ICU group than
Table 4 Comparison of survival 1-5 years after ICU discharged by age and diagnostic group
Time of follow-up At ICU
discharge
1 year 2 year 3 year 4 year 5 year
Number of patients at each follow up time 7,070 5,606 5,236 4,972 4,730 4,543
Age (median, [IQR]) 54.5 [38.2, 67.8] 51.4 [35.2, 65.6] 50.5 [34.2, 64.8] 49.5 [33.8, 63.8] 48.5 [33.0, 63.0] 47.5 [32.6, 62.2]
Length of hospital stay 7.0 [3,12] 7.0 [3,11] 7.0 [3,11] 7.0 [3,11] 7.0 [3,11] 7.0 [3,11]
Sex (% female) 38.2% 37.6% 37.3% 37.2% 36.7% 36.5%
Age group
15 to 29 100.0% 93.0% 91.8% 90.7% 89.8% 88.8%
30 to 44 100.0% 88.4% 85.1% 83.1% 81.8% 80.3%
45 to 59 100.0% 80.2% 75.0% 71.4% 68.4% 66.1%
60 to 74 100.0% 70.7% 64.5% 58.9% 53.7% 50.4%
≥75 100.0% 65.4% 54.6% 48.5% 41.9% 36.2%
Diagnostic group
Heart diseases, other forms (I00 to I99
except I60 to I69)
100.0% 83.0% 76.9% 72.0% 67.9% 63.7%
Cerebrovascular diseases (I60 to I69) 100.0% 62.1% 55.9% 52.5% 49.3% 46.5%
Injury, poison and other external causes
(S00 to T98)
100.0% 92.6% 90.9% 89.3% 87.4% 86.5%
Digestive system (K00 to K93) 100.0% 78.2% 71.9% 67.7% 62.9% 59.3%
Respiratory system (J00 to J99) 100.0% 69.1% 62.0% 57.2% 52.9% 43.6%
Neoplasms (C00 to D48) 100.0% 51.4% 42.4% 38.1% 35.5% 33.6%
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in the general population in the first two years, but
lower in the following years, resulting in a slightly longer
LE than the general population. This might be explained
by the possibility that these patients are on average
healthier than the general population, having survived
their ICU admission.
Limitations
This study has several limitations. Data from a single re-
gional hospital may not be representative of the national
population due to differences in patient characteristics
and quality of hospital care. However, similar regional
hospitals provide care to most of the population in
Thailand and the large population (n >7,000) and long-
term follow-up strengthen our findings. Nonetheless,
had resources permitted, this study could have been
improved (and its external validity strengthened) by
collecting data from multiple sites across Thailand. A
second limitation is that this study was based on retro-
spective data, which were inevitably incomplete. More-
over, as the regional death registry was used (not
national data), it is possible that we have missed some
deaths in patients who moved and died outside of the
northeast region. Our analysis might, therefore, under-
estimate mortality. However, any such bias is likely to be
small as the five-year migration rate amongst the north-
east Thai population was estimated to be 3.1% in 2000
[46]. This rate is likely to be even lower in older age
groups where most of the mortality occurs. Another
limitation is the lack of a standardised measure of severity
of illness. A standard severity score (such as Acute
Physiology and Chronic Health Evaluation (APACHE)
II) would have helped to inform comparisons of our
findings with those from other studies, but such data
are not routinely collected in ICUs in Thailand. Finally,
this study would have been improved by the addition
of Health Related Quality of Life (HRQOL) data to es-
timate the quality adjusted life expectancy (QALE)
amongst the post-ICU patients. Ideally, such HRQOL
information would be obtained from a long-term cohort
study in the local population; resources for this were
not available to us. Given the range of the HRQOL between
0.56 and 0.88 as shown in the literature [13,14,16,19]
(all from high-income countries) the expected QALE
of post-ICU patients would range from 10.2 to 16.1
QALYs. Prospective collection of such quality of life
data is an important area for future health economic
research in developing countries.
Conclusions
This study represents one of the first attempts to esti-
mate long-term post-ICU survival in a developing coun-
try context. Post-ICU patients had higher mortality than
members of the general population (matched for age
and sex) over the five-year follow-up period. The esti-
mated LE is useful for economic evaluations and should
support decision-makers considering potential invest-
ments in interventions that could prevent unnecessary
deaths during ICU or hospital admissions.
Key messages
! Five-year mortality amongst post-ICU patients in
Thailand was estimated to be 35.7%. This is about
2.5 times higher than that in the general population
(age and sex matched).
! The risk of death was greatly elevated in the first
year after ICU discharge and approached that in the
general population in subsequent years.
! The extrapolated lifetime survival indicated that
post-ICU patients had 27.4% lower life expectancy
than the general population (age and sex matched).
! Patients admitted to the ICU as a result of injury,
poisoning or other external causes had the lowest
mortality rate over the five-year follow-up; patients
with neoplasms had the highest.
! Estimates of the number of life years gained from
interventions preventing ICU deaths will aid
policy-makers considering potential investments
in this area.
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